etoposide has been researched along with Brain Neoplasms in 588 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 44 (7.48) | 18.7374 |
| 1990's | 193 (32.82) | 18.2507 |
| 2000's | 175 (29.76) | 29.6817 |
| 2010's | 150 (25.51) | 24.3611 |
| 2020's | 26 (4.42) | 2.80 |
| Authors | Studies |
|---|---|
| Barrows, LR; Ireland, CM; Kokoshka, JM | 1 |
| Béliveau, R; Castaigne, JP; Ché, C; Currie, JC; Demeule, M; Lacoste, MC; Régina, A; Thiot, C; Yang, G | 1 |
| Bartels, U; Bhatia, A; Boyett, JM; Dhall, G; Embry, L; Fangusaro, J; Fouladi, M; Gajjar, A; Khatua, S; Leary, S; MacDonald, S; Murphy, ES; Onar-Thomas, A; Patel, SK; Shaw, D; Souweidane, M; Trask, CL; Wu, S | 1 |
| Dunkel, IJ; Ellison, DW; Ermoian, R; Fouladi, M; Geyer, JR; Goldman, S; Hadley, J; Huang, J; Kilburn, L; Kocak, M; Leary, SES; MacDonald, TJ; Northcott, PA; Olson, JM; Onar-Thomas, A; Phillips, P; Smith, KS; Young Poussaint, T | 1 |
| Chen, J; Gao, X; Hou, X; Huang, H; Li, S; Shi, Q; Zhao, Y | 1 |
| Chen, K; Deng, K; Duan, L; Lian, X; Mao, X; Wang, L; Yao, Y; You, H; Zhang, W; Zhu, H | 1 |
| An, J; Cao, L; Chen, C; Deng, P; Gu, Q; He, B; Hu, C; Jiang, J; Li, M; Qin, L; Yang, H | 1 |
| Das, SK; Panthi, RC; Shahi, A | 1 |
| Abu-Gharbieh, E; Abuhelwa, AY; Ahmed, M; Alqudah, MAY; Alsoud, LO; Alzoubi, KH; Bustanji, Y; El-Awady, R; El-Huneidi, W; Ramadan, WS; Semreen, AM; Semreen, MH; Shara, M; Soares, NC | 1 |
| Fatkhudinov, T; Gordon, K; Gulidov, I; Koryakin, S | 1 |
| Akimov, M; Boiko, S; Dudina, P; Ermolenko, Y; Gelperina, S; Kovshova, T; Malinovskaya, J; Mantrov, S; Merkulova, M; Moiseeva, N; Osipova, N; Senchikhin, I | 1 |
| Batur, A; Isik Bedir, S; Karabagli, H; Karabagli, P; Koksal, Y; Ozturk, M; Yavas, G | 1 |
| Jiang, XX; Lai, JL; Lei, KJ; Li, A; Li, B; Li, XK; Liu, J; Liu, SP; Ye, XJ; Zhou, L | 1 |
| Adler, S; Aljumaily, R; Antal, JM; Beck, JT; Boccia, RV; Bulat, I; Chiu, VK; Csoszi, T; Domine Gomez, M; Dragnev, KH; Hamm, JT; Hanna, W; Hart, LL; Hoyer, RJ; Hussein, MA; Lai, AY; Lowczak, A; Maglakelidze, M; Malik, RK; Morris, SR; Nikolinakos, P; Owonikoko, TK; Richards, DA; Roberts, PJ; Rocha Lima, CM; Sawrycki, P; Schuster, SR; Sorrentino, JA; Weiss, JM; Yang, Z | 1 |
| Gulbas, I; Kopa, P; Macieja, A; Pastwa, E; Poplawski, T | 1 |
| Cappellano, AM; Chen, MJ; de Carvalho, ÍT; de Rezende, ACP; Hamerschlak, N; Helito, JK; Sakuraba, RK; Silva, NS; Weltman, E | 1 |
| Cash, T; Goldsmith, KC; Katzenstein, HM; Kean, L; MacDonald, TJ; Qayed, M; Suessmuth, Y; Tanos, R; Tighiouart, M; Watkins, B; Wetmore, C | 1 |
| Aftandilians, T; Dombrovsky, I; Stowe, RJ; Tilden, HR; Wong, S | 1 |
| Gao, W; Liu, Z; Lockman, PR; Mohammad, A; Pinti, MV; Saralkar, PA; Shah, N; Sprowls, SA; Tallman, RM; Vickers, SD | 1 |
| Almutereen, M; Elborai, Y; Hafez, H; Lee, MA; Lehmann, L; Maher, OM | 1 |
| Cho, HW; Ju, HY; Kim, JH; Koo, HH; Lee, JW; Lim, DH; Shin, HJ; Suh, YL; Sung, KW; Yoo, KH | 1 |
| Ahmed, A; Awah, CU; Balyasnikova, IV; Bansal, M; Burdett, KB; Chen, L; Feldstein, E; Gonzalez-Buendia, E; Győrffy, B; Hsu, P; Konerman, S; Lad, M; Mahajan, A; Martuscello, R; Park, C; Scholtens, DM; Sonabend, AM; Stupp, R; Warnke, L; Winter, J; Yu, D; Zannikou, M; Zhang, D | 1 |
| Dang, TT; Morales, JC | 1 |
| Kuhn, AK; Rubin, MF | 1 |
| Clarke, PA; Fay, M; Lovato, T; Marlow, M; McCrorie, P; Mistry, J; Rahman, R; Ritchie, AA; Smith, SJ; Taresco, V; Ward, I | 1 |
| Cho, H; Koo, HH; Lee, JW; Lim, DH; Ma, Y; Shin, HJ; Suh, YL; Sung, KW; Yoo, KH | 1 |
| Bruce, JN; Canoll, PD; Englander, ZK; Feldstein, NA; Guo, J; Jan, CI; Konofagou, EE; Mela, A; Pouliopoulos, AN; Upadhyayula, PS; Wang, TJC; Wei, HJ; Wu, CC; Zacharoulis, S; Zhang, X; Zhang, Z | 1 |
| Bison, B; Friedrich, C; Gerber, NU; Gessi, M; Haberler, C; Juhnke, BO; Kool, M; Kortmann, RD; Kwiecien, R; Mynarek, M; Pfister, SM; Pietsch, T; Rutkowski, S; Schüller, U; Spix, C; Timmermann, B; von Bueren, AO; von Hoff, K; Warmuth-Metz, M | 1 |
| Ai, L; Cao, Y; Li, K; Shen, C; Sun, D; Wu, H | 1 |
| Beberok, A; Maszczyk, M; Rok, J; Rzepka, Z; Wrześniok, D | 1 |
| Kamdar, M; Major, A; Pan, Z | 1 |
| Clark, C; Gaze, MN; Mankad, K; Michalski, A; Seunarine, K; Szychot, E; Thust, S | 1 |
| Dean, RK; Gill, D; Nat, A; Subedi, R | 1 |
| Aiba, S; Terui, H; Yamasaki, K; Yoshida, S | 1 |
| DeLuca, JG; Herman, JA; Lee, E; Paddison, P; Pain, M; Toledo, CM; Wang, H; Yong, RL; Zhu, J | 1 |
| Bison, B; Bojko, S; Gielen, GH; Hoffmann, M; Kortmann, RD; Kramm, CM; Pietsch, T; Seidel, C; von Bueren, AO; Warmuth-Metz, M | 1 |
| Alapetite, C; Calaminus, G; Frappaz, D; Garre, ML; Göbel, U; Kortmann, RD; Krefeld, B; Mann, JR; Murray, MJ; Nicholson, JC; Pietsch, T; Ricardi, U; Saran, F; Vasiljevic, A | 1 |
| Brennum, J; Hamerlik, P; Jensen, KE; Michaelsen, SR; Pedersen, H; Poulsen, HS; Rasmussen, RD; Skjoth-Rasmussen, J; Staberg, M; Villingshøj, M; Vitting-Seerup, K | 1 |
| Ahmed, EM; Bandopadhyay, G; Coyle, B; Grabowska, A | 1 |
| Babincová, M; Babinec, P; Durdík, Š; Sourivong, P; Vrbovská, H | 1 |
| Fu, C; Huang, R; Liang, Y; Ren, Z; Xie, M; Yu, L; Zhang, Z; Zhu, F | 1 |
| He, X; Liang, P; Liu, Q; Liu, Z; Qian, Y; Wang, S; Wang, Z; Wu, B; Wu, H; Xu, Z; Zhu, R | 1 |
| Damiani, E; Doyle, AP; Solorio, JA; Wallace, HM | 1 |
| Bettler, B; Gassmann, M; Tchorz, J; Tomé, M | 1 |
| Galita, G; Kopa, P; Macieja, A; Majsterek, I; Pastwa, E; Poplawski, T | 1 |
| Fillmore, HL; Loveson, KF; Mather, RL | 1 |
| Cheon, JE; Choi, JY; Choi, YH; Hong, CR; Hong, KT; Kang, HJ; Kim, IH; Kim, SK; Lee, YJ; Park, JD; Park, KD; Park, SH; Phi, JH; Shin, HY; Wang, KC | 1 |
| Alapetite, C; Calaminus, G; Frappaz, D; Garrè, ML; Kortmann, R; Nicholson, JC; Patte, C; Ricardi, U; Saran, F; Worch, J | 1 |
| Allen, J; Atlas, M; Dhall, G; Finlay, J; Gardner, S; Garvin, J; Haley, K; Ji, L; Judkins, A; Kennedy, G; Lasky, J; Moertel, C; Moore, T; Olshefski, R; Rassekh, SR; Shore, R; Sposto, R; Tekautz, T; Venkatramani, R; Zhou, S | 1 |
| Abujamra, AL; Brunetto, AL; de Farias, CB; Lenz, G; Nör, C; Roesler, R; Sassi, FA; Schwartsmann, G | 1 |
| Bauer, D; Biassoni, V; Casanova, M; Catania, S; De Pava, MV; Gandola, L; Indini, A; Massimino, M; Modena, P; Pecori, E; Podda, M; Polastri, D; Rampini, P; Schiavello, E | 1 |
| Attinà, G; Bertolini, P; Colosimo, C; Lazzareschi, I; Mastrangelo, S; Maurizi, P; Migliorati, R; Riccardi, R; Ridola, V; Rizzo, D; Ruggiero, A | 1 |
| Ahn, HS; Kang, HJ; Kim, H; Lee, JW; Park, JD; Park, KD; Shin, HY | 1 |
| Ganti, AK; West, WW; Zhen, W | 1 |
| Antonelli, M; Biassoni, V; Gandola, L; Giangaspero, F; Massimino, M; Modena, P; Pecori, E; Poggi, G; Schiavello, E; Spreafico, F; Vajna De Pava, M | 1 |
| Leonard, A; Wolff, JE | 1 |
| Biasoli, D; Borges, HL; Campanati, L; Chneiweiss, H; Cornélio, TA; Furtado, M; Kahn, SA; Moura-Neto, V | 1 |
| Arakawa, Y; Fujimoto, K; Kikuchi, T; Kunieda, T; Miyamoto, S; Mizowaki, T; Murata, D; Takagi, Y; Takahashi, JC | 1 |
| Clarke, PA; Grundy, RG; Langmack, KA; Macarthur, DC; Morgan, PS; Rahman, CV; Ritchie, AA; Rose, FR; Shakesheff, KM; Smith, SJ | 1 |
| Fukuoka, K; Matsutani, M; Nishikawa, R; Sasaki, A; Suzuki, T; Wakiya, K; Yanagisawa, T | 1 |
| Afaq, A; Bomanji, J; Panagiotidis, E; Shankar, A | 1 |
| Garami, M; Hauser, P; Pócza, T; Schuler, D; Vancsó, I | 1 |
| Fukuoka, M; Horai, T; Katakami, N; Nakagawa, K; Ohmatsu, H; Okamoto, H; Saijo, N; Sekine, I; Shibuya, M; Yokoyama, A | 1 |
| Couez, D; Delneste, Y; Donnou, S; Fremaux, I; Jarry, U; Jeannin, P; Pineau, L; Vincent, M | 1 |
| Joung, YS; Kim, JH; Koo, HH; Lee, NH; Lee, SH; Lim, DH; Shin, HJ; Suh, YL; Sung, KW; Yoo, KH | 1 |
| Bozinov, O; Branscheidt, M; Frontzek, K; Rushing, EJ; Valavanis, A; Wegener, S; Weller, M | 1 |
| Amendolara, B; Bansal, M; Bruce, JN; Califano, A; Canoll, P; Carminucci, AS; Karan, C; Lei, L; Leung, R; Li, H; O, J; Realubit, R; Rothcock, R; Showers, C; Sonabend, AM; Yun, J | 1 |
| Chen, GY; Kuo, CH; Liao, HW; Lin, CH; Lu, YS; Tsai, IL | 1 |
| Choi, YB; Koo, HH; Lee, NH; Lee, SH; Lim, DH; Shin, HJ; Son, MH; Sung, KW; Yoo, KH | 1 |
| Ak, G; Akcay, M; Bayman, E; Etiz, D | 1 |
| Fan, YN; Meley, D; Pizer, B; Sée, V | 1 |
| Ausserlechner, MJ; Geiger, K; Hagenbuchner, J; Hermann, M; Kiechl-Kohlendorfer, U; Kofler, R; Obexer, P; Rainer, J; Salcher, S; Seiter, MA | 1 |
| Ausch, C; Bajna, E; Brenner, S; Buxhofer-Ausch, V; Hamilton, G; Jäger, W; Klameth, L; Reiner, A; Riha, J; Schölm, M; Thalhammer, T | 1 |
| Ahmad, S; Ahmed, M; Al-Badawi, IA; Al-Hashem, H; Al-Hayli, S; Al-Husaini, H; Darwish, A; Edesa, W; Elghamry, W; Elhassan, T; Eltigani, A; Madkhali, I; Omar, A; Soudy, H | 1 |
| Ando, R; Etani, T; Iida, K; Kawai, N; Kohri, K; Naiki, T; Tozawa, K | 1 |
| Azendorf, R; Eichler, M; Jahnke, HG; Krinke, D; Müller, A; Robitzki, AA; Schmidt, S | 1 |
| Huang, S; Nie, X; Wu, L; Xu, H; Yi, W; Zhu, X | 1 |
| Al-Dandan, S; Alharbi, M; Alharbi, Q; Alharbi, T; Aljamaan, K; Alomari, A; Alsudairy, R; Alsultan, A; Bayoumi, Y; Jarrar, M; Musleh, O | 1 |
| Chen, YC; Kuo, YC | 1 |
| Alexander, C; Ashford, MB; Garnett, MC; Gellert, PR; Ivanov, DP; Parker, TL; Walker, DA | 1 |
| Carrasco, R; Cruz, O; de Torres, C; Guillen, A; Lavarino, C; Mañé, S; Mora, J; Parareda, A; Rios, J; Salvador, H; Suñol, M; Vancells, M | 1 |
| Kelpanides, I; Savage, P; Seckl, MJ; Short, D; Tuthill, M | 1 |
| Brown, RJ; Dhall, G; Finlay, JL; Gardner, SL; Ginn, KF; Khatua, S; Yankelevich, M; Yildiz, VO; Zaky, W | 1 |
| Chao, TC; Chen, BB; Chen, TW; Cheng, AL; Huang, CS; Huang, SM; Lin, CH; Lu, YS; Rau, KM; Shih, TT; Tseng, LM; Wu, PF; Yeh, DC | 1 |
| Adachi, J; Fujimaki, T; Fukuoka, K; Matsutani, M; Mishima, K; Nishikawa, R; Shirahata, M; Suzuki, T; Yanagisawa, T | 1 |
| Iwafuchi, H; Iwama, J; Kiyotani, C; Matsuoka, K; Morota, N; Ogiwara, H; Terashima, K | 1 |
| Chang, FC; Chang, KP; Chen, HH; Chen, YW; Guo, WY; Ho, DM; Hu, YW; Lai, IC; Lee, YY; Liang, ML; Shiau, CY; Wong, TT; Yen, SH | 1 |
| Elhag, R; Mazzio, EA; Soliman, KF | 1 |
| Busse, PM; Ebb, DH; Friedmann, AM; Ladra, MM; Lucas, JT; MacDonald, SM; Marcus, KJ; Tarbell, NJ; Yock, TI | 1 |
| Feng, F; Ren, T; Wan, X; Xiang, Y; Xiao, C; Yang, J; Zhao, J | 1 |
| Chen, X; Song, Z; Tang, Y; Yu, X; Zhou, D; Zhou, L | 1 |
| Cohen, BH; Curran, JG; Dunkel, IJ; Finlay, JL; Gajjar, A; Geyer, JR; Hilden, J; Holmes, E; Ingles, SA; Miller, DC; Packer, RJ; Pollack, IF; Zhou, T | 1 |
| Allen, JC; Bouffet, E; Buxton, AB; Chuba, PJ; Donahue, B; Fisher, PG; Goldman, S; Kretschmar, CS; Pollack, IF; Robertson, PL; Zhou, T | 1 |
| Hoffmann, L; Khalil, AA; Knap, MM; Moeller, DS; Winther-Larsen, A | 1 |
| Kawaguchi, H; Kobayashi, M; Kurisu, K; Nosaka, R; Sugiyama, K; Takayasu, T; Yamasaki, F | 1 |
| Al-Nedawi, K; Garnier, D; Guha, A; Lee, TH; Lee, WJ; Meehan, B; Montermini, L; Rak, J | 1 |
| Bolze, PA; Golfier, F; Hajri, T; Lotz, JP; Massardier, J; Riedl, C; Schott, AM; You, B | 1 |
| Nosaki, K; Seto, T | 1 |
| Eisele, G; Roth, P; Tonder, M; Weller, M | 1 |
| Heppner, P; Joret, MO; Scotter, J; Starke, RM | 1 |
| Bartels, U; Bouffet, E; Hader, W; Hawkins, C; Lafay-Cousin, L; Laperriere, N; Laughlin, S; Lindzon, G; Nordal, R; Taylor, MD | 1 |
| Elborai, Y; Elhaddad, A; Hafez, H; Hammad, M; Hussein, H; Lehmann, L; Moussa, EA | 1 |
| Gilligan, T | 1 |
| Kuo, YC; Wang, IH | 1 |
| Kuo, YC; Lee, CH | 1 |
| Kondo, Y; Nakagawa, N; Nakao, S; Yamashita, T; Yamazaki, H | 1 |
| Sablauer, A; Shirinifard, A; Thiagarajan, S; Vogel, P | 1 |
| Kitahara, T; Shirase, T; Takeichi, Y; Tsuji, Y; Yamazoe, N; Yukawa, H | 1 |
| Benesch, M; Bode, U; Fleischhack, G; Gnekow, A; Mikasch, R; Pajtler, KW; Pietsch, T; Reichling, S; Rutkowski, S; Siegler, N; Tippelt, S; Zimmermann, M | 1 |
| Fukuda, T; Hashiguchi, Y; Ichimura, T; Kasai, M; Kuno, I; Matsumoto, Y; Sumi, T; Yasui, T | 1 |
| Antonelli, M; Balter, R; Barra, S; Bertin, D; Bertolini, P; Biassoni, V; Boschetti, L; Buccoliero, A; Buttarelli, FR; Calareso, G; Cama, A; Cinalli, G; Diletto, B; Ferroli, P; Gandola, L; Garrè, ML; Genitori, L; Giangaspero, F; Giombelli, E; Giussani, C; La Spina, M; Marras, CE; Mascarin, M; Massimino, M; Mastronuzzi, A; Miceli, R; Modena, P; Mussano, A; Pecori, E; Peretta, P; Pollo, B; Quaglietta, L; Sardi, I; Scarzello, G; Schiavello, E; Scoccianti, S; Valentini, L; Viscardi, E | 1 |
| Chen, BB; Chen, WW; Cheng, AL; Hsu, CY; Lin, CH; Lu, YS; Shih, TT; Wei, SY; Wu, PF; Yu, CW | 1 |
| Ju, Y; Liang, G; You, C; Zhang, S | 1 |
| Adra, N; Albany, C; Einhorn, LH; Giannatempo, P; Hanna, NH; Necchi, A; Nicolai, N; Pond, GR; Raggi, D; Salvioni, R | 1 |
| Amini, M; Belderbos, JSA; Biesma, B; Bootsma, GP; Brouns, -JWM; Bussink, J; De Ruysscher, DKM; Dingemans, AC; Hendriks, LEL; Oei, SB; Stigt, JA; Uyterlinde, W; Van den Heuvel, MM; Wijsman, R | 1 |
| Ikegami, M; Matsutani, M; Mukasa, A; Nakao, Y; Saito, K; Saito, N; Shibahara, J; Takai, K; Takeshita, K; Tanaka, S; Yanagisawa, S | 1 |
| Pagliaro, LC | 1 |
| Koo, HH; Lee, HJ; Lee, JW; Lim, DH; Shin, HJ; Suh, YL; Sung, KW; Yi, ES; Yoo, KH | 1 |
| Ceylan, S; Gokturk, D; Kelebek, H; Yilmaz, DM | 1 |
| Mufazalov, FF; Sakaeva, DD; Shtefan, AIu | 1 |
| Mashiko, R; Matsumura, A; Osuka, S; Takano, S | 1 |
| Aoyama, H; Fujieda, K; Ikeda, J; Ishii, N; Iwasaki, Y; Kashiwamura, M; Sawamura, Y; Shirato, H; Taguchi, H; Yasuda, K | 1 |
| Amoroso, L; Benhamou, E; Cacchione, A; Couanet, DV; Hartmann, O; LeMaitre, A; Simonnard, N | 1 |
| Behnamfar, F; Behtash, N; Hamedi, B; Ramezanzadeh, F | 1 |
| Cho, SG; Choi, HY; Choi, TW; Jeong, HS; Kim, BW; Kim, JH; Lee, ER | 1 |
| Doglioni, C; Ghimenton, C; Iuzzolino, P; Moretto, G; Musso, AM; Passarin, MG; Pedersini, R; Romito, S; Vattemi, E | 1 |
| Boyett, JM; Dhall, G; Dunkel, IJ; Finlay, JL; Gardner, SL; Goldman, S; Packer, RJ; Pollack, IF; Rosenblum, MK; Stanley, P; Wallace, D; Yates, AJ; Zimmerman, RA | 1 |
| Chen, L; Cheng, J; Feng, P; Li, S; Long, D; Lu, Y; Zhou, D | 1 |
| Chamberlain, MC; Glantz, MJ | 1 |
| Aguilar-Ponce, JL; Chilaca-Rosas, F; Cruz-López, JC; Martínez-Cedillo, J; Molina-Calzada, C; Vidal-Millán, S | 1 |
| Boldrini, R; Cozza, R; De Ioris, MA; De Sio, L; Donfrancesco, A; Fidani, P; Garrè, ML; Ilari, I; Milano, GM; Serra, A | 1 |
| Hann, CL; Rudin, CM | 1 |
| Allen, J; Chan, KW; Donahue, B; Holmes, E; Jakacki, R; Mehta, M; Miller, DC; Muraszko, K; Prados, M; Puccetti, D; Robertson, P; Rorke, LB; Sposto, R; Vezina, G | 1 |
| Fukushima, T; Inoue, T; Komatsu, F; Ohmura, T; Ohta, M; Oshiro, S; Sakamoto, S; Tsugu, H | 1 |
| Abe, H; Fukushima, T; Komatsu, F; Matsumoto, S; Nabeshima, K; Nomura, Y; Oshiro, S; Takano, K; Tsugu, H; Utsunomiya, H; Yanai, F | 1 |
| Dinney, CP; Grossman, HB; Kamat, AM; Millikan, RE; Qiao, W; Siefker-Radtke, AO; Thall, PF; Williams, DL | 1 |
| André, N; De Paula, AM; Gentet, JC; Padovani, L; Pasquier, E; Rome, A; Scavarda, D | 1 |
| Aoki, T; Matsutani, M; Miyatake, S; Mizutani, T; Nojima, K; Nozaki, K; Okumura, R; Takagi, T; Takahashi, JA; Taki, W; Ueba, T; Yuba, Y | 1 |
| Athale, UH; Barr, R; Duckworth, J; Odame, I | 1 |
| Brentrup, A; Frühwald, MC; Hasselblatt, M; Holling, M; Jeibmann, A; Niederstadt, T; Paulus, W; Pfister, S; Sträter, R | 1 |
| Abramson, DH; Chantada, GL; Dunkel, IJ; Finlay, JL; Goldman, S; Gururangan, S; Jubran, RF; Khakoo, Y; O'Brien, JM; Orjuela, M; Rodriguez-Galindo, C; Souweidane, MM | 1 |
| Bigner, DD; Desjardins, A; Friedman, AH; Friedman, HS; Gururangan, S; Herndon, JE; Marcello, JE; McLendon, RE; Norfleet, J; Reardon, DA; Sampson, JH; Sathornsumetee, S; Vredenburgh, JJ | 1 |
| Manapov, F | 1 |
| Brown, PD; Buckner, JC; Jensen, AW; Laack, NN; Schomberg, PJ; Wetmore, CJ | 1 |
| Cappellano, AM; Cavalheiro, S; da Silva, NS; Diez, B; Finlay, J; Gardner, S; Garvin, J; Kellie, S; Parker, R; Wisoff, J | 1 |
| Biassoni, V; Casanova, M; Catania, S; Clerici, CA; Gandola, L; Genitori, L; Giangaspero, F; Massimino, M; Meazza, C; Modena, P; Poggi, G; Potepan, P; Riva, D; Sardi, I; Simonetti, F; Solero, C; Spreafico, F | 1 |
| He, Q; Wang, D; Yang, B; Zhang, L; Zhang, X; Zhu, Q | 1 |
| Dhall, G; Fan, J; Finlay, JL; Gilles, F; Gonzalez, I; Jubran, R; Khatua, S; Krieger, M; Lavey, R; Marachelian, A; McComb, G; Nastia, A; Nelson, M; O'Neil, S; Olch, AJ; Panigrahy, A; Sposto, R; Villablanca, JG | 1 |
| Feng, J; Guo, YJ; Jiang, XB; Jin, F; Shao, T; Wang, HT; Wei, YJ; Zhang, H; Zhang, SL; Zhao, HY; Zhao, L; Zhao, WJ | 1 |
| Abdelouafi, A; Benchakroun, N; Benider, A; Benkirane, A; Elbenna, N; Kadiri Fatmi, ME; Lakhrib, N; Mansouri, I; Mharech, A; Roubal, M; Tawfiq, N; Zamiati, S | 1 |
| Bartels, U; Bouffet, E; Finkelstein-Shechter, T; Gassas, A; Hawkins, C; Huang, A; Janzen, L; Laura, J; Mabbott, D; Tabori, U; Taylor, M | 1 |
| Fijuth, J; Jesien-Lewandowicz, E; Kordek, R; Spych, M | 1 |
| Dupre, S; Francesconi, AB; Hughes, BG; Lickliter, JD; Martin, D; Matos, M; Wyld, DK | 1 |
| Akaza, H; Fukuhara, Y; Joraku, A; Kandori, S; Kawai, K; Miyanaga, N; Shimazui, T | 1 |
| Le Péchoux, C; Paumier, A | 1 |
| Estlin, EJ; Moulin, CJ; Pauly-Takacs, K | 1 |
| Alapetite, C; Baranzelli, MC; Ben-Hassel, M; Bernier, V; Bouffet, E; Brisse, H; Carrie, C; Cuilliere, JC; Frappaz, D; Gaboriaud, G; Habrand, JL; Patte, C; Raquin, MA; Thiesse, P | 1 |
| Desjardins, A; Friedman, AH; Friedman, HS; Gururangan, S; Herndon, JE; Marcello, J; McLendon, R; Peters, K; Reardon, DA; Rich, JN; Sampson, J; Threatt, S; Vredenburgh, JJ | 1 |
| Berrak, SG; Liu, DD; Wolff, JE; Wrede, B | 1 |
| Bandopadhyay, G; Bowman, KJ; Braker, P; Coyle, B; Grundy, RG; Heath, R; Hussein, D; Jones, GD; Kerr, ID; Kumari, R; Lowe, J; Miller, S; Othman, R; Ottoman, R; Peet, A; Punjaruk, W; Rahman, R; Shaw, L; Storer, LC; Watson, S | 1 |
| Kanamori, M; Kumabe, T; Saito, R; Sonoda, Y; Tominaga, T; Yamashita, Y | 1 |
| Narita, Y; Ohno, M | 1 |
| Abdelbar, O; Asmae, N; Fouad, E; Hassane, S; Houcine, C; Karim, R; Said, I | 1 |
| Kumabe, T; Niizuma, H; Osawa, S; Saito, R; Sonoda, Y; Tominaga, T; Watanabe, M | 1 |
| Ferreti Bonan, PR; Martelli-Júnior, H; Miranda Soares, PB; Pereira DE Souza, W; Quirino Filho, S | 1 |
| Ashley, DM; Bandopadhayay, P; Cohn, RJ; Downie, PA; Hassall, TE; Kirby, ML; Rosenfeld, JV; Sullivan, MJ; Wheeler, GC | 1 |
| Lima, BR; Rychwalski, PJ; Schoenfield, L | 1 |
| De Ciucis, C; Domenicotti, C; Marengo, B; Marinari, UM; Nitti, M; Passalacqua, M; Pronzato, MA; Ricciarelli, R; Zingg, JM | 1 |
| Di Giannatale, A; Mastrangelo, S; Riccardi, R; Rufini, V; Ruggiero, A | 1 |
| Babyn, P; Chan, HS; Dimaras, H; Doyle, J; Gallie, BL; Halliday, W; Héon, E; Paton, KE; Strahlendorf, C | 1 |
| Descourt, R; Noel-Savina, E; Paleiron, N; Quéré, G; Tromeur, C | 1 |
| Azoff, J; Borchert, M; Buranahirun, C; Dhall, G; Finlay, J; Ji, L; Khatua, S; O'Neil, S; Panigrahy, A; Patel, S; Sposto, R | 1 |
| Jaing, TH; Liau, CT; Lin, KL; Tsang, NM; Tseng, CK; Wu, CT | 1 |
| Cárcamo, JG; Garrido, W; Melo, R; Peigñan, L; Quezada, C; Rojas, D; San Martín, R; Segura, R | 1 |
| Kanamori, M; Kumabe, T; Saito, R; Sonoda, Y; Tominaga, T; Watanabe, M; Yamashita, Y | 1 |
| Li, Z; Nakamura, K; Oh, DY; Thiele, CJ | 1 |
| Bhat, K; Doucette, M; Gu, Y; Hsieh, TC; Kang, JX; Law, B; Liu, X; Qian, SY; Wang, F; Wong, ET; Wu, E; Zhou, S | 1 |
| Kawase, T; Takahashi, S; Yoshida, K | 1 |
| Boström, J; Glas, M; Herrlinger, U; Kim, Y; Mack, F; Rieger, J; Schäfer, N; Scheffler, B; Simon, M; Steinbach, JP; Stuplich, M; Thanendrarajan, S; Tichy, J | 1 |
| Cathomas, R; Frick, H; Furrer, M; Potocnik, P; Schwitter, M; von Moos, R | 1 |
| Chen, LK; Dinglin, XX; Huang, H; Liao, H; Liu, GZ; Wei, WD; Xu, GC; Zeng, YD | 1 |
| McDonald, KL; Parkinson, JF; Sevim, H | 1 |
| Cheema, TA; Kanai, R; Kim, GW; Martuza, RL; Passer, B; Rabkin, SD; Wakimoto, H | 1 |
| Desjardins, A; Sampson, JH | 1 |
| Ikenoue, M; Iwakiri, T; Kodama, Y; Marutsuka, K; Miyata, S; Moriguchi, S; Ryu, S; Sawa, D; Takeshima, H; Uchinokura, S; Uehara, H; Yamada, N; Yamashita, S; Yokogami, K | 1 |
| Cho, YJ; Duk Lee, J; Go, SI; Hwang, YS; Jeong, YY; Kim, DC; Kim, HC; Ko, GH; Lee, GW; Lee, JH; Lee, JS; Oh, S; Yang, JW | 1 |
| Adachi, M; Aida, N; Hata, M; Inoue, T; Ito, S; Kigasawa, H; Niwa, T; Odagiri, K; Ogino, I; Omura, M | 1 |
| Dosal, J; Handler, MZ; Kerdel, FA; Ricotti, CA; Tosti, A; Vega, J | 1 |
| Hai-Yan, S; Jian-Qing, Z; Lan-Fang, L; Ya-Qing, C; Zuo-Ming, Y | 1 |
| Guo, C; Li, H; Liu, C; Ma, C; Shi, Y; Song, X; Wang, Q; Wang, X; Zhang, L; Zhang, X; Zhu, F | 1 |
| Eijk, PP; Groenendijk, MR; Paul, MA; Postmus, PE; Smit, EF; Thunnissen, E; van de Wiel, MA; Ylstra, B | 1 |
| Choi, KM; Gorospe, M; Hwang, SJ; Jeong, MR; Kim, HH; Masuda, K; Nam, DH; Park, YM | 1 |
| Escalon, E; Melnick, SJ; Nair, SM; Ramachandran, C | 1 |
| Andry, MC; Callewaert, M; Dukic, S; Gafa, V; Molinari, M; Roullin, VG; Van Gulick, L; Vittier, M | 1 |
| Anderluh, G; Assunção, Fdos S; Biasoli, D; de Souza, JM; Frauches, AC; Garcia, C; Geraldo, LH; Kahn, SA; Lima, FR; Moura-Neto, V; Pontes, B; Romão, L; Sobrinho, M; Soletti, RC; Tovar-Moll, F | 1 |
| Benesch, M; Deinlein, F; Faldum, A; Friedrich, C; Gerber, NU; Kortmann, RD; Kuehl, J; Kwiecien, R; Ottensmeier, H; Pietsch, T; Rutkowski, S; von Bueren, AO; von Hoff, K; Warmuth-Metz, M | 1 |
| Fujii, M; Goto, H; Ideguchi, M; Nomura, S; Sadahiro, H; Sugimoto, K; Suzuki, M; Yoshikawa, K | 1 |
| Eckschlager, T; Groh, T; Hrabeta, J; Poljakova, J; Stiborova, M | 1 |
| Ikeda, H; Jokura, H; Kumabe, T; Kusaka, Y; Shirane, R; Yoshimoto, T | 1 |
| Fenner, MH; Possinger, K | 1 |
| Gnekow, A; Kuehl, J; Mölenkamp, G; Rating, D; Warmuth-Metz, M; Westphal, S; Wolff, JE | 1 |
| Fujiyama, Y; Kanaya, H; Kim, P; Watanabe, K | 1 |
| Jereb, B; Macedoni-Luksic, M; Todorovski, L | 1 |
| Nagase, S; Ohkuma, S; Sato, S; Shimosato, K; Watanabe, S | 1 |
| Baujan, MA; Bourekas, EC; Chakeres, DW; Christoforidis, GA; Newton, HB; Slivka, MA; Slone, W; Volpi, C | 1 |
| Ebert, BL; Niemierko, E; Salgia, R; Shaffer, K | 1 |
| Baeksgaard, L; Sørensen, JB | 1 |
| Arellano-Rodrigo, E; Bessell, EM; Graus, F; López-Guillermo, A; Montserrat, E; Nomdedeu, B | 1 |
| Beauchesne, PD; Bertrand, S; Branche, R; Dore, JF; Linke, SP; Pedeux, RM; Revel, R | 1 |
| Benita-Weiss, M; Bushunow, P; Coyle, TE; Evans, B; Friedman, H; Korones, DN; Mechtler, L; Quinn, JA; Reardon, DA | 1 |
| Adachi, W; Amano, J; Hiraguri, M; Kishimoto, K; Koide, N; Miyabayashi, H; Nakamura, T; Terai, N | 1 |
| Baertschi, E; Bargetzi, MJ; Mironov, A; Notter, M; Wernli, M | 1 |
| Hasinoff, BB; Hofland, KF; Jensen, PB; Langer, SW; Schroeder, PE; Sehested, M | 2 |
| Fukumoto, M; Hashimoto, N; Itoh, N; Kono, K; Murai, N; Myoumoto, A; Takahashi, JA; Ueba, T | 1 |
| Houkin, K; Ichimiya, S; Kikuchi, T; Kondo, N; Momota, H; Sato, N; Torigoe, T; Yamaki, T | 1 |
| Das, M; Gmori, M; Konstantini, S; Nagler, A; Panigrahi, S; Slavin, S; Stagler, D | 1 |
| Bamberg, M; Jeremic, B; Molls, M; Zimmermann, FB | 1 |
| Czech, T; Dieckmann, K; Dietrich, W; Falger, J; Günes, M; Hainfellner, J; Pillwein, K; Prayer, D; Rössler, K; Schuller, E; Slavc, I | 1 |
| Greco, FA | 1 |
| Bilgin, T; Ozan, H; Ozkan, L; Ozuysal, S | 1 |
| Bode, U; Fleischhack, G; Henke, G; Jaehde, U; Kloft, C; Reif, S; Sirisangtragul, C | 1 |
| Aoyagi, N; Boshi, H; Kounami, S; Nakayama, K; Sakiyama, M; Takeuchi, T; Yoshikawa, N; Yoshiyama, M | 1 |
| Byrne, M; Nolan, RC; Van Gessel, H | 1 |
| Abrey, LE; DeAngelis, LM; Lai, R; Rosenblum, MK | 1 |
| Kunishio, K; Matsumoto, Y; Miyake, K; Nagao, S; Nishiyama, Y; Ohkawa, M; Okada, M | 1 |
| Ishizuka, O; Mizuno, H; Mizusawa, H; Nishizawa, O; Satoh, T; Seki, S | 1 |
| Benyahia, B; Bernaudin, JF; Crinière, E; Declèves, X; Delattre, JY; Huguet, S; Mokhtari, K; Scherrmann, JM | 1 |
| Buffardi, F; D'Amico, A; De Caro, MD; Fiorillo, A; Greco, N; Maggi, G; Migliorati, R; Sabbatino, MS | 1 |
| Balter, R; Barra, S; Brisigotti, M; Burnelli, R; Cama, A; Collini, P; Fidani, P; Forni, M; Gandola, L; Gardiman, M; Garrè, ML; Genitori, L; Giangaspero, F; Madon, E; Mascarin, M; Massimino, M; Navarria, P; Perilongo, G; Podda, M; Pollo, B; Potepan, P; Ricardi, U; Sandri, A; Scarzello, G; Sotti, G; Spreafico, F; Stefanelli, M; Valagussa, P | 1 |
| Qi, ST; Qiu, BH | 1 |
| Bourg, V; Chanalet, S; Chatel, M; Fontaine, D; Frenay, M; Lebrun, C; Lonjon, M; Michiels, JF; Paquis, P; Ramaioli, A; Vandenbos, F | 1 |
| Cmelak, A; Jennings, MT; Johnson, MD; Moots, PL; Pais, R; Shyr, Y | 1 |
| Jackson, AS; Plowman, PN | 1 |
| Dwarakanath, BS; Khaitan, D; Ravindranath, T | 1 |
| Bartolini, S; Cavallo, G; Conforti, R; Crinò, L; Esposti, RD; Franceschi, E; Magrini, E; Paioli, A; Palmerini, E; Pession, A; Rimondini, S; Scopece, L | 1 |
| Eto, Y; Hoshi, Y; Ito, F; Kato, Y; Yanagisawa, T; Yano, I | 1 |
| Chen, LK; Liang, Y; Liu, JL; Xu, GC; Yang, QY; Zhang, LN | 1 |
| Chen, GY; Fu, XL; Jiang, GL; Qian, H; Wang, LJ; Wu, KL; Yang, H; Zhao, S | 1 |
| Buckner, JC; Dinapoli, RP; Fitch, TR; Krishnan, S; Maurer, MJ; Nordstrom, K; O'Fallon, JR; Rao, RD; Scheithauer, B; Schomberg, PJ | 1 |
| Bellincampi, L; Bernardini, S; Biroccio, A; Federici, G; Poland, J; Schnölzer, M; Sinha, P; Urbani, A | 1 |
| Bogart, J; Evans, L; Green, MR; Herndon, JE; McClay, EF; Seagren, SL; Watson, D | 1 |
| Amador, R; Aparicio, J; Beltrán, A; Calderero, V; Díaz, R; Jordá, MV; Reynés, G; Segura, A | 1 |
| Nakayama, H; Takahashi, H; Teramoto, A; Yamada, S; Yamada, SM | 1 |
| Cohen, ZR; Fuller, GN; Lang, FF; Majumder, S; Price, RE; Sawaya, R; Su, X | 1 |
| Albain, KS; Chansky, K; Crowley, JJ; Gandara, DR; Gaspar, LE; Livingston, RB; Rusch, V; Vallieres, E | 1 |
| Miranda, P; Ramos, A; Ricoy, JR | 1 |
| Katayama, Y; Watanabe, T; Yoshino, A | 1 |
| Bamias, A; Briasoulis, E; Christodoulou, C; Dimopoulos, MA; Fountzilas, G; Kalofonos, H; Kosmidis, P; Makatsoris, T; Pavlidis, N; Samantas, E; Skarlos, D | 1 |
| Bauduceau, O; Ceccaldi, B; Fayolle, M; Le Moulec, S; Védrine, L | 1 |
| Alshehadat, S; Sahmoun, AE | 1 |
| Basso, ME; Bertin, D; Gandola, L; Genitori, L; Giangaspero, F; Madon, E; Massimino, M; Mastrodicasa, L; Paglino, A; Perilongo, G; Ricardi, U; Sandri, A; Sardi, N; Todisco, L; Valentini, L | 1 |
| Takahashi, H; Tanaka, R | 1 |
| Axtell, RA; Boyett, JM; Breiger, D; Broxson, E; Donahue, B; Finlay, JL; Geyer, JR; Goldwein, JW; Heier, LA; Jennings, M; Johnson, D; Mazewski, C; Miller, DC; Packer, R; Puccetti, D; Radcliffe, J; Shiminski-Maher, T; Sposto, R; Tao, ML | 1 |
| Hiramatsu, Y; Ishida, M; Masuyama, H; Murakami, K; Sakurai, M | 1 |
| Alvaro, F; Cohn, RJ; McCowage, G; Mrongovius, R; Oswald, C; White, L; Ziegler, DS | 1 |
| Chen, SH; Hung, CS; Jung, SM; Lo, FS; Lui, TN; Wang, HS | 1 |
| De Maria, R; Eramo, A; Larocca, LM; Lotti, F; Pallini, R; Peschle, C; Pilozzi, E; Ricci-Vitiani, L; Sette, G; Zeuner, A | 1 |
| Kamani, N; Lafond, D; Loechelt, B; MacDonald, TJ; Packer, RJ; Perez-Albuerne, E; Rood, B; Thorarinsdottir, HK | 1 |
| Bourekas, EC; Figg, GM; Newton, HB; Slone, HW | 1 |
| Kamei, M; Kawamura, A; Kohmura, E; Mizukawa, K; Sasaki, M; Sasayama, T; Tanaka, K | 1 |
| Burger, P; Greenberg, M; Holmes, E; Kleinberg, L; Kretschmar, C; Wharam, M | 1 |
| Addo-Yobo, SO; Donson, AM; Foreman, NK; Gore, L; Handler, MH | 1 |
| Berzioli, C; Cavallo, G; Conforti, R; Crinò, L; Esposti, RD; Franceschi, E; Paioli, A; Paioli, G; Palmerini, E; Scopece, L; Spagnolli, F | 1 |
| Bedano, PM; Bonnin, J; Einhorn, LH | 1 |
| Chayama, K; Date, I; Ichikawa, T; Takao, S; Tamiya, T | 1 |
| Ahn, SD; Ghim, TT; Goo, HW; Khang, SK; Kim, YJ; Lee, MJ; Park, JB; Ra, YS; Song, JS | 1 |
| Anai, H; Anegawa, G; Honda, M; Kai, T; Kaneko, S; Masuda, T; Nakamura, Y; Ohta, R; Saeki, H; Yokoyama, S | 1 |
| Asgharzadeh, S; Belasco, J; Chi, SN; Diez, B; Dubowy, R; Dunkel, I; Finlay, J; Gardner, S; Hukin, J; Ji, L; Kellie, S; Levy, A; Miller, DC; Rosenblum, M; Sposto, R; Termuhlen, A; Zacharoulis, S | 1 |
| Gilligan, D; Gower, NH; Hackshaw, AK; Harper, PG; James, LE; Murray, PA; O'Donnell, KM; Rudd, RM; Ruiz de Elvira, MC; Snee, M; Spiro, SG; Tobias, JS; Trask, CW | 1 |
| Chastagner, P; Doz, F; Dufour, C; Frappaz, D; Gentet, JC; Grill, J; Kalifa, C; Lellouch-Tubiana, A; Pichon, F; Plantaz, D; Puget, S; Raquin, MA | 1 |
| Abbracchio, MP; Ceruti, S; Mazzola, A | 1 |
| Boehme, V; Kaiser, U; Kloess, M; Loeffler, M; Pfreundschuh, M; Schmitz, N; Zeynalova, S | 1 |
| Benesch, M; Berthold, F; Gnekow, AK; Kortmann, RD; Pietsch, T; Rutkowski, S; Sträter, R; Wagner, S; Warmuth-Metz, M; Wolff, JE | 1 |
| Feun, LG; Heros, D; Herrera, C; Landy, H; Marini, A; Markoe, A; Robles, C; Savaraj, N | 1 |
| Akalan, N; Akyüz, C; Atahan, L; Büyükpamukçu, M; Kutluk, T; Selek, U; Söylemezoglu, F; Varan, A; Yalçin, B | 1 |
| Cai, Y; Wang, WL; Xu, B; Zhang, SW; Zhu, GY | 1 |
| Chan, G; Lotocka-Reysner, H; Strahlendorf, C | 1 |
| Armstrong, MB; Bian, X; Castle, VP; Kwok, RP; Liu, Y; Opipari, AW; Ratanaproeksa, AB; Shao, F; Subramanian, C; Yu, VC | 1 |
| Clarke-Pearson, DL; Kirkpatrick, JP; Sampson, JH; Soper, JT; Spillman, M; Wolf, JK | 1 |
| Chen, ZP; Mu, YG; Sai, K; Shi, HL; Yue, WY; Zhang, JP; Zhang, XH | 1 |
| Kageji, T; Kanematsu, Y; Matsuzaki, K; Nagahiro, S; Nakatani, M; Okamoto, Y; Watanabe, T | 1 |
| Boudrias, M; Fortin, D; Garant, MP; Gendron, C | 1 |
| Berthold, F; Hero, B; Klingebiel, T; Längler, A; Simon, T | 1 |
| Aboody, KS; Gevorgyan, A; Gutova, M; Metz, MZ; Najbauer, J; Shih, CC; Weng, Y | 1 |
| Ido, K; Kubota, T; Matsuda, K; Nakagawa, T; Sakuma, T | 1 |
| Batchelor, TT; Black, PM; Bradshaw, J; Chen-Plotkin, AS; Doherty, L; Drappatz, J; Folkman, J; Gigas, DC; Kesari, S; Kieran, M; Kracher, J; Laforme, A; Levy, B; Muzikansky, A; O'Neill, A; Ramakrishna, N; Schiff, D; Weiss, SE; Wen, PY | 1 |
| Berthold, F; Claviez, A; Frühwald, MC; Harnischmacher, U; Hero, B; Jorch, N; Längler, A; Simon, T | 1 |
| Julie, C; Lepère, C; Maindrault-Goebel, F; Mitry, E; Otmezguine, Y; Rakotomalala, S; Rougier, P; Vaillant, JN | 1 |
| Aguilera, D; Das, CM; Gopalakrishnan, V; Prasad, P; Vasquez, H; Wolff, JE; Zhang, M | 1 |
| Drosik, K; Jankowska, R; Jassem, J; Konopa, K; Koralewski, P; Kowalski, D; Kozielski, J; Krzakowski, M; Olszewski, W; Orłowski, T; Ramlau, R; Reinfuss, M; Roszkowski, K; Wojtukiewicz, M | 1 |
| Ang, LC; Dennis, KE; Fisher, BJ | 1 |
| Ference, SJ; Galor, A; Lee, MS; Peereboom, DM; Perez, VL; Singh, AD; Stevens, GH | 1 |
| Fujisawa, I; Kageyama, N; Kato, SF; Nakao, S; Ooyama, K; Seto, S; Ueba, T; Yamashita, K; Yorihuji, T | 1 |
| Choi, YK; Chung, YG; Jeon, HM; Jin, X; Jung, JE; Kim, H; Kim, TK; Lee, JB; Lee, JS; Oh, SY; Park, HJ; Park, JW; Sohn, YW; You, S | 1 |
| Jiang, S; Lin, P; Ren, JJ; Wang, J; Wang, X; Wu, Y; Xiong, Z; Yang, H; Zhang, J | 1 |
| Azar, JM; Einhorn, LH; Schneider, BP | 1 |
| Choi, LM; Kamani, N; La Fond, D; Macdonald, TJ; Packer, RJ; Rood, B; Santi, MR | 1 |
| Fujisawa, M; Hara, I; Miyake, H; Nakano, Y; Takenaka, A; Tanaka, K; Terakawa, T | 1 |
| Goldstein, DA; Tessler, HH | 1 |
| Bouffet, E; Fukushima, S; Katsuki, H; Shigemori, M; Terasaki, M | 1 |
| Chinen, T; Hirayasu, T; Ishikawa, K; Kawabata, T; Kawasaki, H; Kuniyoshi, M; Ogawa, K; Ohta, M; Oshiro, Y; Samura, H; Teruya, J; Teruya, T; Uehara, T; Yohena, T | 1 |
| Bianchi, G; Lee, C; Longo, VD; Madia, F; Raffaghello, L; Safdie, FM; Wei, M | 1 |
| Casasnovas, O; Choquet, S; Dupriez, B; Fourme, E; Gisselbrecht, C; Hoang-Xuan, K; Jaccard, A; Janvier, M; Kolb, B; Leblond, V; Omuro, A; Sanson, M; Souleau, B; Soussain, C; Taillandier, L; Taksin, AL; Witz, F; Zini, JM | 1 |
| Donati, PA; Genitori, L; Giordano, F; Mussa, F; Sandri, A; Sanzo, M; Sardi, I | 1 |
| Haaxma-Reiche, H; Meinesz, AF; Mulder, NH; Postmus, PE; Sleijfer, DT; Vencken, LM | 1 |
| Kessinger, A | 1 |
| Aisner, J; Wiernik, PH | 1 |
| Hilaris, BS; Natale, RB; Shank, B; Wittes, RE | 1 |
| Aisner, J; Van Echo, DA; Whitacre, M; Wiernik, PH | 1 |
| Aisner, J; VanEcho, DA; Wesley, M; Whitacre, M; Wiernik, PH | 1 |
| Dhingra, HM; Dicke, KA; Farha, P; Minnhaar, G; Spitzer, G; Umsawasdi, T; Valdivieso, M; Vellekoop, L; Verma, DS; Zander, A | 1 |
| Haaxma-Reiche, H; Holthuis, JJ; Mulder, NH; Postmus, PE; Sleijfer, DT; Sluiter, HJ; van Oort, WJ; Vencken, LM | 1 |
| Chen, TT; Costanzi, JJ; Livingston, RB; McGavran, M; Mira, JG; Samson, M | 1 |
| Belanger, R; Dennery, JM; Gerin-Lajoie, J; Hopkins, HS; Hugenholtz, H; Montpetit, V; Nundy, D; Prior, J; Richard, MT; Stewart, DJ | 1 |
| Canetta, R; D'Incalci, M; Franchin, G; Galligioni, E; Grigoletto, E; Rossi, C; Tirelli, U; Trovò, MG; Tumolo, S; Veronesi, A | 1 |
| Creagan, ET; Eagan, RT; Kvols, LK | 1 |
| Akiyama, Y; Kumai, J; Nishikawa, M | 1 |
| Agranat, P; Epardeau, B; Extra, JM; Jedynak, P; Mignot, L | 1 |
| Brock, C; Gallagher, C; King, TT; Monson, JP; Oliver, RT; Snodgrass, GJ; Vijayaraghavan, S | 1 |
| Herrmann, HD; Laas, RW; Schulte, FJ; Westphal, M; Winkler, K | 1 |
| Bakri, Y; Berkowitz, RS; Goldstein, DP; Jabbar, FA; Senoussi, M; Subhi, J; von Sinner, W | 1 |
| Lurain, JR | 2 |
| Hagiwara, Y; Hayakawa, T; Kanayama, T; Miyawaki, Y; Nakagawa, H; Tokiyoshi, K; Tsuruzono, K; Yamada, M | 1 |
| Hara, A; Kaku, Y; Nishimura, Y; Sakai, N; Yamada, H | 1 |
| Chang, TK; Hwang, B; Wong, TT | 1 |
| Mead, GM; Simmonds, PD; Whitehouse, JM | 1 |
| Matsutani, M; Miyoshi, A; Nagashima, C; Yoshizawa, H | 1 |
| Ansari, R; Einhorn, LH; Fisher, W; Gonin, R; Loehrer, PJ; Monaco, F; Sandler, A | 1 |
| Aledo, A; Boland, P; Casper, ES; Gerald, WL; Healey, JH; Heller, G; Kushner, BH; La Quaglia, MP; Meyers, PA; Wollner, N | 1 |
| Newton, CL; Newton, HB | 1 |
| Brewster, AE; Burt, PA; Hopwood, P; Stout, R; Thatcher, N | 1 |
| Castello, MA; Clerico, A; Gualdi, GF; Operamolla, P; Padula, A; Properzi, E; Schiavetti, A; Trasimeni, G; Varrasso, G | 1 |
| Indelli, M; Maestri, A; Malacarne, P; Santini, A | 1 |
| Abe, T; Hirao, A; Kawano, Y; Okamoto, Y; Saito, S; Sato, J; Shimizu, T; Suzue, T; Takaue, Y; Watanabe, T | 1 |
| Itoyama, Y; Kochi, M; Kuratsu, J; Ushio, Y; Yamashiro, S; Yoshizato, K | 1 |
| Kobayashi, T; Matsutani, M; Nagai, H; Shitara, N; Sugita, K; Takakura, K; Tanaka, R; Yamada, H; Yamashita, J; Yoshida, J | 1 |
| Bouffet, E; Courbon, B; Desjardins, L; Doz, F; Gentet, JC; Mechinaud, F; Mosseri, V; Neuenschwander, S; Plantaz, D; Vannier, JP | 1 |
| Arita, N; Inoue, K; Kasayama, M; Kimura, H; Kishimoto, T; Koga, M; Miyashita, Y; Nakahara, K; Ogawa, H; Sato, F | 1 |
| Fairclough, DL; Friedman, HS; Heideman, RL; Horowitz, ME; Jenkins, JJ; Kun, LE; Razzouk, BI | 1 |
| Bando, K; Kannuki, S; Kuroda, Y; Matsumoto, K; Shirakawa, N; Takaue, Y | 1 |
| Basu, HS; Deen, DF; Feuerstein, BG; Marton, LJ; Pellarin, M; Smirnov, IV | 1 |
| Burt, P; Hicks, F; Leahy, B; Lorigan, P; Prendiville, J; Stout, R; Thatcher, N | 1 |
| Frenkel, EP; Henner, WD; Mickey, BE; Neuwelt, EA; Wiliams, PC | 1 |
| Deigert, FA; Eagan, RT; Jett, JR; Maksymiuk, AW; Shaw, EG; Su, JQ | 1 |
| Ariyoshi, Y; Fukuoka, M; Furuse, K; Ikegami, H; Nishiwaki, Y; Saijo, N; Shimoyama, M; Suemasu, K; Tamura, T | 1 |
| Horichi, H; Kumaki, T; Matsuki, N; Shima, K; Tajima, H; Takeda, T | 1 |
| Hagiwara, Y; Kanayama, T; Kobayashi, H; Koezuka, M; Miyawaki, Y; Nakagawa, H; Tokiyoshi, K; Tsuruzono, K; Yamada, M | 1 |
| Barrett, A; Gaze, MN; Rampling, RP; Simpson, E; Smith, DB | 1 |
| Muggia, FM | 1 |
| de Jonge, A; Karim, AB; Meyer, OW; Njo, KH; Slotman, BJ | 1 |
| Bessho, H; Hujimoto, T; Kamada, K; Nakaue, Y; Sakaki, T; Sasaoka, Y; Tunoda, S | 1 |
| Abe, M; Kikuchi, H; Oda, Y; Shibamoto, Y; Takahashi, M; Yamashita, J | 1 |
| Turrisi, AT | 1 |
| Schmoor, C; Schumacher, M; Ulm, K | 1 |
| Greco, FA; Hainsworth, JD; Johnson, DH; Lamar, RE; Murphy, PB | 1 |
| Bouissou, F; Chancholle, A; Claeyssens, S; Fabre, J; Robert, A; Rubie, H; Tscherning, C | 1 |
| Boor, R; Gutjahr, P; Huber, A | 1 |
| Goto, S; Itoyama, Y; Uemura, S; Ushio, Y; Yamada, K; Yamashiro, S | 1 |
| Hayakawa, T; Kanayama, T; Miyawaki, Y; Nakagawa, H; Tokiyoshi, K; Tsuruzono, K; Yamada, M | 1 |
| de Veber, LL; Del Maestro, RF; Ramsay, DA; Sahjpaul, RL | 1 |
| Fujita, T; Hayakawa, T; Kadota, T; Kanayama, T; Kubo, S; Miyawaki, Y; Nakagawa, H; Tokiyoshi, K; Tsuruzono, K; Yamada, M | 1 |
| Akita, S; Aoki, S; Fujii, H; Kawakami, R; Kosuda, S; Kusano, S; Mezaki, T; Nakamura, O; Shidara, N; Suzuki, K | 1 |
| Crocker, I; Davis, P; Ghim, TT; Krawiecki, N; O'Brien, M; Seo, JJ | 1 |
| Johnson, BE | 1 |
| Hansen, HH; Kristjansen, PE; Skov Hansen, M; Soelberg Sørensen, P | 1 |
| Chang, TK; Hsien, YL; Hwang, B; Jeng, MJ; Tang, RB; Wong, TT | 1 |
| Cole, M; Lowis, SP; Newell, DR; Pearson, AD | 1 |
| Hotta, T; Kiya, K; Kurisu, K; Mikami, T; Ogasawara, H; Sugiyama, K; Uozumi, T | 5 |
| Chamberlain, MC | 2 |
| Kaneko, T; Okoshi, T; Okubo, T; Shoji, A; Tsubakihara, M | 1 |
| Fujita, T; Hagiwara, Y; Hiraoka, M; Kanayama, T; Kubo, S; Nakagawa, H; Nakanomyo, H; Tokiyoshi, K; Yamada, M | 1 |
| Brummett, RE; Dahlborg, SA; Dana, BW; Henner, WD; Neuwelt, EA; Roman-Goldstein, S; Tableman, M; Williams, PC | 1 |
| Fujiwara, S; Fukui, M; Inamura, T; Morioka, T; Nishio, S; Shono, T; Takeshita, I | 1 |
| Berger, M; Geyer, JR; Sievers, EL | 1 |
| Creagan, ET; Eagan, RT; Foote, RL; Frytak, S; Jett, JR; Richardson, RL; Shaw, EG; Su, JQ | 1 |
| Boneu, A; Hartmann, O; Hattchouel, JM; Lumbroso, J; Robert, A; Rodary, C; Rubie, H; Suc, A | 1 |
| Bridges, JD; Edison, M; Frame, JN; Gazdar, AF; Glatstein, E; Gray, J; Hankins, L; Holden, D; Ihde, DC; Johnson, BE; Linnoila, RI; Mulshine, JL; Nesbitt, J; Pass, H; Sobczeck, M; Steinberg, SM | 1 |
| Jones, WB; Lewis, JL; Schneider, J; Shapiro, F | 1 |
| Dana, A; Doshi, R; Rustin, GJ; Saldanha, GJ | 1 |
| An, T; Asano, T; Herzog, CE; Kleinerman, ES; Loughlin, SM; Mayes, J; McWatters, A; Zwelling, LA | 1 |
| Holm, B; Jensen, PB; Sehested, M | 2 |
| Bilaniuk, LT; Duhaime, AC; Galetta, SL; Liu, GT; Molloy, PT; Needle, M; Phillips, PC; Rorke, LB; Sutton, LN; Vojta, DD; Volpe, NJ | 1 |
| Furuta, T; Matsumoto, K; Ohmoto, T; Tada, E; Tomita, S | 1 |
| Kowada, M; Mineura, K; Sasajima, T; Takeda, O; Watanabe, A | 1 |
| Friedman, HS; Heideman, RL; Murry, DJ; Petros, WP; Rodman, JH; Tonda, ME | 1 |
| August, C; Bostrom, B; Boyett, JM; Cairo, M; Cohen, BH; Finlay, JL; Garvin, J; Geyer, JR; Goldman, S; Harris, RE; Packer, RJ; Sanders, J; Stanley, P; Wong, MC; Yates, AJ; Zimmerman, RA | 1 |
| Allen, JC; Siffert, J | 1 |
| Balat, O; Edwards, CL; Kavanagh, JJ; Kudelka, AP; Silva, E; Verschraegen, CF | 1 |
| An, T; Asano, T; Kleinerman, ES; Mayes, J; Zwelling, LA | 1 |
| Kemeny, AA; Leslie, MD; Mangili, G; Newlands, ES | 1 |
| Ang, PT; Soh, LT | 1 |
| Bouffet, E; Brunat-Mentigny, M; Carrie, C; Frappaz, D; Jouvet, A; Mottolese, C; Philip, I | 1 |
| Balmaceda, C; Fetell, MR; Hesdorffer, C | 1 |
| Belasco, JB; Geyer, JR; Goldwein, JW; Herman-Liu, A; Molloy, PT; Needle, MN; Phillips, PC; Sutton, L | 1 |
| Champlin, R; Edwards, CL; Giralt, S; Kavanagh, JJ; Kudelka, AP; Mehra, R; Piamsonboom, S; Termrungruanglert, W; van Besien, K; Verschraegen, C | 1 |
| Bergman, I; Cnaan, A; Garvin, JH; Goldwein, JW; Grass, J; Molloy, P; Needle, MN; Phillips, PC; Sutton, L; Zhao, H | 1 |
| Caralt, L; Estapé, J; Graus, F; Mellado, B; Viñolas, N | 1 |
| Bentzen, SM; Fode, K; Nielsen, OS; Palshof, T; Work, E | 1 |
| Caldemeyer, K; Hanna, M; Heifetz, SA; Jakacki, RI; Jamison, C; Sender, L | 1 |
| Furuta, T; Kuriyama, M; Matsumoto, K; Ohmoto, T; Ono, Y; Tamiya, T; Tsutsui, K | 1 |
| Jensen, PB; Sehested, M | 1 |
| Gajjar, A; Heideman, R; Kun, LE; Langston, JW; Ochs, JS; Sanford, RA; Walter, AW | 1 |
| Harada, M; Hayashi, K; Kohara, H; Shinagawa, K; Tabata, M; Ueoka, H | 1 |
| Kortmann, RD | 1 |
| Beck, D; Béhar, C; Bergeron, C; Bernard, JL; Bordigoni, P; Coze, C; Dusol, F; Frappaz, D; Hartmann, O; Leverger, G; Mechinaud, F; Michon, J; Otten, J; Philip, T; Plantaz, D; Plouvier, E; Rubie, H; Zucker, JM | 1 |
| Abe, H; Fujieda, K; Ikeda, J; Ishii, N; Kato, T; Sawamura, Y; Shirato, H; Tada, M | 1 |
| Fisher, C; Harmer, CL; Judson, IR; Thomas, JM; Verrill, MW; Wiltshaw, E | 1 |
| Kayama, T; Saino, M; Saito, S; Sakurada, K; Sato, K | 1 |
| Davis, BJ; Leibel, SA; Merchant, TE; Sheldon, JM | 1 |
| Allen, J; Bayer, L; Dunkel, IJ; Finlay, JL; Gardner, S; Garvin, J; Grovas, A; Halpern, S; Heller, G; Lindsley, K; Lyden, D; Mason, WP; Merchant, TE; O'Malley, B; Petriccione, MM; Puccetti, D; Rosenblum, M; Sands, S | 1 |
| Champlin, R; Edwards, CL; Kavanagh, JJ; Kudelka, AP; Lifshitz, S; Mante, RP; Piamsomboon, S; Schomer, DF; Termrungruanglert, W; Van Besien, K; Verschraegen, CF | 1 |
| Agata, H; Fujimoto, T; Hamaguchi, N; Hirota, T; Iwata, A; Katano, N; Kitagawa, S; Kobayashi, S; Konno, K; Sato, T; Sawada, K; Takeuchi, M | 1 |
| Alexander, MA; Alvord, WG; Arguello, F; Greene, JF; Jorden, JL; Kalavar, NT; Klabansky, RL; Sausville, EA; Smith, EM; Stinson, SF | 1 |
| Boyett, JM; Cairo, M; Dunkel, IJ; Ettinger, LJ; Finlay, JL; Garvin, JH; Goldman, S; Kaplan, AM; Li, H | 1 |
| Drumea, K; Goldsher, D; Ravkin, A; Stein, ME; Tzuk-Shina, Z | 1 |
| Buckner, JC; Lewis, JE; McElroy, EA | 1 |
| Boyett, JM; Dunkel, IJ; Finlay, JL; Gardner, S; Garvin, JH; Goldman, S; Gollamudi, S; Guruangan, S; Merchant, TE; Rosenblum, M | 1 |
| Benesch, M; Kerbl, R; Lackner, H; Oberbauer, R; Pakisch, B; Schwinger, W; Urban, C | 1 |
| Cnaan, A; Janss, AJ; Levow, C; Phillips, PC; Shpilsky, A; Sutton, L; Zhao, H | 1 |
| Herzog, CE; Kleinerman, ES; McWatters, A; Zwelling, LA | 1 |
| Antman, KH; Bagiella, E; Balmaceda, C; Bruce, J; De LaPaz, R; Fetell, M; Garrett, TJ; Garvin, JH; Hawks, R; Hesdorffer, CS; Isaacson, S; Papadopoulos, KP; Savage, DG; Sisti, M; Vahdat, LT | 1 |
| Kamath, SS; McCarley, DL; Zlotecki, RA | 1 |
| Furuta, T; Maeda, Y; Matsumoto, K; Mizumatsu, S; Ohmoto, T; Tamiya, T | 2 |
| Hirayama, A; Kadota, T; Maeda, N; Nakagawa, H; Tsuzuki, T; Yamamoto, H | 1 |
| Bernhardt, G; Czech, T; Fuiko, R; Hawliczek, G; Köller, U; Nirnberger, G; Pillwein, K; Slavc, I | 1 |
| Borsi, JD; Csáki, C; Ferencz, T; Horváth, J; Paál, K; Schuler, D | 1 |
| Ames, MM; Bagniewski, PJ; Buckner, JC; Cascino, TL; Marks, RS; Rajkumar, SV; Reid, JM; Schomberg, PJ | 1 |
| Arias-Gomez, J; Cerecedo-Diaz, F; Lopez-Aguilar, E; Quintana-Roldan, G; Rivera-Marquez, H; Santacruz-Castillo, E; Sepulveda-Vildosola, AC; Valdez-Sanchez, M | 1 |
| Idezuki, Y; Ishizuka, N; Kobayashi, M; Murata, N; Suwata, J; Takada, S | 1 |
| Fukui, I; Hiratsuka, H; Izutani, T; Kin, T; Maeda, Y; Nakagawa, K; Okumura, S; Oyama, H; Shishido, T; Yonese, J | 1 |
| Lauer, AK; Neuwelt, EA; Shults, WT; Wilson, MW; Wobig, JL | 1 |
| Boerman, RH; Mattijssen, V; Mulder, AH; Raemaekers, JM | 1 |
| Bokemeyer, C; Culine, S; Fosså, SD; Gerl, A; Germa-Luch, JR; Jones, WG; Mead, GM; Pont, J; Schmoll, HJ; Tjulandin, S | 1 |
| Ikeda, J; Kitamura, K; Miyasaka, K; Sawamura, Y; Shirato, H; Suzuki, K | 1 |
| Coleman, RE; Gillespie, AM; Hancock, BW; Siddiqui, N | 1 |
| Boni, C; Carlini, P; Cocconi, G; Di Costanzo, F; Di Sarra, S; Fosser, V; Franciosi, V; Michiara, M; Tonato, M | 1 |
| Boiardi, A; Broggi, G; Fariselli, L; Pozzi, A; Salmaggi, A; Silvani, A | 1 |
| Abe, T; Hori, S; Kawashima, H; Mori, T; Morikawa, N; Takeyama, M | 1 |
| Ciesielski, MJ; Fenstermaker, RA | 1 |
| Chowhan, N; Davis, R; Hentschel, P; Iliya, A; Madajewicz, S; Manzione, J; Meek, A; Roche, P; Roque, C; Shady, M; Tfayli, A | 1 |
| Aleksandrovic, J; Dagovic, A; Grujicic, D; Jeremic, B; Milicic, B; Nikolic, N; Shibamoto, Y; Stojanovic, M | 2 |
| Boyett, JM; Finlay, JL; Grovas, AC; Lindsley, K; Rosenblum, M; Yates, AJ | 1 |
| Drumea, K; Goldsher, D; Kuten, A; Stein, ME; Tzuk-Shina, Z | 1 |
| Itoyama, Y; Kochi, M; Kuratsu, J; Marubayashi, T; Ushio, Y | 1 |
| Osmak, M; Skrk, J; Vrhovec, I | 1 |
| Fleming, DR; Goldsmith, GC; Herzig, RH; Stevens, DA | 1 |
| de Bruijckere, LM; Defesche, HF; Hupperets, PS; Twijnstra, A | 1 |
| Beauchesne, P; Brunon, J; Duthel, R; Fotso, MJ; Rusch, P; Schmitt, T; Soler, C | 1 |
| Nieder, C | 1 |
| Arita, K; Harada, K; Ide, T; Kurisu, K; Sadatomo, T; Tahara, E; Tahara, H; Uozumi, T | 1 |
| Kosteljanetz, M; Kristjansen, PE; Lassen, U; Poulsen, HS; Wagner, A | 1 |
| Hovi, L; Lipsanen, M; Saarinen-Pihkala, UM; Tapanainen, P; Vettenranta, K | 1 |
| de Montpreville, V; Munck, JN; Regnard, JF; Terrier, P; Ulusakarya, A | 1 |
| Amistà, P; Brandes, AA; Carollo, C; Danieli, D; Gardiman, M; Guglielmi, B; Monfardini, S; Pinna, G; Turazzi, S; Volpin, L | 1 |
| Antman, KH; Balmaceda, C; Bruce, J; De LaPaz, R; Fetell, M; Hesdorffer, CS; Isaacson, S; Kaufman, E; Papadopoulos, KP; Savage, DG; Sisti, M; Troxel, A; Vahdat, LT | 1 |
| Kawakami, K; Kayama, T; Saino, M; Sakurada, K; Sato, S | 1 |
| Asai, A; Kuchino, Y; Nagane, M; Nomura, K; Oyama, H; Shibui, S | 1 |
| Frenay, M; Lebrun, C; Lonjon, M; Marcy, PY; Paquis, P | 1 |
| Allen, JC; Boyett, JM; Finlay, JL; Garvin, JH; Kobrinsky, NL; Packer, RJ; Shiminski-Maher, T; Stanley, P; Stewart, DJ | 1 |
| Atkins, H; Braun, A; Cabahug, C; Chowhan, N; Davis, R; Hentschel, P; Iliya, A; Madajewicz, S; Manzione, J; Meek, A; Roche, P; Roque, C; Shady, M; Tfayli, A; Wolf, W | 1 |
| Cohen, KJ; Dubowy, RL; Fisher, PG; Korones, DN | 1 |
| Bondiau, PY; Chatel, M; Frenay, M; Lebrun, C; Lonjon, M | 1 |
| Bamberg, M; Beyer, J; Böhlke, I; Bokemeyer, C; Derigs, G; Hartmann, JT; Kanz, L; Kollmannsberger, C; Nichols, C; Rüther, U; Schleucher, N; Schmoll, HJ; Schöfski, P | 1 |
| Banno, Y; Nakashima, S; Nishimura, Y; Nozawa, Y; Sakai, N; Sawada, M; Shinoda, J; Takenaka, K; Yamakawa, H | 1 |
| Kokunai, T; Tamaki, N; Yin, D | 1 |
| Hao, YJ; Mizuno, M; Natsume, A; Taniguchi, K; Wakabayashi, T; Yoshida, J | 1 |
| Ichikawa, Y; Kubo, T; Minami, R; Nishida, M; Nozue, A; Tsunoda, H | 1 |
| Hatano, H; Hatano, N; Kajita, Y; Kinoshita, T; Takasu, S; Usui, T; Wakabayashi, T; Yoshida, J | 1 |
| Hirata, M; Kanda, M; Kikuchi, M; Kumagawa, M; Nagano, M; Nawa, Y; Ohshima, K; Suzumiya, J; Tamura, K | 1 |
| Fraser, G; Nicoll, J; Rampling, R; Smith, C; Stephen, M | 1 |
| Hochstenbag, MM; ten Velde, GP; Twijnstra, A; Wilmink, JT; Wouters, EF | 1 |
| Abe, T; Hikawa, T; Hori, S; Mori, T | 1 |
| Czorny, A; Godard, J; Jacquet, G; Miny, J; Plouvier, E; Raul, JS; Viennet, G | 1 |
| Kushner, BH; Meyers, PA | 1 |
| Diociaiuti, L; Mastrangelo, R; Mastrangelo, S; Pession, A; Prete, A; Rufini, V; Tornesello, A; Troncone, L | 1 |
| Chastagner, P; Couanet, D; Doz, F; Edan, C; Frappaz, D; Gambarelli, D; Gentet, JC; Grill, J; Habrand, JL; Kalifa, C; Le Deley, MC; Pierre-Kahn, A; Raquin, MA | 1 |
| Janjindamai SHirunpat, S; Maipang MVasiknanonte, P | 1 |
| Bourg, V; Chichmanian, RM; Frenay, M; Lebrun, C; Thomas, P | 1 |
| Bayer, R; Cairncross, G; Forsyth, P; Hu, W; Kaminer, L; Macdonald, D; Paleologos, N; Peterson, K; Ramsay, D; Rosenfeld, S; Salzman, D; Smith, A; Stewart, D; Swinnen, L | 1 |
| Ashby, LS; Shapiro, WR | 1 |
| Mazeron, JJ; Noël, G | 1 |
| Bode, U; Fleischhack, G; Hasan, C; Hettmer, S; Jaehde, U; Reif, S | 1 |
| Ashkenazi, E; Blass, M; Blumberg, PM; Brodie, C; Kazimirsky, G; Kronfeld, I; Lorenzo, PS; Mandil, R; Rosenthal, G; Umansky, F | 1 |
| Altintaş, A; Vardar, MA | 1 |
| Lavicka, J; Mirossay, A; Mirossay, L; Mojzis, J; Sarisský, M; Sulla, I | 1 |
| Carvalho, C; Meadows, AT; Shields, CL; Shields, JA; Smith, AF | 1 |
| Cohn, DA; Stuart-Harris, R | 1 |
| Ashley, DM; Chow, CW; Gray, AZ; Hawkins, CJ; Riffkin, CD | 1 |
| Kherfellah, D; Montaudon, D; Pavillard, V; Richard, S; Robert, J | 1 |
| Alcaraz, L; Benboubker, L; Bergemer-Fouquet, AM; Calais, G; Colombat, P; Destrieux, C; Jan, M; Linassier, C | 1 |
| Bello, L; Bikfalvi, A; Black, PM; Carrabba, G; Carroll, RS; Cerutti, F; Giussani, C; Landré, J; Lucini, V; Pluderi, M; Scaglione, F; Tomei, G; Villani, R | 1 |
| Bonner, JA; Brown, PD; Creagan, ET; Foote, RL; Frytak, S; Marks, RS; Richardson, RL | 1 |
| Gillmore, R; Kendall, A; Newlands, E | 1 |
| Aoyama, H; Fujieda, K; Ikeda, J; Miyasaka, K; Sawamura, Y; Shirato, H | 1 |
| Nakahara, I; Nishikawa, M; Sugimoto, K | 1 |
| Bernaudin, JF; Declèves, X; Fajac, A; Hurbain, I; Laplanche, JL; Lehmann-Che, J; Mercier, C; Scherrmann, JM; Tardy, M | 1 |
| Newton, HB; Santi, M; Stevens, C | 1 |
| Hisada, T; Ito, T; Masuda, S; Mochida, A; Morinari, H; Nakahara, K; Nishi, K; Saito, K; Sasaki, S; Tahara, M; Yakumaru, K | 1 |
| Baujan, MA; Bourekas, EC; Chakeres, DW; Christoforidis, GA; Newton, HB; Slivka, MA; Stevens, CL | 1 |
| Berg, S; Bernstein, M; Blaney, SM; Cherrick, I; Kuttesch, N; Murry, DJ; Salama, V | 1 |
| Holden, L; McNeish, I; Newlands, ES; Rustin, GJ; Seckl, MJ; Strickland, S | 1 |
| Henney, JE; Muggia, FM; Rozencweig, M; Von Hoff, DD | 1 |
| Douek, E; Kingston, JE; Plowman, PN; Sebag-Montefiore, DJ | 1 |
| Ban, Y; Iwata, H; Kanematsu, E; Kawada, Y; Kawamoto, S; Kuriyama, M; Saitoh, A; Takahashi, Y; Yamamoto, N | 1 |
| Djuric, L; Grujicic, D; Jeremic, B; Jevremovic, S; Mijatovic, L; Milojevic, L; Stanisavljevic, B | 1 |
| Berendsen, HH; Haaxma-Reiche, H; Postmus, PE; Smit, EF | 1 |
| Doughty, D; Plowman, PN; Sebag-Montefiore, DJ | 1 |
| Chang, TK; Ho, DM; Wong, TT | 1 |
| Einhorn, LH; Lester, SG; Morphis, JG; Spears, WT; Williams, SD | 1 |
| Ishikawa, J; Nozaki, K; Okuno, S; Yamamoto, K | 1 |
| Ash, RC; Beatty, PA; Lundberg, JH; Weissman, DE | 1 |
| Finlay, JL; McElwain, M; Packer, RJ; Pons, MA; Puccetti, D; Walker, RW | 1 |
| Higashihara, T; Hojo, K; Kajiyama, K; Kumasaka, Y; Nishiyama, S; Okada, M; Oku, Y | 1 |
| Boiardi, A; Botturi, M; Broggi, G; Milanesi, I; Silvani, A | 2 |
| Boiardi, A; Botturi, M; Broggi, G; Milanesi, I; Munari, L; Silvani, A | 1 |
| Ellerbroek, NA; Glisson, BS; Holoye, PY; Hong, WK; Komaki, R; Pang, AC; Roth, JA; Ryan, MB; Zatopek, NK | 1 |
| Castañeda, VL; Geiser, CF; Marlin, AE; Mullins, JK; Parmley, RT; Saldivar, VA | 1 |
| Itoyama, Y; Kochi, M; Kuratsu, J; Uemura, S; Ushio, Y; Yamamoto, H | 1 |
| Bagshawe, KD; Begent, RH; Bradley, J; Dawson, PM; Kulkarni, RP; Makey, AR; Newlands, ES; Reynolds, KW; Rustin, GJ; Theodorou, NA | 1 |
| Cantwell, B; Fossà, SD; Harding, MJ; Jones, WG; Lewis, CR; Mead, G; Mill, L; Paul, J; Rodenburg, CJ; ten Bokkel Huinink, W | 1 |
| Hanakita, J; Iihara, K; Nishi, S; Nishihara, K; Ohta, F; Sakaida, H; Suwa, H | 1 |
| Coulombier, DM; Spooner, SF | 1 |
| Arita, N; Fujita, T; Hayakawa, T; Kubo, S; Miyawaki, Y; Nakagawa, H; Tsuruzono, K | 1 |
| Bakri, YN; Nassar, M; Pedersen, P | 1 |
| Dombernowsky, P; Hansen, HH; Hansen, M; Hirsch, FR; Osterlind, K; Pedersen, AG; Sörenson, S | 1 |
| Boiardi, A; Botturi, M; Milanesi, I; Munari, L; Silvani, A; Solero, CL | 1 |
| Alvarez, O; Beaton, R; Chowhan, N; Davis, R; Fertman, S; Iliya, A; Madajewicz, S; Meek, A; Pampati, M; Roque, C | 1 |
| Andriessen, MP; Mulder, JG; Sleijfer, DT | 1 |
| Carson, BS; Corden, BJ; Killmond, T; Kumar, AJ; Phillips, PC; Piantadosi, S; Robb, PA; Strauss, LC; Wharam, MD | 1 |
| August, C; Bayever, E; Finlay, JL; Freid, A; Kamani, N; Kramer, E; Packer, R; Rorke, L; Sutton, L; Zimmerman, R | 1 |
| Carson, BS; Killmond, TM; Leventhal, BG; Maria, BL; Strauss, LC; Wharam, MD | 1 |
| Butti, G; D'Incalci, M; Donelli, MG; Gaetani, P; Knerich, R; Rossi, C; Silvani, V; Zucchetti, M | 1 |
| Flora, G; Grunberg, SM; Sharma, D | 1 |
| Brown, LD; Buckner, JC; Cascino, TL; Gerstner, JB; Krook, JE; O'Fallon, JR; Scheithauer, B; Westberg, MW; Wiesenfeld, M | 1 |
| Ash, CM; Earl, HM; Geddes, DM; Harper, PG; Quinn, H; Souhami, RL; Spiro, SG; Tobias, JS; Twelves, CJ | 1 |
| Douglass, EC; Etcubanas, EE; Fairclough, DL; Horowitz, ME; Jenkins, JJ; Kellie, SJ; Kovnar, EH; Langston, JW; Mulhern, RK; Sanford, RA | 1 |
| Calogero, JA; Hellman, RM; Kaplan, BM | 1 |
| Ando, T; Hao, K; Miyashita, M; Onda, M; Sasajima, K; Takubo, K; Watanabe, M; Yamashita, K | 1 |
| Castello, MA; Clerico, A; Deb, G; Dominici, C; Donfrancesco, A; Fidani, P | 1 |
| De Boben, M; Diedrich, H; Freund, M; Ganser, A; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Knauf, U; Koch, P | 1 |
| Bacchi, M; Bassi, P; Belsanti, V; Bisagni, G; Boni, C; Cocconi, G; Lottici, R; Passalacqua, R; Tonato, M | 1 |
| Chan, KW; Fryer, CJ; Steinbok, P | 1 |
| Furuyama, J; Kaba, K; Kochi, N; Matsumoto, T; Sakamoto, H; Shindo, H; Tani, E; Yamamoto, Y | 1 |
| Amemiya, Y; Kida, Y; Kobayashi, T; Matsui, M | 1 |
| Herkert, A; Kleisbauer, JP; Soyez, F; Thomas, P | 1 |
| Ishii, Y; Matsumoto, S; Murashima, N; Ohsaki, A; Seno, N; Yoshimoto, A | 1 |
| Carrasco, CH; Charnsangavej, C; Feun, LG; Gianturco, C; Lee, YY; Savaraj, N; Wallace, S; Yung, WK | 1 |
| Barnard, RO; Crockard, A; Ellis, SJ | 1 |
| Einhorn, LH | 1 |
| Bagshawe, KD; Begent, RH; Crawford, SM; Newlands, ES; Rustin, GJ | 1 |
| Bagshawe, KD; Begent, RH; Dent, J; Newlands, ES; Rustin, GJ | 1 |
| Emoto, K; Kodama, Y; Onda, J; Uozumi, T; Yukawa, O; Yuki, K | 1 |
| Haaxma-Reiche, H; Kirkpatrick, A; Kleisbauer, JP; McVie, JG; Postmus, PE; Sleijfer, DT | 1 |
| Ishiyama, J; Kida, Y; Kito, A; Kobayashi, T; Noda, S; Yoshida, J | 1 |
| Dhingra, HM; Glisson, BS; Holoye, PY; Hong, WK; Lee, JS; Murphy, WK | 1 |
| Carney, DN; Grogan, L; Harford, P; Kearns, F | 1 |
| Wilkinson, PM | 1 |
| Hanada, R; Hayashi, Y; Inaba, T; Nishimoto, H; Tsukiyama, T; Yaginuma, A; Yamamoto, K | 1 |
| Mizuno, M; Noda, S; Yoshida, J | 1 |
| Kuchiwaki, H; Mizuno, M; Shimosawa, S; Yoshida, J | 1 |
| Berendsen, HH; Haaxma-Reiche, H; Postmus, PE | 1 |
| Abeloff, MD; Berkman, AW; Markman, M; Waterfield, WC | 1 |
| Chak, LY; Cox, RS; Kushlan, PD; Porzig, KJ; Sikic, BI; Wasserstein, P; Zatz, LM | 1 |
| Budd, GT; Coltman, CA; Crowley, JP; Grever, MR; Harker, G; Livingston, RB; Mira, JG; Rivkin, SE; Schulman, S; Vogel, S | 1 |
| Dixon, RH; Gottleib, RJ; Harvey, HA; Hoffman, SL; Lipton, A; Messeih, AA; Ricci, JA; Schweitzer, JM; Simmonds, MA; Stryker, JA | 1 |
| Haaxma-Reiche, H; Kirkpatrick, A; Kleisbauer, JP; Postmus, PE; Sleijfer, DT; ten Velde, G | 1 |
| Ben-Sira, I; Cohen, S; Nissenkorn, I; Stark, B; Wysenbeek, YS; Zaizov, R | 1 |
| Arends, JW; Blijham, GH; Braat, SH; de Haan, J; Hoogland, HJ; van Krimpen, C | 1 |
| Ayela, P; Frenay, M; Lagrange, JL; Schneider, M; Thyss, A; Viens, P | 1 |
| Daly, MB; Harden, EA; Johnson, DB; Leff, RS; Mercier, RJ; Messerschmidt, GL; Thompson, JM | 1 |
| Blaive, B; Carles, P; Clary, C; Dongay, G; Guerin, JC; Kleisbauer, JP; Orehek, J; Poirier, R; Saretto, S; Vesco, D | 1 |
| Kleisbauer, JP; Lena-Nosny, N; Vesco, D | 1 |
| Feun, LG; Lee, YY; Savaraj, N; Wallace, S; Yung, WK | 1 |
| Ajima, J; Fukui, I; Gotoh, S; Higashi, Y; Kihara, K; Kobayashi, N; Kojima, S; Matsubara, O; Takagi, K; Yoshino, S | 1 |
| Wolff, SN | 1 |
| Bozek, T; Finn, GP; Slevin, ML; Souhami, RL; Thomas, DG | 1 |
34 review(s) available for etoposide and Brain Neoplasms
| Article | Year |
|---|---|
Current concepts in the management of small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Etoposide; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Platinum; Randomized Controlled Trials as Topic; Recurrence; Small Cell Lung Carcinoma; Treatment Outcome | 2013 |
Etoposide improves survival in high-grade glioma: a meta-analysis.
Topics: Brain Neoplasms; Cohort Studies; Demography; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Survival Analysis; Topoisomerase Inhibitors | 2013 |
Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Complex and Mixed; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms; Transplantation, Autologous | 2017 |
Management of small-cell lung cancer: incremental changes but hope for the future.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Cranial Irradiation; Dose Fractionation, Radiation; Etoposide; Humans; Lung Neoplasms; Neoplasm Staging; Practice Guidelines as Topic; Prognosis; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Survival Analysis; Topotecan; Treatment Outcome | 2008 |
Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Craniotomy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Infant; Infant, Newborn; Injections, Spinal; Kaplan-Meier Estimate; Male; Prognosis; Prospective Studies; Rhabdoid Tumor; Spinal Neoplasms; Teratoma; Treatment Outcome; Vincristine | 2009 |
Radiotherapy in small-cell lung cancer: where should it go?
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Disease Progression; Early Detection of Cancer; Etoposide; Humans; Lung Neoplasms; Neoplasm Staging; Radiotherapy; Small Cell Lung Carcinoma | 2010 |
Yolk sac tumor of the bilateral basal ganglia in a patient with Down syndrome.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia; Brain Neoplasms; Chemoradiotherapy; Cisplatin; Disease Progression; Down Syndrome; Endodermal Sinus Tumor; Etoposide; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Paresis; Treatment Outcome | 2013 |
Chemotherapy for breast cancer brain metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Survival Rate; Treatment Outcome | 2002 |
Limited-disease small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dose Fractionation, Radiation; Etoposide; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis | 2003 |
Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cranial Irradiation; Cytarabine; Dementia; Dementia, Vascular; Demyelinating Diseases; Disease Progression; Doxorubicin; Epilepsy, Complex Partial; Etoposide; Eye Neoplasms; Fatal Outcome; Female; Gait Disorders, Neurologic; Humans; Immunocompetence; Intracranial Arteriosclerosis; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Procarbazine; Radiation Injuries; Retrospective Studies; Survival Analysis; Thiotepa; Vincristine | 2004 |
[Genetic analysis and individualized therapy for diffuse glioma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinases; Drug Administration Schedule; Etoposide; Female; Genes, p53; Glioma; Humans; Male; Middle Aged; Oligodendroglioma; Proteasome Endopeptidase Complex; Proteins; Tumor Suppressor Proteins | 2005 |
[Chemotherapy for brain tumor].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Drug Delivery Systems; Etoposide; Humans; Lymphoma; Medulloblastoma; Methotrexate; Neoplasms, Germ Cell and Embryonal; Nimustine; Oligodendroglioma; Platinum Compounds; Randomized Controlled Trials as Topic; Vincristine | 2005 |
Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Etoposide; Humans; Infant; Maximum Tolerated Dose; Survival Analysis; Vincristine | 2006 |
Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Cyclophosphamide; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Humans; London; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Survival Analysis; Time Factors; Treatment Outcome; Vincristine | 2006 |
Is the blood-brain barrier relevant in metastatic germ cell tumor?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood-Brain Barrier; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Fatal Outcome; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Space; Testicular Neoplasms | 2007 |
High dose chemotherapy with autologous bone marrow rescue for high grade gliomas of the brain: a potential for improvement in therapeutic results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Carmustine; Combined Modality Therapy; Etoposide; Glioblastoma; Glioma; Humans; Lomustine; Teniposide | 1984 |
High-risk metastatic gestational trophoblastic tumors. Current management.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Clinical Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Lung Neoplasms; Methotrexate; Neoplasm Staging; Pregnancy; Prognosis; Remission Induction; Risk Factors; Survival Rate; Thoracotomy; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vaginal Neoplasms; Vincristine | 1994 |
Combination chemotherapy with cisplatin and etoposide for hematogenous spinal metastasis of intracranial germinoma--case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Dysgerminoma; Etoposide; Humans; Magnetic Resonance Imaging; Male; Pinealoma; Spinal Neoplasms | 1993 |
Teniposide: overview of its therapeutic potential in adult cancers.
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Etoposide; Female; Genital Neoplasms, Female; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Sarcoma, Kaposi; Teniposide | 1994 |
Brain metastasis from clear cell sarcoma of the kidney--a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Craniotomy; Dactinomycin; Doxorubicin; Etoposide; Fatal Outcome; Frontal Lobe; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Nephrectomy; Vincristine | 1993 |
DNA topoisomerase II rescue by catalytic inhibitors: a new strategy to improve the antitumor selectivity of etoposide.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Etoposide; Humans; Mice; Razoxane; Topoisomerase II Inhibitors | 1997 |
Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Pregnancy; Remission Induction; Trophoblastic Neoplasms | 1997 |
Management of high-risk gestational trophoblastic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Humans; Liver Neoplasms; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1998 |
Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Mesna; Methotrexate; Middle Aged; Mitomycin; Nasal Cavity; Nose Neoplasms; Paranasal Sinus Neoplasms; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
Extraskeletal osteosarcoma of the mediastinum after treatment of a mediastinal germ-cell tumor.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Etoposide; Fatal Outcome; Follow-Up Studies; Germinoma; Humans; Male; Mediastinal Neoplasms; Neoplasm, Residual; Neoplasms, Second Primary; Osteosarcoma; Teratoma | 1999 |
How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Brain Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Melphalan; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Thiotepa; Vincristine; Whole-Body Irradiation | 2001 |
Isolated central nervous system relapse of non-seminomatous germ cell tumour of the testis. A case report and review of the literature.
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Carcinoma, Embryonal; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Occipital Lobe; Orchiectomy; Radiotherapy, Adjuvant; Remission Induction; Testicular Neoplasms; Tomography, X-Ray Computed; Vision Disorders | 2001 |
[Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Glioma; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Transplantation, Autologous | 2001 |
Chemotherapy for trophoblastic disease: current standards.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Methotrexate; Neoplasm Staging; Pregnancy; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2002 |
Bilateral metachronous germinoma of the basal ganglia occurring long after total removal of a mature pineal teratoma: case report.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia Diseases; Brain Neoplasms; Carboplatin; Child; Combined Modality Therapy; Etoposide; Germinoma; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Second Primary; Pineal Gland; Teratoma | 2002 |
VM 26 and VP 16-213: a comparative analysis.
Topics: Animals; Brain Neoplasms; Drug Evaluation; Etoposide; Humans; Kinetics; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms, Experimental; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1977 |
Chemotherapy of metastatic Merkel cell carcinoma: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Merkel Cell; Cisplatin; Etoposide; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Skin Neoplasms | 1991 |
Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Drug Evaluation; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Remission Induction | 1990 |
New drugs and new delivery techniques.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Bleomycin; Brain Neoplasms; Carboplatin; Carmustine; Cisplatin; Etoposide; Humans; Infusions, Intra-Arterial; Interferons; Nitrosourea Compounds; Organoplatinum Compounds; Rats | 1985 |
128 trial(s) available for etoposide and Brain Neoplasms
| Article | Year |
|---|---|
Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children's Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Germinoma; Humans; Pineal Gland; Prospective Studies; Young Adult | 2022 |
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Humans; Infant; Isotretinoin; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive; Prospective Studies; Vincristine; Vorinostat | 2022 |
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cisplatin; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Double-Blind Method; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Myeloid Cells; Paclitaxel; Prognosis; Pyrimidines; Pyrroles; Small Cell Lung Carcinoma; Survival Rate; Tissue Distribution | 2019 |
A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors.
Topics: Administration, Metronomic; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Celecoxib; Child; Child, Preschool; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Male; Maximum Tolerated Dose; Neoplasms; Sirolimus; Young Adult | 2020 |
Induction Chemotherapy Reduces Radiation Therapy Dose and Volume in the Treatment of Intracranial Germinoma: Results of the SMC-G13 Trial.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Chorionic Gonadotropin, beta Subunit, Human; Cranial Irradiation; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Germinoma; Humans; Induction Chemotherapy; Male; Neutropenia; Pilot Projects; Progression-Free Survival; Prospective Studies; Proton Therapy; Radiotherapy Dosage; Radiotherapy, Conformal; Young Adult | 2020 |
Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Glioma; Humans; Male; Maximum Tolerated Dose; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Salvage Therapy; Temozolomide | 2013 |
Evolving of therapeutic strategies for CNS-PNET.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Neuroectodermal Tumors, Primitive; Thiotepa; Vincristine | 2013 |
A randomized phase III study of single-agent amrubicin vs. carboplatin/etoposide in elderly patients with extensive-disease small-cell lung cancer.
Topics: Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Neoplasm Staging; Prognosis; Quality of Life; Small Cell Lung Carcinoma; Survival Rate | 2014 |
Intensive chemotherapy followed by reduced-dose radiotherapy for biopsy-proven CNS germinoma with elevated beta-human chorionic gonadotropin.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Etoposide; Female; Germinoma; Humans; Induction Chemotherapy; Male; Radiotherapy Dosage; Young Adult | 2014 |
Timing of thoracic radiotherapy in limited stage small cell lung cancer: results of early versus late irradiation from a single institution in Turkey.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Cisplatin; Deoxycytidine; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Time Factors | 2014 |
Bevacizumab preconditioning followed by Etoposide and Cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Brain Neoplasms; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Radiotherapy; Treatment Outcome | 2015 |
Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group.
Topics: Antineoplastic Agents; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Combined Modality Therapy; Consolidation Chemotherapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Infant; Male; Pilot Projects; Thiotepa; Treatment Outcome; Vincristine | 2015 |
Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Second-Look Surgery; Thiotepa; Treatment Outcome | 2015 |
Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cerebral Ventricles; Child; Child, Preschool; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Humans; Infant; Male; Treatment Outcome; Young Adult | 2016 |
Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Neurosurgical Procedures; Radiotherapy; Treatment Outcome; Vincristine | 2016 |
A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Breast Neoplasms; Cisplatin; Contrast Media; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pilot Projects; Prospective Studies; Time Factors; Treatment Outcome | 2016 |
[Radiotherapy of malignant brain gliomas using teniposide].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Chemotherapy, Adjuvant; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Prospective Studies; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome | 2008 |
Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Radiation; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Analysis | 2008 |
A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Radiotherapy; Rhabdoid Tumor; Teratoma; Thiotepa; Tomography, X-Ray Computed | 2009 |
A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Central Nervous System Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Vincristine; Young Adult | 2009 |
Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prospective Studies; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium | 2009 |
Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease Progression; Etoposide; Female; Glioblastoma; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Time Factors; Treatment Outcome; Young Adult | 2010 |
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study.
Topics: Administration, Oral; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Brain Neoplasms; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Failure; Vascular Endothelial Growth Factor A | 2009 |
Central nervous system relapse continues to be a therapeutic challenge in extensive disease small-cell lung cancer patients with initial symptomatic brain metastases and good response to chemoradiotherapy.
Topics: Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Secondary Prevention; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2010 |
Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Infant; Male; Neoplasms, Germ Cell and Embryonal; Treatment Outcome; Young Adult | 2010 |
A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Electroencephalography; Etoposide; Evoked Potentials, Visual; Female; Glioma; Humans; Infant; Infant, Newborn; Longitudinal Studies; Magnetic Resonance Imaging; Male | 2010 |
Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Etoposide; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Middle Aged; Neoplasm Recurrence, Local; Temozolomide | 2011 |
Outcome of central nervous system germinoma treatment by chemoradiation.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Male; Radiation Dosage; Treatment Outcome; Young Adult | 2011 |
Chemotherapy with concurrent brain and thoracic radiotherapy in brain-only metastases of treatment naive small-cell lung cancer: a phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Cisplatin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma | 2012 |
Treatment of paediatric pontine glioma with oral trophosphamide and etoposide.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Glioblastoma; Glioma; Humans; Male; Pons; Postoperative Care; Survival Rate; Treatment Outcome | 2002 |
Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Survival Rate | 2002 |
Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Dose-Response Relationship, Drug; Etoposide; Female; Glioma; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Temozolomide; Treatment Outcome | 2003 |
Feasibility of long-term intraventricular therapy with mafosfamide (n = 26) and etoposide (n = 11): experience in 26 children with disseminated malignant brain tumors.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Headache; Humans; Injections, Intraventricular; Injections, Spinal; Male; Meningeal Neoplasms; Nausea; Pain; Treatment Outcome | 2003 |
Pharmacokinetics of etoposide in cancer patients treated with high-dose etoposide and with dexrazoxane (ICRF-187) as a rescue agent.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Brain Neoplasms; Carcinoma, Small Cell; Catheters, Indwelling; Chromatography, High Pressure Liquid; Etoposide; Humans; Infusions, Intravenous; Lung Neoplasms; Razoxane | 2004 |
Cerebrospinal fluid pharmacokinetics after different dosage regimens of intraventricular etoposide.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Injections, Intraventricular; Male | 2003 |
Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Female; Glioma; Humans; Male; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive; Pilot Projects; Statistics, Nonparametric; Survival Rate; Vincristine | 2004 |
Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma.
Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Glioma; Humans; In Situ Hybridization; Male; Survival Analysis | 2004 |
Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy; Radiotherapy Dosage | 2005 |
Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Radiotherapy Dosage; Survival Rate | 2005 |
A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Survival Analysis; Tamoxifen | 2005 |
Neoadjuvant cisplatin and etoposide, with or without tamoxifen, prior to radiotherapy in high-grade gliomas: a single-center experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cisplatin; Drug Administration Schedule; Etoposide; Female; Glioblastoma; Humans; Male; Middle Aged; Neoadjuvant Therapy; Survival Rate; Tamoxifen | 2005 |
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Camptothecin; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Irinotecan; Liver Neoplasms; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Survival Analysis | 2005 |
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Ependymoma; Etoposide; Female; Glioma; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive, Peripheral; Survival Rate; Treatment Outcome; Vincristine | 2005 |
Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children's Oncology Group.
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Child; Child, Preschool; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Germinoma; Humans; Infant; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Pilot Projects; Pinealoma; Risk; Treatment Outcome; Vincristine | 2007 |
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Loss of Heterozygosity; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome | 2006 |
Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Fluorouracil; Glioma; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Prospective Studies; Treatment Outcome; Vincristine | 2006 |
Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Cyclophosphamide; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Humans; London; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Survival Analysis; Time Factors; Treatment Outcome; Vincristine | 2006 |
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Health Surveys; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Prednisone; Risk Factors; Survival Rate; Vincristine | 2007 |
Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Etoposide; Female; Glioma; Humans; Irinotecan; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Teniposide; Tomography, X-Ray Computed | 2007 |
Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Carboplatin; Cyclophosphamide; Etoposide; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Lymphoma; Male; Methotrexate; Middle Aged; Osmosis; Ovarian Neoplasms; Prospective Studies; Survival Rate | 2007 |
Topotecan and etoposide in the treatment of relapsed high-risk neuroblastoma: results of a phase 2 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neuroblastoma; Topotecan; Treatment Outcome | 2007 |
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Celecoxib; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Pyrazoles; Sulfonamides; Thalidomide | 2007 |
Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Neoplasm Recurrence, Local; Neuroblastoma; Topotecan; Treatment Outcome | 2007 |
Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Neuroepithelial; Neoplasms, Second Primary; Pilot Projects; Temozolomide; Treatment Outcome | 2008 |
Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Eye Neoplasms; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Survival Rate; Thiotepa | 2008 |
Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Leukopenia; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Vincristine | 1982 |
Doxorubicin, Cyclophosphamide and VP16-213 (ACE) in the treatment of small cell lung cancer.
Topics: Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1982 |
Combined modality treatment of extensive small cell lung cancer: a Southwest Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Leukopenia; Lung Neoplasms; Methotrexate; Random Allocation; Stomatitis; Vincristine | 1984 |
Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Radiography; Regression Analysis; Survival Rate | 1995 |
Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Remission Induction; Risk Factors; Sarcoma, Ewing; Survival Rate; Vincristine | 1995 |
Attempted dose intensified cyclophosphamide, etoposide, and granulocyte colony-stimulating factor for treatment of malignant astrocytoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Evaluation Studies as Topic; Female; Granulocyte Colony-Stimulating Factor; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Survival Rate; Tomography, X-Ray Computed | 1995 |
Single fraction prophylactic cranial irradiation for small cell carcinoma of the lung.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cognition; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Memory; Psychomotor Performance; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Survival Rate; Vincristine | 1995 |
Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Etoposide; Eye Neoplasms; Female; Follow-Up Studies; France; Humans; Infant; Male; Orbital Neoplasms; Remission Induction; Retinoblastoma | 1995 |
A phase II evaluation of thiotepa followed by other multiagent chemotherapy regimens in infants and young children with malignant brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Pilot Projects; Thiotepa; Vincristine | 1995 |
Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Survival Rate; Thoracic Neoplasms; Vincristine | 1994 |
Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy; Remission Induction; Treatment Outcome | 1994 |
Comparison of the Cox model and the regression tree procedure in analysing a randomized clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bias; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Regression Analysis; Survival Analysis; Treatment Outcome | 1993 |
Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Child; Etoposide; Female; Germinoma; Glioblastoma; Humans; Lymphoma; Male; Middle Aged; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Tomography, X-Ray Computed | 1995 |
Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cause of Death; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Follow-Up Studies; Humans; Infusions, Intravenous; Leukopenia; Lung; Lung Neoplasms; Neoplasm Staging; Radiation Pneumonitis; Remission Induction; Survival Rate; Thrombocytopenia | 1996 |
Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cause of Death; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Remission Induction; Vincristine | 1996 |
[Usefulness and problems of high dose chemotherapy using CBDCA, VP-16, and MCNU with peripheral blood stem cell transplantation in pediatric malignant brain tumors].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Nitrosourea Compounds | 1996 |
Carboplatin pharmacokinetics in young children with brain tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Etoposide; Glomerular Filtration Rate; Hematologic Diseases; Humans; Prospective Studies; Reproducibility of Results; Statistics, Nonparametric | 1996 |
Contemporary chemotherapy issues for children with brainstem gliomas.
Topics: Antineoplastic Agents; Brain Neoplasms; Brain Stem; Carboplatin; Carmustine; Dose-Response Relationship, Drug; Etoposide; Glioma; Humans; Neoplasm Recurrence, Local; Thiotepa; Vincristine | 1996 |
Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Survival Rate; Thiotepa | 1997 |
Thiotepa and etoposide treatment of recurrent malignant gliomas: phase I study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Thiotepa | 1997 |
Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Infant; Neoplasm Recurrence, Local; Neoplasms; Treatment Outcome | 1997 |
Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Ifosfamide; Male; Pilot Projects; Prognosis; Vincristine | 1997 |
Phase II trial of cisplatinum and etoposide in brain metastases of solid tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Survival Rate; Tomography, X-Ray Computed | 1997 |
Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platelet Count; Radiography; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Time Factors; Treatment Outcome; Vincristine | 1997 |
Feasibility of sequential high-dose chemotherapy and peripheral blood stem cell support for pediatric central nervous system malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasm Recurrence, Local; Survival Analysis; Treatment Failure | 1997 |
Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Dose Fractionation, Radiation; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Male; Pons; Radiotherapy, Adjuvant; Treatment Outcome | 1998 |
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infant; Infections; Infusions, Intravenous; Leukopenia; Male; Neuroblastoma; Neutropenia; Thrombocytopenia; Treatment Outcome; Vincristine | 1997 |
High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Brain Stem; Carboplatin; Carmustine; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Humans; Male; Pons; Survival Rate; Thiotepa | 1998 |
Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Carboplatin; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Male; Myeloablative Agonists; Neoplasm Recurrence, Local; Survival Analysis; Thiotepa; Transplantation, Autologous; Treatment Outcome | 1998 |
Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Deafness; Disease Progression; Disease-Free Survival; Etoposide; Follow-Up Studies; Glioma; Hearing Loss; Hematologic Diseases; Humans; Ifosfamide; Infections; Life Tables; Lomustine; Medulloblastoma; Methotrexate; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Vincristine | 1998 |
[A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Interferon-beta; Male; Middle Aged; Nitrosourea Compounds; Prognosis; Survival Rate | 1998 |
Effect of etoposide on the pharmacokinetics of methotrexate in vivo.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Etoposide; Humans; Leucovorin; Medulloblastoma; Methotrexate; Mitolactol; Procarbazine | 1998 |
Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Survival Analysis | 1998 |
[CBDCA, etoposide and epirubicin high-dose combination chemotherapy supported by peripheral blood stem cell transplantation (PBSCT) in metastatic breast cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local | 1999 |
Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Melanoma; Middle Aged; Prospective Studies; Survival Rate | 1999 |
Interstitial chemotherapy plus systemic chemotherapy for glioblastoma patients: improved survival in sequential studies.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carmustine; Catheters, Indwelling; Cisplatin; Combined Modality Therapy; Etoposide; Glioblastoma; Humans; Postoperative Care; Survival Analysis | 1999 |
Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Humans; Male; Middle Aged; Radiotherapy Dosage; Radiotherapy, High-Energy; Survival Analysis | 1999 |
Regimen-related toxicity of myeloablative chemotherapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: report from the Children's Cancer Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Glioblastoma; Hematopoietic Stem Cell Transplantation; Humans; Male; Pilot Projects; Survival Analysis; Thiotepa; Transplantation, Autologous | 1999 |
Carboplatin and etoposide for recurrent malignant glioma following surgical and radiotherapy failure: A clinical study conducted at the Northern Israel Oncology Center.
Topics: Adolescent; Adult; Antineoplastic Agents; Brain Neoplasms; Carboplatin; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Treatment Failure; Treatment Outcome | 1999 |
Phase II study of a radiotherapy/etoposide combination for patients with newly malignant gliomas.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Etoposide; Female; Glioma; Humans; Karnofsky Performance Status; Male; Middle Aged; Survival Analysis | 1999 |
Telomerase activity in central nervous system malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Catalytic Domain; Combined Modality Therapy; DNA-Binding Proteins; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Prednisolone; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA; Survival Analysis; Telomerase; Vincristine | 1999 |
Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Female; Glioblastoma; Humans; Male; Middle Aged; Radiotherapy; Survival Analysis | 1999 |
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Risk Factors; Survival Analysis; Thiotepa; Treatment Outcome | 1999 |
Etoposide with or without mannitol for the treatment of recurrent or primarily unresponsive brain tumors: a Children's Cancer Group Study, CCG-9881.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Drug Therapy, Combination; Etoposide; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Mannitol; Neoplasm Recurrence, Local; Survival Analysis; Treatment Failure | 1999 |
Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Female; Glioblastoma; Humans; Injections, Intra-Arterial; Male; Middle Aged; Prospective Studies | 2000 |
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Female; Genital Neoplasms, Female; Genital Neoplasms, Male; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Survival Analysis; Treatment Outcome | 2000 |
[Effectiveness of DeVIC chemotherapy for recurrent primary central nervous system lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Treatment Outcome | 2000 |
Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Infant; Infusions, Intravenous; Iodine Radioisotopes; Male; Mediastinal Neoplasms; Neuroblastoma; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2001 |
Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Procarbazine; Prognosis; Treatment Outcome; Vincristine | 2001 |
Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Ependymoma; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome | 2001 |
Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebral Angiography; Cisplatin; Etoposide; Female; Glioma; Humans; Infusions, Intra-Arterial; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome | 2001 |
Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Chromatography, High Pressure Liquid; Etoposide; Female; Half-Life; Humans; Injections, Intraventricular; Male; Medulloblastoma; Neoplasm Metastasis | 2001 |
Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Etoposide; Female; Follow-Up Studies; Glioblastoma; Humans; Male; Middle Aged; Radiotherapy; Survival Rate; Time Factors | 2001 |
Long-term results of a phase I/II study of high-dose thoracic radiotherapy with concomitant cisplatin and etoposide in limited stage small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged | 2001 |
Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Female; Glioma; Humans; Injections, Intra-Arterial; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Treatment Outcome | 2002 |
Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cisplatin; Drug Administration Schedule; Drug Evaluation; Drug Synergism; Etoposide; Female; Glioblastoma; Humans; Male; Middle Aged; Recurrence; Treatment Outcome | 1992 |
Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Clinical Trials, Phase II as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Pilot Projects; Remission Induction; Survival Rate; Vincristine | 1992 |
Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Growth Disorders; Hematologic Diseases; Humans; Infant; Intellectual Disability; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Nervous System Diseases; Radiation Injuries; Remission Induction; Salvage Therapy; Treatment Outcome; Vincristine | 1992 |
Carboplatin combined with carmustine and etoposide in the treatment of glioblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carmustine; Etoposide; Glioma; Humans; Middle Aged; Survival Analysis | 1992 |
Local immunotherapy (beta-IFN) and systemic chemotherapy in primary glial tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Glioblastoma; Humans; Immunotherapy; Interferon Type I; Middle Aged; Tomography, X-Ray Computed | 1991 |
BOP/VIP--a new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Brain Neoplasms; Chorionic Gonadotropin; Cisplatin; Creatinine; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Remission Induction; Survival Analysis; Vincristine | 1991 |
Combination chemotherapy of limited-stage small-cell lung cancer. A controlled trial on 221 patients comparing two alternating regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prospective Studies; Recurrence; Remission Induction; Survival Rate; Vincristine | 1991 |
Cisplatin and etoposide combination therapy for primary glial tumors: preliminary results.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Glioblastoma; Glioma; Humans; Middle Aged | 1991 |
Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Cisplatin; Cytarabine; Drug Evaluation; Ependymoma; Etoposide; Female; Glioma; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local; Pinealoma; Probability; Prognosis | 1991 |
High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Transplantation; Brain Neoplasms; Carmustine; Child; Combined Modality Therapy; Etoposide; Female; Glioblastoma; Humans; Male; Spinal Cord Neoplasms; Thiotepa; Transplantation, Autologous | 1990 |
Efficacy of postoperative chemotherapy using cisplatin plus etoposide in young children with brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Male; Pilot Projects; Tomography, X-Ray Computed | 1991 |
Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent astrocytoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cisplatin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local | 1990 |
The response of cerebral metastases in small cell lung cancer to systemic chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Vincristine | 1990 |
Treatment of relapsed acute lymphocytic leukemia in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Germany, West; Humans; Ifosfamide; Leucovorin; Life Tables; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spinal Cord Neoplasms; Teniposide; Testicular Neoplasms; Vindesine | 1990 |
Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Chorionic Gonadotropin; Clinical Trials as Topic; Craniotomy; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Prognosis; Vincristine | 1989 |
Primary chemotherapy of brain metastasis in small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Vincristine | 1989 |
Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Hematologic Diseases; Humans; Liver Neoplasms; Lung Neoplasms; Random Allocation | 1986 |
Addition of etoposide to cyclophosphamide, doxorubicin, and vincristine for remission induction and survival in patients with small cell lung cancer.
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Random Allocation; Vincristine | 1987 |
427 other study(ies) available for etoposide and Brain Neoplasms
| Article | Year |
|---|---|
Cell-based screen for identification of inhibitors of tubulin polymerization.
Topics: Animals; Brain Neoplasms; Bucladesine; Cell Differentiation; Drug Screening Assays, Antitumor; Formazans; Glioma; Rats; Tubulin; Tumor Cells, Cultured | 1996 |
New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Doxorubicin; Etoposide; Female; Humans; Inhibitory Concentration 50; Kinetics; Male; Mice; Peptides | 2010 |
Combined carboplatin and etoposide chemotherapy for patients with recurrent glioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Glioma; Humans; Retrospective Studies; Treatment Outcome | 2021 |
Sellar germinoma mimicking IgG4-related hypophysitis: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Hypophysitis; Brain Neoplasms; Cisplatin; Diagnosis, Differential; Etoposide; Germinoma; Humans; Immunoglobulin G; Male; Sella Turcica | 2022 |
Anlotinib plus platinum-etoposide as a first-line treatment for extensive-stage small cell lung cancer: A single-arm trial.
Topics: Brain Neoplasms; Etoposide; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Platinum; Quinolines; Small Cell Lung Carcinoma | 2022 |
Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report.
Topics: Brain Neoplasms; Choriocarcinoma; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Placenta; Pregnancy; Trophoblastic Neoplasms | 2022 |
Metabolomics Analysis Revealed Significant Metabolic Changes in Brain Cancer Cells Treated with Paclitaxel and/or Etoposide.
Topics: Brain Neoplasms; Etoposide; Glioblastoma; Humans; Paclitaxel; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2022 |
External Beam Fast Neutron Therapy: Russian Clinical Experience and Prospects for Further Development.
Topics: Boron Neutron Capture Therapy; Brain Neoplasms; Carmustine; Etoposide; Fast Neutrons; Humans; Neutrons; Radiotherapy Dosage | 2023 |
Co-delivery of paclitaxel and etoposide prodrug by human serum albumin and PLGA nanoparticles: synergistic cytotoxicity in brain tumour cells.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Etoposide; Humans; Mice; Nanoparticles; Paclitaxel; Prodrugs; Serum Albumin, Human | 2023 |
Radiation-induced Desmoid Tumor Development in the Radiotherapy Field in a Child With Pineoblastoma: A Case Report.
Topics: Brain Neoplasms; Child; Etoposide; Female; Fibromatosis, Aggressive; Humans; Pineal Gland; Pinealoma; Sarcoma | 2023 |
Can Optical Surface Imaging Replace Non-coplanar Cone-beam Computed Tomography for Non-coplanar Set-up Verification in Single-isocentre Non-coplanar Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy for Single and Multiple Brain Met
Topics: Brain Neoplasms; Carmustine; Cone-Beam Computed Tomography; Etoposide; Humans; Radiosurgery; Radiotherapy Planning, Computer-Assisted | 2023 |
Inhibition of DNA-PK potentiates the synergistic effect of NK314 and etoposide combination on human glioblastoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Chromones; DNA-Activated Protein Kinase; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Etoposide; Glioblastoma; Humans; Morpholines; Phenanthrenes | 2020 |
Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: Survival analysis and impact of salvage re-irradiation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child; Cranial Irradiation; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome | 2019 |
Metastatic Brain Choriocarcinoma in a Postmenopausal Woman: A Case Report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Postmenopause; Uterine Neoplasms; Vincristine | 2020 |
Drug resistance occurred in a newly characterized preclinical model of lung cancer brain metastasis.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; ErbB Receptors; Etoposide; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Nude; Pemetrexed; Xenograft Model Antitumor Assays | 2020 |
Changes in glomerular filtration rate and clinical course after sequential doses of carboplatin in children with embryonal brain tumors undergoing autologous stem cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Etoposide; Female; Glomerular Filtration Rate; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Retrospective Studies; Rhabdoid Tumor; Teratoma; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2020 |
Ribosomal protein S11 influences glioma response to TOP2 poisons.
Topics: Apoptotic Protease-Activating Factor 1; Brain Neoplasms; Cell Line, Tumor; CRISPR-Cas Systems; DNA Breaks, Double-Stranded; DNA Repair; DNA Topoisomerases, Type II; Doxorubicin; Etoposide; Gene Knockout Techniques; Glioblastoma; Humans; Ribosomal Proteins; Topoisomerase II Inhibitors | 2020 |
Involvement of POLA2 in Double Strand Break Repair and Genotoxic Stress.
Topics: Brain Neoplasms; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Damage; DNA Polymerase I; DNA Repair; Etoposide; Gene Expression Regulation, Neoplastic; Glioma; Humans; Indazoles; Piperidines; Radiation, Ionizing; Survival Analysis; Up-Regulation | 2020 |
Management of methotrexate-induced neurotoxicity with aminophylline plus dextromethorphan in a pediatric patient with pineoblastoma.
Topics: Adolescent; Aminophylline; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Bronchodilator Agents; Cisplatin; Cyclophosphamide; Dextromethorphan; Disease Management; Drug Therapy, Combination; Etoposide; Excitatory Amino Acid Antagonists; Female; Humans; Methotrexate; Neurotoxicity Syndromes; Pineal Gland; Pinealoma; Prognosis | 2020 |
Etoposide and olaparib polymer-coated nanoparticles within a bioadhesive sprayable hydrogel for post-surgical localised delivery to brain tumours.
Topics: Adhesiveness; Aerosols; Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Drug Carriers; Drug Compounding; Drug Liberation; Etoposide; Glioblastoma; Humans; Hydrogels; Lactates; Male; Mice, Nude; Nanoparticles; Pectins; Phthalazines; Piperazines; Polyethylene Glycols; Rats; Solubility; Tissue Distribution | 2020 |
Tandem High-dose Chemotherapy without Craniospinal Irradiation in Treatment of Non-metastatic Malignant Brain Tumors in Very Young Children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Craniospinal Irradiation; Etoposide; Female; Hearing Loss; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Infant; Male; Neoplasm Recurrence, Local; Progression-Free Survival; Risk Factors; Salvage Therapy; Survival Rate; Thiotepa; Transplantation, Autologous | 2020 |
Focused Ultrasound-Mediated Blood-Brain Barrier Opening Increases Delivery and Efficacy of Etoposide for Glioblastoma Treatment.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Chromatography, Liquid; Contrast Media; Disease Progression; Etoposide; Glioblastoma; Magnetic Resonance Imaging; Male; Mice; Microbubbles; Sonication; Tandem Mass Spectrometry; Ultrasonography, Interventional | 2021 |
Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Humans; Induction Chemotherapy; Infant; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Retrospective Studies | 2022 |
Choriocarcinoma brain metastasis in a patient in the third trimester: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Pregnancy Trimester, Third; Uterine Neoplasms; Vincristine | 2021 |
Neobavaisoflavone May Modulate the Activity of Topoisomerase Inhibitors towards U-87 MG Cells: An In Vitro Study.
Topics: Antibiotics, Antineoplastic; Astrocytes; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Etoposide; Glioblastoma; Glutathione; Humans; Irinotecan; Isoflavones; Plant Extracts; Psoralea; Signal Transduction; Topoisomerase II Inhibitors | 2021 |
Secondary CNS involvement of ALK-negative anaplastic large cell lymphoma.
Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Prednisolone; Receptor Protein-Tyrosine Kinases; Vincristine | 2017 |
Impact of induction chemotherapy, hyperfractionated accelerated radiotherapy and high-dose thiotepa on brain volume loss and functional status of children with primitive neuroectodermal tumour.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child; Child, Preschool; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Male; Neoplasm Staging; Neuroectodermal Tumors, Primitive; Prognosis; Retrospective Studies; Survival Rate; Thiotepa; Tumor Burden | 2017 |
Consideration of alternative causes of lactic acidosis: Thiamine deficiency in malignancy.
Topics: Acidosis, Lactic; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Confusion; Etoposide; Humans; Male; Psychomotor Agitation; Small Cell Lung Carcinoma; Thiamine; Thiamine Deficiency; Treatment Outcome; Vitamin B Complex | 2017 |
Primary Cutaneous Aggressive Epidermotropic CD8+ T-cell Lymphoma with Brain Involvement and Mimicking Dermatomyositis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Brain Neoplasms; CD8-Positive T-Lymphocytes; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Dermatomyositis; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Lymphoma, T-Cell, Cutaneous; Magnetic Resonance Imaging; Male; Predictive Value of Tests; Prednisone; Skin Neoplasms; Transplantation, Homologous; Treatment Outcome; Vincristine | 2018 |
Sensitivity to
Topics: Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Brain Neoplasms; Camptothecin; Cell Cycle Proteins; Cell Line, Tumor; Etoposide; Gene Expression Profiling; Glioblastoma; Humans; Irinotecan; Protein Serine-Threonine Kinases; RNA, Messenger | 2017 |
Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Cohort Studies; Dacarbazine; Etoposide; Female; Glioma; Humans; Ifosfamide; Leukopenia; Male; Neoplasm Grading; Prospective Studies; Temozolomide; Treatment Outcome; Vincristine | 2018 |
Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Cranial Irradiation; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; International Agencies; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Survival Rate; Testicular Neoplasms; Young Adult | 2017 |
Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B.
Topics: Antineoplastic Agents; Apoptosis; Astrocytes; Brain Neoplasms; Cell Line; DNA Damage; Drug Resistance, Neoplasm; Etoposide; F-Box Proteins; Glioblastoma; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lomustine; Lysine; Neoplastic Stem Cells; Primary Cell Culture | 2018 |
A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.
Topics: AC133 Antigen; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Cell Line, Tumor; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; RNA, Messenger; Temozolomide; Tumor Hypoxia; Vascular Endothelial Growth Factors | 2018 |
Application of Albumin-embedded Magnetic Nanoheaters for Release of Etoposide in Integrated Chemotherapy and Hyperthermia of U87-MG Glioma Cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Drug Carriers; Drug Screening Assays, Antitumor; Etoposide; Glioma; Humans; Hyperthermia, Induced; Magnetics; Molecular Structure; Nanoparticles; Serum Albumin, Human; Topoisomerase II Inhibitors | 2018 |
Successful treatment of multisite hemorrhage by several methods in brain metastasis of choriocarcinoma: A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Brain; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Hemorrhage; Hemostatic Techniques; Humans; Magnetic Resonance Imaging; Methotrexate; Pregnancy; Tomography, X-Ray Computed; Uterine Neoplasms; Vincristine | 2018 |
Etoposide loaded layered double hydroxide nanoparticles reversing chemoresistance and eradicating human glioma stem cells in vitro and in vivo.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Resistance, Neoplasm; Etoposide; Glioblastoma; Humans; Hydroxides; Mice; Nanoparticles; Neoplastic Stem Cells; Phosphatidylinositol 3-Kinases; Xenograft Model Antitumor Assays | 2018 |
How reliable are in vitro IC
Topics: Antineoplastic Agents; Apoptosis; Biological Assay; Brain Neoplasms; Carboplatin; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Etoposide; Glioblastoma; Humans; Inhibitory Concentration 50; Necrosis; Neurons; Paraquat; Reproducibility of Results | 2019 |
Constitutive activation of Notch2 signalling confers chemoresistance to neural stem cells via transactivation of fibroblast growth factor receptor-1.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mice, Transgenic; Neural Stem Cells; Proto-Oncogene Proteins c-akt; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Notch2; Signal Transduction; Transcriptional Activation | 2019 |
Comparison of the effect of three different topoisomerase II inhibitors combined with cisplatin in human glioblastoma cells sensitized with double strand break repair inhibitors.
Topics: Apoptosis; Benzamides; Brain Neoplasms; Cannabidiol; Cell Cycle; Cell Line, Tumor; Chromones; Cisplatin; DNA Breaks, Double-Stranded; DNA Repair; Etoposide; Glioblastoma; Humans; Morpholines; Phenanthrenes; Sulfonamides; Topoisomerase II Inhibitors | 2019 |
Human Sialic acid O-acetyl esterase (SIAE) - mediated changes in sensitivity to etoposide in a medulloblastoma cell line.
Topics: Acetylation; Acetylesterase; Acetyltransferases; Brain Neoplasms; Cell Line, Tumor; Child; Clone Cells; Etoposide; Gangliosides; Humans; Medulloblastoma; Membrane Potential, Mitochondrial | 2019 |
Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Melphalan; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Thiotepa; Topotecan; Transplantation, Autologous; Treatment Outcome | 2019 |
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for pat
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; International Agencies; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Survival Rate; Young Adult | 2013 |
Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Ependymoma; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Male; Methotrexate; Prognosis; Prospective Studies; Radiotherapy Dosage; Survival Rate; Vincristine | 2013 |
The histone deacetylase inhibitor sodium butyrate promotes cell death and differentiation and reduces neurosphere formation in human medulloblastoma cells.
Topics: Biomarkers, Tumor; Brain Neoplasms; Butyric Acid; Cell Death; Cell Differentiation; Cell Survival; Etoposide; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Medulloblastoma; RNA, Messenger; Spheroids, Cellular; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2013 |
Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cranial Irradiation; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Irinotecan; Male; Medulloblastoma; Melphalan; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Quality of Life; Radiotherapy; Retrospective Studies; Salvage Therapy; Temozolomide; Young Adult | 2013 |
Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Irinotecan; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive, Peripheral; Radiotherapy; Retrospective Studies; Salvage Therapy; Vincristine; Young Adult | 2013 |
Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide.
Topics: Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; DNA Breaks, Double-Stranded; Drug Resistance, Neoplasm; Etoposide; Gene Knockdown Techniques; Glioblastoma; Humans; Neoplastic Stem Cells; Retinoblastoma Protein; RNA Interference; Tumor Suppressor Protein p53 | 2013 |
Retrospective analysis of bevacizumab in combination with ifosfamide, carboplatin, and etoposide in patients with second recurrence of glioblastoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Glioblastoma; Hematologic Diseases; Humans; Ifosfamide; Interferons; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Temozolomide; Treatment Outcome | 2013 |
Adjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrix.
Topics: Animals; Brain Neoplasms; Cell Death; Cell Line, Tumor; Chemotherapy, Adjuvant; Drug Delivery Systems; Etoposide; Humans; Lactic Acid; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sheep; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2013 |
Successful treatment of hemorrhagic congenital intracranial immature teratoma with neoadjuvant chemotherapy and surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Loss, Surgical; Brain Neoplasms; Carboplatin; Etoposide; Humans; Infant; Infant, Newborn; Male; Neoadjuvant Therapy; Neurosurgical Procedures; Teratoma; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Assessing therapy response of secreting pineal germ cell tumor on simultaneous 18F-choline PET/MRI.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choline; Cisplatin; Cyclophosphamide; Etoposide; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasms, Germ Cell and Embryonal; Pineal Gland; Pinealoma; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2014 |
[Antiangiogenic treatment of pediatric CNS tumors in Hungary with the Kieran schedule].
Topics: Administration, Oral; Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow; Brain Neoplasms; Brain Stem Neoplasms; Carcinoma; Celecoxib; Cerebellar Neoplasms; Child; Child, Preschool; Choroid Plexus Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Ependymoma; Etoposide; Female; Humans; Hungary; Ischemic Attack, Transient; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Optic Nerve Glioma; Pyrazoles; Quality of Life; Retrospective Studies; Sulfonamides; Thalidomide; Treatment Outcome | 2013 |
Treg depletion followed by intracerebral CpG-ODN injection induce brain tumor rejection.
Topics: Adjuvants, Immunologic; Animals; Antibodies; Antigens, Ly; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cytokines; Disease Models, Animal; Etoposide; Flow Cytometry; Gene Expression Regulation, Neoplastic; Interleukin-2 Receptor alpha Subunit; Killer Cells, Natural; Lymphoma; Memory Disorders; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; NK Cell Lectin-Like Receptor Subfamily B; Oligodeoxyribonucleotides; T-Lymphocytes, Regulatory; Time Factors; Toll-Like Receptor 9 | 2014 |
Etoposide/carboplatin chemotherapy for the treatment of metastatic myxomatous cerebral aneurysms.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Female; Heart Neoplasms; Humans; Intracranial Aneurysm; Myxoma | 2014 |
Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma.
Topics: Animals; Antigens, Neoplasm; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Convection; Disease Models, Animal; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Delivery Systems; Etoposide; Glioblastoma; Humans; Mice; Poly-ADP-Ribose Binding Proteins; Survival Analysis; Topoisomerase II Inhibitors | 2014 |
Quantification of target analytes in various biofluids using a postcolumn infused-internal standard method combined with matrix normalization factors in liquid chromatography-electrospray ionization mass spectrometry.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Blood Chemical Analysis; Brain Neoplasms; Calibration; Chromatography, High Pressure Liquid; Etoposide; Humans; Limit of Detection; Reference Standards; Spectrometry, Mass, Electrospray Ionization | 2014 |
Toxicity of tandem high-dose chemotherapy and autologous stem cell transplantation using carboplatin-thiotepa-etoposide and cyclophosphamide-melphalan regimens for malignant brain tumors in children and young adults.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Male; Melphalan; Retrospective Studies; Stem Cell Transplantation; Thiotepa; Transplantation, Autologous; Young Adult | 2014 |
Mir-34a mimics are potential therapeutic agents for p53-mutated and chemo-resistant brain tumour cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Etoposide; Genes, p53; Humans; Medulloblastoma; MicroRNAs; Mutation; Up-Regulation | 2014 |
C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma.
Topics: Apoptosis; beta Catenin; Binding Sites; Brain Neoplasms; Catalase; Etoposide; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HEK293 Cells; Humans; Hydrogen Peroxide; Intracellular Signaling Peptides and Proteins; Mitochondria; Neuroblastoma; Peroxisomes; Promoter Regions, Genetic; Proteins; Reactive Oxygen Species; RNA, Messenger; Transcription, Genetic | 2014 |
Specific expression of OATPs in primary small cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blotting, Western; Brain Neoplasms; Chromogranins; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Lung; Lung Neoplasms; Organic Anion Transporters; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Small Cell Lung Carcinoma; Synaptophysin; Topotecan; Tumor Cells, Cultured | 2015 |
Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Remission Induction; Retrospective Studies; Risk Factors; Salvage Therapy; Survival Rate; Uterine Neoplasms; Vaginal Neoplasms; Vincristine; Young Adult | 2015 |
Metastasectomy as optimal treatment for late relapsing solitary brain metastasis from testicular germ cell tumor: a case report.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Metastasectomy; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Recurrence; Remission Induction; Testicular Neoplasms; Treatment Outcome; Young Adult | 2014 |
A novel 96-well multielectrode array based impedimetric monitoring platform for comparative drug efficacy analysis on 2D and 3D brain tumor cultures.
Topics: Apoptosis; Biosensing Techniques; Brain Neoplasms; Cell Line, Tumor; Dielectric Spectroscopy; Doxorubicin; Etoposide; Glioblastoma; Humans; Spheroids, Cellular; Vincristine | 2015 |
Down-Regulation of MRP1 Expression in C6/VP16 Cells by Chitosan-MRP1-siRNA Nanoparticles.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Chitosan; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Gene Silencing; Glioma; Inhibitory Concentration 50; Lipids; Multidrug Resistance-Associated Proteins; Nanoparticles; Rats; RNA, Small Interfering; Transfection | 2015 |
High-dose Chemotherapy With Autologous Stem Cell Rescue in Saudi Children Less Than 3 Years of Age With Embryonal Brain Tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Humans; Infant; Male; Methotrexate; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Saudi Arabia; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vincristine | 2015 |
Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Topics: Antineoplastic Agents, Phytogenic; Astrocytes; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cells, Cultured; Drug Delivery Systems; Endothelial Cells; Etoposide; Folate Receptors, GPI-Anchored; Folic Acid; Glioblastoma; Humans; Lactic Acid; Lactoferrin; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, Cell Surface; Topoisomerase II Inhibitors | 2015 |
In vitro co-culture model of medulloblastoma and human neural stem cells for drug delivery assessment.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Survival; Cells, Cultured; Coculture Techniques; Drug Screening Assays, Antitumor; Etoposide; Humans; Medulloblastoma; Models, Biological; Neural Stem Cells; Spheroids, Cellular | 2015 |
Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Cohort Studies; Consolidation Chemotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Induction Chemotherapy; Infant; Isotretinoin; Male; Neoadjuvant Therapy; Neoplasm Staging; Neuroblastoma; Neurosurgical Procedures; Pilot Projects; Prospective Studies; Radiotherapy; Thiotepa; Topotecan; Treatment Outcome; Vincristine | 2015 |
Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma, Non-gestational; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Middle Aged; Pregnancy; Treatment Outcome; Vincristine; Young Adult | 2015 |
Choroid plexus carcinoma in children: the Head Start experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma; Chemoradiotherapy; Child, Preschool; Choroid Plexus Neoplasms; Cisplatin; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; International Agencies; Male; Neoplasm Staging; Prognosis; Prospective Studies; Survival Rate; Vincristine | 2015 |
Malignant transformation of germinoma 14 years after onset: Favorable efficacy of oral etoposide.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Transformation, Neoplastic; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Female; Forecasting; Germinoma; Humans; Magnetic Resonance Imaging; Pituitary Gland, Posterior; Time Factors; Young Adult | 2015 |
Neoadjuvant chemotherapy for brain tumors in infants and young children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma; Carcinoma, Embryonal; Child; Child, Preschool; Choroid Plexus Neoplasms; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Ependymoma; Etoposide; Female; Glioblastoma; Humans; Infant; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive; Retrospective Studies; Rhabdoid Tumor; Second-Look Surgery; Treatment Outcome; Vincristine | 2015 |
Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Craniospinal Irradiation; Dacarbazine; Disease-Free Survival; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Neurosurgical Procedures; Prognosis; Retrospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Vinblastine; Young Adult | 2015 |
The effect of silibinin in enhancing toxicity of temozolomide and etoposide in p53 and PTEN-mutated resistant glioma cell lines.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Genes, p53; Glioma; Humans; Inhibitor of Apoptosis Proteins; Mutation; PTEN Phosphohydrolase; Silybin; Silymarin; Survivin; Temozolomide | 2015 |
Proton therapy for pediatric and adolescent esthesioneuroblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Kaplan-Meier Estimate; Male; Meningeal Neoplasms; Nasal Cavity; Nose Neoplasms; Proton Therapy; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Retrospective Studies; Topotecan; Treatment Outcome; Vincristine; Young Adult | 2015 |
Management and prognosis of patients with brain metastasis from gestational trophoblastic neoplasia: a 24-year experience in Peking union medical college hospital.
Topics: Adult; Brain Neoplasms; China; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Risk Factors; Vincristine | 2015 |
[Endoscopic treatment strategy of obstructive hydrocephalus induced by pineal region tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Brain Neoplasms; Cisplatin; Craniotomy; Etoposide; Humans; Hydrocephalus; Neuroendoscopy; Pineal Gland; Pinealoma; Treatment Outcome; Ventriculostomy | 2015 |
Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Cisplatin; Dose Fractionation, Radiation; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2015 |
Cavernous angioma after chemotherapy for desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cerebellar Neoplasms; Child, Preschool; Cisplatin; Cyclophosphamide; Ectodermal Dysplasia; Etoposide; Hemangioma, Cavernous, Central Nervous System; Humans; Infant; Intracranial Hemorrhages; Male; Medulloblastoma; Melphalan; Methotrexate; Neurosurgical Procedures; Peripheral Blood Stem Cell Transplantation; Vincristine | 2016 |
Inhibition of oncogenic epidermal growth factor receptor kinase triggers release of exosome-like extracellular vesicles and impacts their phosphoprotein and DNA content.
Topics: Animals; Antineoplastic Agents; Biomarkers; Brain Neoplasms; Cell Line, Tumor; Cetuximab; Culture Media, Conditioned; DNA; ErbB Receptors; Etoposide; Exosomes; Extracellular Vesicles; Glioma; Humans; Mice; Mice, SCID; Morpholines; Neoplasm Transplantation; Neoplasms; Phosphoproteins; Phosphorylation; Proteomics; Quinazolinones; Transfection | 2015 |
Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Cisplatin; Etoposide; Female; France; Gestational Trophoblastic Disease; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Middle Aged; Mortality; Pregnancy; Prognosis; Retrospective Studies; Risk Factors; Severity of Illness Index; Time Factors; Young Adult | 2016 |
The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Etoposide; Guidelines as Topic; Humans; Japan; Remission Induction; Small Cell Lung Carcinoma | 2015 |
Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade Glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease Progression; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Retrospective Studies | 2014 |
Metastatic choriocarcinoma induced separate simultaneous intracerebral haemorrhages: a very rare occurrence and its novel association with Klinefelter syndrome.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cerebral Hemorrhage; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Etoposide; Fatal Outcome; Headache; Humans; Klinefelter Syndrome; Male; Patient Compliance; Sleep Stages; Testicular Neoplasms; Vomiting | 2015 |
Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Canada; Carboplatin; Cerebrum; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Intracranial Hemorrhages; Male; Neurofibromatoses; Retrospective Studies; Sarcoma; Treatment Outcome | 2016 |
Comparison of toxicity following different conditioning regimens (busulfan/melphalan and carboplatin/etoposide/melphalan) for advanced stage neuroblastoma: Experience of two transplant centers.
Topics: Adolescent; Antineoplastic Agents; Boston; Brain Neoplasms; Busulfan; Carboplatin; Child; Child, Preschool; Egypt; Etoposide; Humans; Infant; Infant, Newborn; Melphalan; Neuroblastoma; Retrospective Studies; Transplantation Conditioning; Treatment Outcome | 2016 |
Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Decision Making; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2016 |
Enhanced delivery of etoposide across the blood-brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles.
Topics: Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Drug Carriers; Etoposide; Glioblastoma; Humans; Membrane Glycoproteins; Nanoparticles; Permeability; Tamoxifen | 2016 |
Dual targeting of solid lipid nanoparticles grafted with 83-14 MAb and anti-EGF receptor for malignant brain tumor therapy.
Topics: Antineoplastic Agents, Phytogenic; Astrocytes; Blood-Brain Barrier; Brain Neoplasms; Capillaries; Cell Line; Cell Survival; Drug Delivery Systems; Electric Impedance; Endothelial Cells; ErbB Receptors; Etoposide; Glioblastoma; Humans; Nanoparticles; Particle Size | 2016 |
[Successful treatment with total cranial irradiation for central nervous system involvement of Langerhans cell sarcoma during chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Chemoradiotherapy; Cisplatin; Cranial Irradiation; Cytarabine; Etoposide; Fatal Outcome; Female; Humans; Langerhans Cell Sarcoma; Methylprednisolone; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
Detection of Phenotypic Alterations Using High-Content Analysis of Whole-Slide Images.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Brain Neoplasms; Child; Cyclophosphamide; Data Interpretation, Statistical; Double-Blind Method; Doxorubicin; Etoposide; Heterografts; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Mice, Nude; Neoplasm Transplantation; Neuroblastoma | 2016 |
Neoadjuvant Chemotherapy for Facilitating Surgical Resection of Infantile Massive Intracranial Immature Teratoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Humans; Infant; Male; Neoadjuvant Therapy; Teratoma; Treatment Outcome | 2016 |
Primary mediastinal choriocarcinoma with brain metastasis in a female patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma, Non-gestational; Cyclophosphamide; Dactinomycin; Etoposide; Fatal Outcome; Female; Humans; Mediastinal Neoplasms; Methotrexate; Middle Aged; Vincristine | 2016 |
Clinical and Radiologic Features of Pediatric Basal Ganglia Germ Cell Tumors.
Topics: Adolescent; Aftercare; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia Diseases; Brain Neoplasms; Carboplatin; Carcinoma, Embryonal; Caudate Nucleus; Child; Choriocarcinoma, Non-gestational; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Cognitive Dysfunction; Corpus Striatum; Cranial Irradiation; Diffusion Tensor Imaging; Endodermal Sinus Tumor; Etoposide; Female; Germinoma; Humans; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Neurosurgical Procedures; Paresis; Retrospective Studies; Second-Look Surgery; Seizures; Tomography, X-Ray Computed | 2016 |
A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors.
Topics: Adolescent; Adult; Age of Onset; Antineoplastic Agents; Bleomycin; Brain Neoplasms; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prognosis; Risk Assessment; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Young Adult | 2017 |
Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Bridged-Ring Compounds; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Docetaxel; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Risk Factors; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 2016 |
Successful treatment of mixed yolk sac tumor and mature teratoma in the spinal cord: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Endodermal Sinus Tumor; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Spinal Cord Neoplasms; Teratoma; Treatment Outcome; Young Adult | 2017 |
Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Grade Gliomas in Children and Adolescents.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Glioma; Humans; Male; Neoplasm Grading; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2017 |
The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Central Nervous System Neoplasms; Dacarbazine; DNA Damage; Drug Synergism; Etoposide; Glioblastoma; Humans; Temozolomide | 2018 |
[Case report of germinoma with synchronous lesions in the thalamus and para lateral ventricle].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebral Ventricle Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Germinoma; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Multiple Primary; Radiotherapy Dosage; Radiotherapy, Adjuvant; Thalamus; Tomography, X-Ray Computed; Treatment Outcome; Ventriculostomy | 2008 |
Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen.
Topics: Adolescent; Antineoplastic Agents; Brain Neoplasms; Busulfan; Carboplatin; Child; Child, Preschool; Clonazepam; Etoposide; Female; Hepatic Veno-Occlusive Disease; Humans; Infant; Male; Retrospective Studies; Risk Factors; Sarcoma; Seizures; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2008 |
Term delivery following successful treatment of choriocarcinoma with brain metastases, a case report and review of literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Craniotomy; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Pregnancy Outcome; Term Birth; Uterine Neoplasms | 2009 |
Differential regulation of the antiapoptotic action of B-cell lymphoma 2 (Bcl-2) and B-cell lymphoma extra long (Bcl-xL) by c-Jun N-terminal protein kinase (JNK) 1-involved pathway in neuroglioma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; bcl-X Protein; Blotting, Western; Brain Neoplasms; Cell Death; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Enzyme Activation; Etoposide; Glioma; Humans; Mitogen-Activated Protein Kinase 8; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transfection | 2008 |
Intracranial granulocytic sarcoma after chemotherapy for pineal germinoma and testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Etoposide; Fatal Outcome; Germinoma; Humans; Male; Meningeal Neoplasms; Neoplasm Staging; Neoplasms, Multiple Primary; Orchiectomy; Pinealoma; Remission Induction; Sarcoma, Myeloid; Spinal Cord Neoplasms; Testicular Neoplasms | 2008 |
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Transplantation; Brain Neoplasms; Carboplatin; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Etoposide; Female; Humans; Infant; Male; Myeloablative Agonists; Neoplasm Recurrence, Local; Prognosis; Salvage Therapy; Thiotepa; Transplantation, Autologous | 2008 |
Effect of hypoxia-inducible factor-1alpha silencing on the sensitivity of human brain glioma cells to doxorubicin and etoposide.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Gene Silencing; Glioma; Humans; Hypoxia-Inducible Factor 1; Multidrug Resistance-Associated Proteins; RNA, Small Interfering | 2009 |
Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Routes; Drug Administration Schedule; Etoposide; Female; Hemangiopericytoma; Humans; Ifosfamide; Interferon-alpha; Kaplan-Meier Estimate; Liposomes; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Rare Diseases; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine | 2008 |
Treatment experiences of testicular cancer in Hispanic patients with Down's syndrome at the National Cancer Institute of Mexico.
Topics: Abnormalities, Multiple; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cryptorchidism; Down Syndrome; Etoposide; Fatal Outcome; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mexico; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Remission Induction; Retroperitoneal Neoplasms; Seminoma; Testicular Neoplasms; Treatment Outcome; Young Adult | 2008 |
Efficacy of temozolomide treatment in patients with high-grade glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Etoposide; Female; Glioblastoma; Gliosarcoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Prognosis; Temozolomide; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
Management of pilomyxoid astrocytomas: our experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Prognosis | 2009 |
Metronomic chemotherapy-induced bilateral subdural hematoma in a child with meningeal carcinomatosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Celecoxib; Child; Cyclooxygenase 2 Inhibitors; Cyclophosphamide; Etoposide; Hematoma, Subdural, Intracranial; Humans; Male; Meningeal Carcinomatosis; Neuroectodermal Tumors, Primitive; Pyrazoles; Sulfonamides | 2009 |
From glioblastoma to gangliocytoma: an unforeseen but welcome shift in biological behavior.
Topics: Antigens, Nuclear; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Carboplatin; Cell Differentiation; Cell Proliferation; Etoposide; Female; Ganglioneuroma; Glioblastoma; Humans; Hydrocephalus; Infant; Nerve Tissue Proteins; Neurofilament Proteins; Neurosurgical Procedures; Reverse Transcriptase Polymerase Chain Reaction; Synaptophysin | 2009 |
Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Meningeal Neoplasms; Pineal Gland; Pinealoma; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2010 |
Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma.
Topics: Adolescent; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Germinoma; Humans; Male; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Survival Rate; Young Adult | 2010 |
Hypoxia promotes etoposide (VP-16) resistance in neuroblastoma CHP126 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Brain Neoplasms; Cell Cycle; Cell Hypoxia; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Etoposide; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Genes, p53; Humans; Indicators and Reagents; Neoplasm Proteins; Neuroblastoma; Signal Transduction | 2010 |
Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Dose-Response Relationship, Radiation; Etoposide; Female; Germinoma; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Young Adult | 2010 |
Influence of Etoposide on anti-apoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cells.
Topics: AC133 Antigen; Adaptor Proteins, Signal Transducing; Antigens, CD; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Separation; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Gene Expression; Genes, MDR; Glioblastoma; Glycoproteins; Humans; Inhibitor of Apoptosis Proteins; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neoplastic Stem Cells; Peptides; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2010 |
[Malignant pilomatrixoma of head and neck. A case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Facial Neoplasms; Fatal Outcome; Humans; Lung Neoplasms; Male; Pilomatrixoma; Skin Neoplasms; Vinblastine; Vinorelbine | 2010 |
Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Humans; Infant; Male; Neoplasm Metastasis; Radiotherapy Dosage; Retrospective Studies; Rhabdoid Tumor; Survival Rate; Teratoma; Treatment Outcome; Vincristine | 2010 |
Solitary brain metastasis of an occult and stable small-cell lung cancer in a schizophrenic patient: a 3-year control.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Brain Neoplasms; Carboplatin; Clozapine; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Radiotherapy; Schizophrenia; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2010 |
Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Carboplatin; Disease-Free Survival; Etoposide; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome | 2010 |
A case of metastatic testicular cancer complicated by pulmonary hemorrhage due to choriocarcinoma syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Choriocarcinoma; Cisplatin; Endodermal Sinus Tumor; Etoposide; Hemorrhage; Humans; Lung Diseases; Lung Neoplasms; Male; Prognosis; Syndrome; Testicular Neoplasms | 2010 |
SenseCam as a rehabilitation tool in a child with anterograde amnesia.
Topics: Adolescent; Amnesia, Anterograde; Antineoplastic Combined Chemotherapy Protocols; Brain Damage, Chronic; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cues; Environmental Monitoring; Etoposide; Feasibility Studies; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Image Processing, Computer-Assisted; Male; Memory, Long-Term; Memory, Short-Term; Meningeal Neoplasms; Mental Recall; Microcomputers; Neuropsychological Tests; Photography; Radiation Injuries; Recognition, Psychology; Self-Help Devices | 2011 |
Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2010 |
Which therapy works better in choroid plexus carcinomas?
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Choroid Plexus Neoplasms; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Radiotherapy; Survival Rate; Treatment Outcome; Vincristine | 2011 |
Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion.
Topics: Adolescent; Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Cycle; Child; Child, Preschool; Chromosome Aberrations; Comet Assay; DNA Repair; Drug Resistance, Neoplasm; Etoposide; Glioblastoma; Humans; Mice; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Polymorphism, Single Nucleotide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2011 |
[The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases].
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Ependymoma; Etoposide; Female; Glioblastoma; Hematologic Diseases; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive; Retrospective Studies | 2010 |
A case of pathological complete remission of a brain metastasis from germ cell tumor of the testis after systemic chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Endodermal Sinus Tumor; Etoposide; Humans; Ifosfamide; Male; Remission Induction; Testicular Neoplasms; Tomography, X-Ray Computed | 2010 |
Orbital metastatic angiosarcoma.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Etoposide; Fatal Outcome; Hemangiosarcoma; Humans; Lung Neoplasms; Male; Middle Aged; Orbital Neoplasms; Tomography, X-Ray Computed | 2010 |
Infratentorial brain metastases of pediatric non-epithelial malignant tumors: three case reports.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Infratentorial Neoplasms; Irinotecan; Melphalan; Neoplasm Metastasis; Neuroblastoma; Rhabdomyosarcoma; Thiotepa; Topotecan; Vincristine | 2011 |
Neuroblastoma in an adult: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Brain Neoplasms; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Mesna; Neuroblastoma; Spinal Cord Compression; Spinal Cord Neoplasms; Thoracic Vertebrae; Vincristine; Young Adult | 2010 |
ANZCCSG BabyBrain99; intensified systemic chemotherapy, second look surgery and involved field radiation in young children with central nervous system malignancy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Glioma; Humans; Infant; Male; Melphalan; Radiotherapy Dosage; Remission Induction; Second-Look Surgery; Spinal Neoplasms; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vincristine | 2011 |
Germinoma presenting as a fourth cranial nerve palsy in a patient with adenomatous polyposis coli (APC) gene mutation.
Topics: Adenomatous Polyposis Coli; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Diplopia; Etoposide; Genes, APC; Germinoma; Headache; Humans; Magnetic Resonance Imaging; Male; Papilledema; Point Mutation; Trochlear Nerve Diseases | 2011 |
PKCδ sensitizes neuroblastoma cells to L-buthionine-sulfoximine and etoposide inducing reactive oxygen species overproduction and DNA damage.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Buthionine Sulfoximine; DNA Damage; Enzyme Activation; Enzyme Inhibitors; Etoposide; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Neuroblastoma; Onium Compounds; Protein Kinase C-delta; Reactive Oxygen Species; RNA, Small Interfering; Transfection; Tumor Cells, Cultured | 2011 |
Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Pilot Projects; Radiopharmaceuticals; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 2011 |
Multifaceted chemotherapy for trilateral retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cyclosporine; Cytarabine; Etoposide; Fatal Outcome; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pineal Gland; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Topotecan; Vincristine | 2011 |
[Pneumocystis and Staphylococcus aureus pulmonary co-infection after chemotherapy for lung cancer].
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Ceftriaxone; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Fatal Outcome; Female; Humans; Immunocompromised Host; Lung Neoplasms; Opportunistic Infections; Pneumonia, Pneumocystis; Pneumonia, Staphylococcal; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Neurocognitive outcomes in pediatric and adolescent patients with central nervous system germinoma treated with a strategy of chemotherapy followed by reduced-dose and volume irradiation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Cognition; Combined Modality Therapy; Etoposide; Germinoma; Humans; Neuropsychological Tests; Radiotherapy; Radiotherapy Dosage; Young Adult | 2011 |
Combined use of anticancer drugs and an inhibitor of multiple drug resistance-associated protein-1 increases sensitivity and decreases survival of glioblastoma multiforme cells in vitro.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Child; Drug Therapy, Combination; Etoposide; Glioblastoma; Humans; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; RNA, Small Interfering; Vincristine | 2011 |
Combination chemotherapy with ifosfamide, cisplatin, and etoposide for medulloblastoma: single-institute experience and differences in efficacy for subgroups of medulloblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Retrospective Studies; Treatment Outcome | 2011 |
Perifosine-induced inhibition of Akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo.
Topics: Brain Neoplasms; Brain-Derived Neurotrophic Factor; Cell Line, Tumor; Drug Resistance, Neoplasm; Etoposide; Humans; Neuroblastoma; Phosphorylation; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Receptor, trkB; Tetracycline | 2011 |
Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Carrier Proteins; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; DNA Repair; Docosahexaenoic Acids; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hyaluronan Receptors; Inhibitor of Apoptosis Proteins; Medulloblastoma; Mitogen-Activated Protein Kinase 14; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Survivin; Transcription Factors | 2011 |
Intracranial germ cell tumors: efficacy of neoadjuvant chemo-radiotherapy without surgical biopsy.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Carboplatin; Child; Chorionic Gonadotropin; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Proportional Hazards Models; Radiotherapy Dosage; Treatment Outcome; Young Adult | 2011 |
Ifosfamide, carboplatin and etoposide in recurrent malignant glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Dacarbazine; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Ifosfamide; Male; Middle Aged; Recurrence; Retrospective Studies; Temozolomide; Treatment Failure | 2011 |
Dyspnoea and a lung mass in a young female 2 weeks after Caesarean delivery.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cesarean Section; Cyclophosphamide; Doxorubicin; Dyspnea; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Paresis; Pulmonary Blastoma; Radiography, Thoracic; Smoking; Treatment Outcome; Vincristine | 2011 |
Etoposide-mediated glioblastoma cell death: dependent or independent on the expression of its target, topoisomerase II alpha?
Topics: Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Death; Cohort Studies; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Glioblastoma; Humans; Immunohistochemistry | 2011 |
Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Camptothecin; Cell Cycle; Cell Line, Tumor; Combined Modality Therapy; Etoposide; Glioblastoma; Humans; Irinotecan; Mice; Mice, Nude; Neural Stem Cells; Oncolytic Virotherapy; Oncolytic Viruses; Simplexvirus; Topoisomerase I Inhibitors; Xenograft Model Antitumor Assays | 2011 |
Avastin: more questions than answers. . .
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Camptothecin; Chemoradiotherapy; Dacarbazine; Etoposide; Female; Glioblastoma; Glioma; Humans; Male; Neoplasm Recurrence, Local; Salvage Therapy; Supratentorial Neoplasms; Temozolomide | 2012 |
A huge intraventricular congenital anaplastic astrocytoma: case report with histopathological and genetic consideration.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Combined Modality Therapy; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Etoposide; Female; Humans; Incidental Findings; Infant, Newborn; Isocitrate Dehydrogenase; Neurosurgical Procedures; Pregnancy; Promoter Regions, Genetic; Tumor Suppressor Proteins; Ultrasonography, Prenatal | 2012 |
Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Brain Neoplasms; Camptothecin; Carboplatin; Cisplatin; DNA-Binding Proteins; Endonucleases; Etoposide; Female; Follow-Up Studies; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoenzyme Techniques; Irinotecan; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2012 |
Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Body Height; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child; Cranial Irradiation; Craniospinal Irradiation; Disease-Free Survival; Endocrine Glands; Etoposide; Female; Growth; Growth Hormone; Humans; Male; Neoplasms, Germ Cell and Embryonal; Obesity; Pituitary Hormones; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Survival Rate; Treatment Outcome; Trophoblasts; Young Adult | 2012 |
Ulceration of abdominal striae distensae (stretch marks) in a cancer patient.
Topics: Abdominal Wall; Adult; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biopsy; Brain Neoplasms; Dexamethasone; Disease Progression; Drug Eruptions; Drug Interactions; Elastin; Etoposide; Fatal Outcome; Glioblastoma; Humans; Male; Neoplasm Staging; Ribonucleoproteins; Skin; Skin Ulcer; Striae Distensae | 2012 |
Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Neuroendocrine; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Time Factors; Uterine Cervical Neoplasms | 2012 |
PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Brain Neoplasms; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Cisplatin; Etoposide; Gene Expression; Gene Knockdown Techniques; Glioma; Humans; Mitochondria; Neoplasm Proteins; RNA Interference; Vincristine | 2012 |
An 82-year-old woman with small-cell lung cancer: relapse after 9 years or a new primary?
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Fatal Outcome; Female; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Small Cell Lung Carcinoma; Time Factors | 2012 |
Heterogeneous nuclear ribonucleoprotein C1/C2 controls the metastatic potential of glioblastoma by regulating PDCD4.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Etoposide; Gene Expression Regulation, Neoplastic; Gene Silencing; Glioblastoma; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; MicroRNAs; Neoplasm Invasiveness; Oncogene Protein v-akt; Ribosomal Protein S6 Kinases, 70-kDa; RNA-Binding Proteins | 2012 |
Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Curcuma; Curcumin; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Glioblastoma; Humans; Inhibitory Concentration 50; Medulloblastoma; Phytotherapy; Plant Extracts; Plants, Medicinal; Rhizome; Temozolomide | 2012 |
Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cells, Cultured; Drug Carriers; Etoposide; Glioma; Humans; Lactic Acid; Mice; Monocytes; Nanoparticles; Particle Size; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2013 |
Equinatoxin II potentiates temozolomide- and etoposide-induced glioblastoma cell death.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cnidarian Venoms; Dacarbazine; Drug Synergism; Etoposide; Glioblastoma; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Temozolomide | 2012 |
Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child, Preschool; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Methotrexate; Neoplasm Grading; Neoplasm, Residual; Neuroectodermal Tumors, Primitive; Neuropsychological Tests; Pineal Gland; Pinealoma; Prognosis; Prospective Studies; Quality of Life; Survival Rate; Vincristine | 2013 |
Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bone Marrow Neoplasms; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Histone Deacetylase Inhibitors; Humans; Neuroblastoma; Risk Factors; Valproic Acid | 2012 |
[Recurrence of intracranial germinoma initially treated with chemotherapy only].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Child; Cisplatin; Etoposide; Fatal Outcome; Follow-Up Studies; Germinoma; Humans; Male; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Treatment Outcome | 2002 |
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disabled Children; Epilepsy; Etoposide; Female; Humans; Hydrocephalus; Infant; Intellectual Disability; Learning Disabilities; Lomustine; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Neoplasm Recurrence, Local; Prevalence; Procarbazine; Radiation Injuries; Slovenia; Survivors; Tomography, X-Ray Computed; Unemployment; Vincristine; Vision Disorders | 2003 |
Chemotherapeutic targeting of etoposide to regions of the brain on the basis of polyamine level.
Topics: Animals; Brain; Brain Neoplasms; Drug Delivery Systems; Etoposide; Male; Polyamines; Rats; Rats, Sprague-Dawley | 2002 |
Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease Progression; Etoposide; Female; Hematologic Diseases; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Middle Aged; Survival Rate; Time Factors; Treatment Outcome | 2003 |
Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Combined Modality Therapy; Dacarbazine; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Prognosis; Temozolomide; Treatment Outcome | 2003 |
Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
Topics: Adult; Allopurinol; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Cisplatin; Etoposide; Fluid Therapy; Humans; Liver Neoplasms; Male; Medulloblastoma; Renal Dialysis; Tumor Lysis Syndrome | 2003 |
Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child, Preschool; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thrombocytopenia; Vincristine | 2003 |
Human malignant glioma cell lines are sensitive to low radiation doses.
Topics: Animals; Brain Neoplasms; Cell Survival; Dose-Response Relationship, Radiation; Etoposide; Female; Glioma; Humans; Mice; Neoplasm Transplantation; Radiation Tolerance; Time Factors; Tumor Cells, Cultured | 2003 |
Small cell carcinoma of the esophagus with reference to alternating multiagent chemotherapy: report of two cases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Liver Neoplasms; Male; Middle Aged; Peptide Fragments; Vincristine | 2003 |
[Cerebral metastasis in choriocarcinoma a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blindness; Brain Neoplasms; Cerebral Angiography; Choriocarcinoma; Chorionic Gonadotropin; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Intracranial Aneurysm; Leucovorin; Methotrexate; Pregnancy; Prognosis; Radiotherapy Dosage; Time Factors; Tomography, X-Ray Computed; Uterine Neoplasms; Vincristine | 2003 |
Metabolism of dexrazoxane (ICRF-187) used as a rescue agent in cancer patients treated with high-dose etoposide.
Topics: Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Ethylenediamines; Etoposide; Female; Glycine; Half-Life; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Razoxane | 2003 |
In vitro growth suppression of human glioma cells by a 16-mer oligopeptide: a potential new treatment modality for malignant glioma.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Division; Cisplatin; Drug Synergism; Etoposide; Fibroblast Growth Factor 2; Glioma; Humans; Nimustine; Oligopeptides; Reverse Transcriptase Polymerase Chain Reaction; RNA, Antisense; Signal Transduction; Tumor Cells, Cultured | 2003 |
Histone H2AX sensitizes glioma cells to genotoxic stimuli by recruiting DNA double-strand break repair proteins.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; BRCA1 Protein; Cell Cycle Proteins; Cell Division; DNA Damage; DNA Repair; DNA, Neoplasm; Etoposide; G2 Phase; Glioblastoma; Histones; Humans; Mitosis; Mutagenicity Tests; Nuclear Proteins; Tumor Cells, Cultured; Up-Regulation; X-Rays | 2003 |
Development of secondary anaplastic oligoastrocytoma after matched unrelated bone marrow transplantation in a child with acute myeloid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Astrocytoma; Bone Marrow Transplantation; Brain Neoplasms; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Etoposide; Female; Humans; Immunosuppressive Agents; Injections, Spinal; Leukemia, Monocytic, Acute; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Parietal Lobe; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2003 |
Topotecan as first-line therapy for small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Forecasting; Humans; Lung Neoplasms; Paclitaxel; Platinum; Topotecan | 2003 |
Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-D, etoposide, cisplatin (EMA/EP).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Dactinomycin; Diagnosis, Differential; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Hysterectomy; Methotrexate; Pregnancy; Salvage Therapy; Trophoblastic Neoplasms; Uterine Neoplasms | 2004 |
Fatal pulmonary thromboembolism after a second course of high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Fatal Outcome; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Peripheral Blood Stem Cell Transplantation; Pulmonary Embolism; Transplantation, Autologous; Vincristine | 2003 |
An unusual complication of chemotherapy: herpes simplex meningoencephalitis and bilateral acute retinal necrosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Encephalitis, Herpes Simplex; Etoposide; Functional Laterality; Herpesvirus 2, Human; Humans; Male; Middle Aged; Pineal Gland; Pinealoma; Retinal Necrosis Syndrome, Acute | 2004 |
[Report of two cases with germinoma treated by individual adjuvant chemotherapy based on the mRNA expression of drug-resistance gene].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Gene Expression; Genes, MDR; Germinoma; Humans; Ifosfamide; Male; Pharmacogenetics; RNA, Messenger; Treatment Outcome | 2004 |
[A difficult case of advanced testicular choriocarcinoma effectively treated by chemotherapy and resection of lung metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Choriocarcinoma; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Peripheral Blood Stem Cell Transplantation; Pneumonectomy; Testicular Neoplasms | 2004 |
Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Glioma; Humans; Indomethacin; Male; Middle Aged; Osmolar Concentration; Vincristine | 2004 |
Second-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumors.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Daunorubicin; Etoposide; Female; Humans; Liposomes; Magnetic Resonance Imaging; Male; Survival Analysis; Treatment Outcome | 2004 |
Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dose Fractionation, Radiation; Ependymoma; Etoposide; Feasibility Studies; Humans; Infratentorial Neoplasms; Patient Compliance; Prospective Studies; Radiotherapy, Adjuvant; Supratentorial Neoplasms; Survival Analysis; Vincristine | 2004 |
[Treatment of recurrent malignant brain gliomas by surgical excision combined with biodegradable polymers of interstitial chemotherapy].
Topics: Adult; Aged; Brain Neoplasms; Combined Modality Therapy; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Polymers | 2004 |
Long-term outcome of oligodendrogliomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Dacarbazine; Epilepsies, Partial; Etoposide; Female; Follow-Up Studies; Humans; Life Tables; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Nitrosourea Compounds; Oligodendroglioma; Organophosphorus Compounds; Procarbazine; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Sestamibi; Temozolomide; Treatment Outcome; Vincristine | 2004 |
Pineal parenchymal tumours: I. Pineocytoma: a tumour responsive to platinum-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Diagnosis, Differential; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Pineal Gland; Pinealoma; Spinal Neoplasms; Vincristine | 2004 |
2-deoxy-D-glucose enhances the cytotoxicity of topoisomerase inhibitors in human tumor cell lines.
Topics: Adenosine Triphosphate; Antimetabolites; Antineoplastic Agents, Phytogenic; Benzimidazoles; Brain Neoplasms; Camptothecin; Carcinoma, Squamous Cell; Cell Survival; Deoxyglucose; DNA Damage; Drug Interactions; Enzyme Inhibitors; Etoposide; Glioma; Humans; Radiation-Sensitizing Agents; Topoisomerase Inhibitors; Tumor Cells, Cultured | 2004 |
Home-based palliative care for children with cancer in Japan, present issues and future prospects.
Topics: Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Child; Etoposide; Female; Forecasting; Headache; Hemiplegia; Home Care Services; Humans; Japan; Magnetic Resonance Imaging; Palliative Care; Terminal Care | 2004 |
[Paclitaxel and cisplatin combined with etoposide chemotherapy in non-small cell lung cancer with brain metastases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Survival Rate | 2004 |
A proteomic investigation into etoposide chemo-resistance of neuroblastoma cell lines.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Death; DNA Fragmentation; Drug Resistance, Neoplasm; Electrophoresis, Gel, Two-Dimensional; Etoposide; Humans; Mass Spectrometry; Neuroblastoma; Proteome; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2005 |
Double-platinum chemotherapy combined with etoposide in metastatic brain tumor from small cell lung carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy, Adjuvant; Treatment Outcome | 2005 |
Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16.
Topics: Adenoviridae; Animals; Apoptosis; Brain; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Etoposide; Green Fluorescent Proteins; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Medulloblastoma; Mice; Mice, Nude; Models, Biological; Neoplasm Transplantation; Neurons; Repressor Proteins; Stem Cells; Time Factors; Transcription Factors; Transcription, Genetic | 2005 |
Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Disease Progression; Etoposide; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Retrospective Studies; Time Factors | 2005 |
Images in neuro-oncology: brain metastases and leptomeningeal dissemination of nonseminomatous germ cell tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Embryonal Carcinoma Stem Cells; Etoposide; Fatal Outcome; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplastic Stem Cells; Testicular Neoplasms; Tomography, X-Ray Computed | 2005 |
[Combined chemotherapy and radiation therapy for intracranial germinomas. The Val-de-Grace hospital experience].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Disease-Free Survival; Etoposide; Germinoma; Humans; Male; Neoadjuvant Therapy; Radiotherapy Dosage; Radiotherapy, Adjuvant | 2005 |
Prophylactic cranial irradiation in limited-stage small-cell lung cancer: a retrospective analysis.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Hospitals, Community; Humans; Lung Neoplasms; Male; Middle Aged; North Dakota; Paclitaxel; Prognosis; Remission Induction; Retrospective Studies; Treatment Outcome; Treatment Refusal | 2004 |
Treatment with oral etoposide for childhood recurrent ependymomas.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2005 |
Term delivery choriocarcinoma patient with brain and lung metastases successfully treated by etoposide, methotrexate, actomycin D, cyclophosphamide and vincristine (EMA-CO) chemotherapy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 2005 |
Primitive neuroectodermal tumor of the brain in a girl with Turner syndrome diagnosed after 4 years of growth hormone therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Female; Growth Disorders; Human Growth Hormone; Humans; Magnetic Resonance Imaging; Neuroectodermal Tumors, Primitive; Radiotherapy, Adjuvant; Recombinant Proteins; Turner Syndrome | 2006 |
Chemotherapy resistance of glioblastoma stem cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cisplatin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Glioblastoma; Humans; Jurkat Cells; Mice; Mice, Nude; Neoplastic Stem Cells; Time Factors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2006 |
Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cognition Disorders; Cranial Irradiation; Cyclophosphamide; Developmental Disabilities; Disease-Free Survival; Ependymoma; Etoposide; Follow-Up Studies; Ganglioglioma; Glioma; Humans; Infant; Medulloblastoma; Mitotic Index; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Peripheral Blood Stem Cell Transplantation; Quadriplegia; Retrospective Studies; Sensation Disorders; Spinal Cord Neoplasms; Thiotepa; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Prevalence and rupture rate of cerebral aneurysms discovered during intra-arterial chemotherapy of brain tumors.
Topics: Adult; Aged; Aged, 80 and over; Aneurysm, Ruptured; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cause of Death; Cerebral Angiography; Cross-Sectional Studies; Etoposide; Female; Humans; Incidental Findings; Infusions, Intra-Arterial; Infusions, Intravenous; Intracranial Aneurysm; Male; Middle Aged; Retrospective Studies; Risk; Survival Rate | 2006 |
Synthetic Smac peptide enhances the effect of etoposide-induced apoptosis in human glioblastoma cell lines.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Brain Neoplasms; Caspases; Cell Line, Tumor; DNA Fragmentation; Drug Synergism; Etoposide; Glioblastoma; Humans; Intracellular Signaling Peptides and Proteins; Mitochondrial Proteins; Recombinant Proteins | 2006 |
MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Child; Child, Preschool; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; DNA, Neoplasm; Drug Resistance, Neoplasm; Etoposide; Gene Silencing; Glioblastoma; Humans; Kaplan-Meier Estimate; Neoplasm Proteins; Retrospective Studies; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins | 2007 |
Metachronous intracranial germinoma in a patient with a previous primary mediastinal seminoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neurosurgical Procedures; Radiotherapy; Seminoma; Vinblastine | 2006 |
Successful chemotherapy for congenital malignant gliomas: a report of two cases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Etoposide; Ganglioglioma; Humans; Infant; Male; Nitrosourea Compounds | 2006 |
[A case of inoperable gastric small cell carcinoma effectively treated by chemotherapy and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Drug Administration Schedule; Drug Combinations; Etoposide; Humans; Irinotecan; Lymph Nodes; Lymphatic Metastasis; Male; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur | 2006 |
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Ependymoma; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Thiotepa; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Infant; Male; Neoplasm, Residual; Procarbazine; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2006 |
Proteasome inhibitors potentiate etoposide-induced cell death in human astrocytoma cells bearing a mutated p53 isoform.
Topics: Amino Acid Sequence; Antineoplastic Agents, Phytogenic; Apoptosis; Astrocytoma; Blotting, Western; Brain Neoplasms; Caspases; Cell Death; Cell Line, Tumor; Cloning, Molecular; Drug Resistance, Neoplasm; Etoposide; Genes, p53; Humans; Membrane Potentials; Mitochondria; Molecular Sequence Data; Mutation; Phosphorylation; Proteasome Endopeptidase Complex; RNA, Neoplasm; Signal Transduction; Subcellular Fractions | 2006 |
Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Brain Stem Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Glioblastoma; Glioma; Humans; Infant; Kaplan-Meier Estimate; Male; Meningeal Neoplasms; Pons; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine | 2006 |
Astrocytic tumors in children: treatment results from a single institution.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Infant; Lomustine; Male; Neurosurgical Procedures; Prednisone; Procarbazine; Radiotherapy; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2007 |
[Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Particle Accelerators; Radioisotope Teletherapy; Radiotherapy, Conformal; Radiotherapy, High-Energy; Retrospective Studies; Survival Analysis | 2006 |
Successful peripheral blood stem cell harvest on a 5.5-kg infant.
Topics: Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Volume; Body Weight; Brain Neoplasms; Cisplatin; Citric Acid; Combined Modality Therapy; Cyclophosphamide; Ependymoma; Etoposide; Female; Glucose; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heparin; Humans; Infant; Leukapheresis; Peripheral Blood Stem Cell Transplantation | 2006 |
Signaling from p53 to NF-kappaB determines the chemotherapy responsiveness of neuroblastoma.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Doxorubicin; Etoposide; Humans; MAP Kinase Kinase 1; Mutation; Neuroblastoma; NF-kappa B; Prognosis; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Tumor Suppressor Protein p53 | 2006 |
High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Craniotomy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Staging; Pregnancy; Radiosurgery; Risk Factors; Vincristine | 2007 |
[Individualized chemotherapy based on drug sensitivity and resistance assay and MGMT protein expression for patients with malignant glioma--analysis of 42 cases].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; Humans; Male; Middle Aged; Nausea; Neutropenia; O(6)-Methylguanine-DNA Methyltransferase; Remission Induction; Temozolomide; Young Adult | 2006 |
Successful neoadjuvant synchronous chemo- and radiotherapy for disseminated primary intracranial choriocarcinoma: case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Etoposide; Humans; Male; Methotrexate; Neoadjuvant Therapy; Peripheral Blood Stem Cell Transplantation; Treatment Outcome | 2007 |
Identification of uPAR-positive chemoresistant cells in small cell lung cancer.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Fluorouracil; Humans; Hyaluronan Receptors; Lung Neoplasms; Neoplasm Proteins; Neoplastic Stem Cells; Phenotype; Receptors, Urokinase Plasminogen Activator; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urokinase-Type Plasminogen Activator | 2007 |
The combined effects of multiple chemotherapeutic agents for malignant glioma cells.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Synergism; Etoposide; Glioma; Humans; Models, Statistical; Nimustine; Vincristine | 2007 |
[Conservative treatment undifferentiated neuroendocrine tumors of the anal canal: two cases].
Topics: Adrenal Cortex Hormones; Aged; Anal Canal; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Biopsy; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Male; Neuroendocrine Tumors; Radiotherapy Dosage; Remission Induction; Time Factors | 2007 |
Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; DNA Topoisomerases, Type II; Drug Synergism; Enzyme Inhibitors; Etoposide; Gene Expression Regulation, Neoplastic; Glioblastoma; Histone Deacetylase Inhibitors; Histones; Humans; Isoenzymes; Valproic Acid | 2007 |
[Small-cell lung cancer diagnostic and therapeutic recommendations of Polish Lung Cancer Group].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Pneumonectomy; Prognosis; Remission Induction | 2007 |
Malignant teratoid/rhabdoid tumour: long-term survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Rhabdoid Tumor; Survivors; Teratoma; Treatment Outcome; Vincristine | 2007 |
Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carotid Artery, Internal; Catheterization, Peripheral; Cyclophosphamide; Cytarabine; Etoposide; Female; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Male; Mannitol; Methotrexate; Middle Aged; Pigment Epithelium of Eye; Retinal Diseases; Retrospective Studies; Tomography, Optical Coherence; Vertebral Artery | 2007 |
Long-term follow-up of 5 patients with intracranial germinoma initially treated by chemotherapy alone.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Basal Ganglia Diseases; Brain Neoplasms; Child; Cisplatin; Endocrine System Diseases; Etoposide; Female; Germinoma; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Pineal Gland; Pituitary Gland, Posterior; Pituitary Neoplasms; Recovery of Function; Remission Induction; Retreatment | 2007 |
Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species mediated damage.
Topics: Animals; Antineoplastic Agents; Astrocytes; Brain Neoplasms; Cell Death; Cell Transformation, Neoplastic; Cyclin-Dependent Kinase Inhibitor p16; Dose-Response Relationship, Drug; Etoposide; Mice; Mice, Nude; Oncogene Protein v-akt; Pepstatins; Reactive Oxygen Species; Time Factors; Transduction, Genetic; Tumor Suppressor Protein p53 | 2007 |
Establishment of a new human glioblastoma multiforme cell line (WJ1) and its partial characterization.
Topics: Abietanes; Adult; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Culture Techniques; Cell Division; Cell Line, Tumor; Cisplatin; Etoposide; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Intermediate Filament Proteins; Karyotyping; Male; Mice; Mice, Nude; Nerve Tissue Proteins; Nestin; Phenanthrenes; Xenograft Model Antitumor Assays | 2007 |
Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Feasibility Studies; Ganglioglioma; Humans; Infant; Medulloblastoma; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Quality of Life; Retrospective Studies; Thiotepa; Treatment Outcome; Vincristine | 2008 |
Transurethral drainage for prostatic abscess in a patient with metastatic testicular cancer undergoing systemic chemotherapy.
Topics: Abscess; Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Ceftazidime; Cisplatin; Drainage; Etoposide; Humans; Immunocompromised Host; Lung Neoplasms; Male; Meropenem; Orchiectomy; Prostatic Diseases; Pseudomonas Infections; Testicular Neoplasms; Thienamycins; Transurethral Resection of Prostate | 2007 |
Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cyclophosphamide; Cytarabine; Etoposide; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Mannitol; Methotrexate; Pigment Epithelium of Eye; Retinal Diseases | 2007 |
[A case of long-term survival of postoperative brain metastasis of small cell lung cancer effectively treated with chemotherapy, whole brain radiotherapy and stereotactic radiosurgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Radiosurgery; Time Factors; Tomography, X-Ray Computed | 2008 |
Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cyclophosphamide; Cytoprotection; Etoposide; Fasting; Female; Glioma; Glucose; Humans; Mice; Mice, Inbred Strains; Neuroblastoma; Oxidative Stress; Proto-Oncogene Mas; Rats; Reactive Oxygen Species; Saccharomyces cerevisiae | 2008 |
Intracavitary chemotherapy (Gliadel) and oral low-dose etoposide for recurrent anaplastic ependymoma.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Brain; Brain Neoplasms; Carmustine; Child; Decanoic Acids; Ependymoma; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Polyesters; Radiotherapy; Recurrence | 2008 |
Remission of brain metastases from small-cell lung cancer after high-dose chemotherapy.
Topics: Brain Neoplasms; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin | 1984 |
Chemotherapy versus chemoimmunotherapy for small-cell undifferentiated carcinoma of the lung.
Topics: Aged; Agranulocytosis; Alopecia; Antineoplastic Agents; BCG Vaccine; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Prognosis; Prospective Studies; Vomiting | 1980 |
Treatment of small cell carcinoma of lung with combined high dose mediastinal irradiation, whole brain prophylaxis and chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Radiotherapy, High-Energy; Vincristine | 1981 |
High-dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Bone Marrow Transplantation; Brain Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vincristine | 1983 |
Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration.
Topics: Adult; Aged; Blood-Brain Barrier; Brain Neoplasms; Carcinoma, Small Cell; Drug Evaluation; Etoposide; Humans; Injections, Intravenous; Lung Neoplasms; Middle Aged; Podophyllotoxin; Tomography, X-Ray Computed | 1984 |
Penetration of VP-16 (etoposide) into human intracerebral and extracerebral tumors.
Topics: Brain Neoplasms; Etoposide; Glioma; Half-Life; Humans; Kinetics; Necrosis; Neoplasms; Podophyllotoxin | 1984 |
Etoposide (VP-16-213) in malignant brain tumors: a phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Drug Evaluation; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Teniposide; Time Factors; Tomography, X-Ray Computed | 1984 |
Preliminary study of the combination, dianhydrogalactitol, cis-diaminedichloroplatinum (II), and VP-16-213 in patients with advanced cancer.
Topics: Brain Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Pilot Projects; Podophyllotoxin; Sugar Alcohols | 1981 |
[A case of pineoblastoma successfully treated with surgery, combined chemotherapy of cisplatin and etoposide, and radiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Pineal Gland; Pinealoma | 1995 |
[Cerebral germ cell tumors in adults. A retrospective study of 19 cases].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Middle Aged; Radiotherapy Dosage; Retrospective Studies; Teratoma; Vinblastine | 1995 |
Does the rapid response to cisplatin-based chemotherapy justify its use as primary treatment for intracranial germ-cell tumours?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Child; Cisplatin; Etoposide; Female; Germinoma; Humans; Male; Pineal Gland; Sella Turcica; Skull Neoplasms; Tomography, X-Ray Computed | 1993 |
Treatment of nongerminomatous germ-cell tumors of the pineal region.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Pineal Gland; Pinealoma | 1994 |
Brain metastases of gestational trophoblastic tumor.
Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; Brain Neoplasms; Chlorambucil; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Palliative Care; Peptide Fragments; Pregnancy; Remission Induction; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 1994 |
Myelin basic protein in the cerebrospinal fluid of patients with brain tumors.
Topics: Adult; Aged; Astrocytoma; Biomarkers, Tumor; Brain Damage, Chronic; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Follow-Up Studies; Glioblastoma; Humans; Infusions, Intra-Arterial; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Myelin Basic Protein; Treatment Outcome | 1994 |
Remission of recurrent primary intracranial malignant lymphoma after high-dose intra-arterial corticosteroid administration and intra-arterial chemotherapy--case report.
Topics: Adrenal Cortex Hormones; Adult; Brain; Brain Neoplasms; Cisplatin; Etoposide; Fatal Outcome; Humans; Infusions, Intra-Arterial; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasm Regression, Spontaneous | 1994 |
Combination chemotherapy with vinblastine, bleomycin, cisplatin, and etoposide (VBPE) in children with primary intracranial germ cell tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Vinblastine | 1995 |
A complicated case of metastatic teratoma. Growing teratoma syndrome and cerebral metastasis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Occipital Lobe; Orchiectomy; Remission Induction; Teratocarcinoma; Testicular Neoplasms; Thoracotomy; Vincristine | 1995 |
[Successful treatment with combined chemotherapy (carboplatin, etoposide, adriamycin, bleomycin) and radiotherapy for recurrent intracranial malignant germ cell tumor: case report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Germinoma; Humans; Neoplasm Recurrence, Local | 1995 |
Does chemotherapy have a role in low-grade astrocytoma management? A report of 13 cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Humans; Infant; Magnetic Resonance Imaging; Male; Thrombocytopenia | 1995 |
Combination chemotherapy with carboplatin and etoposide of brain metastases from cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Etoposide; Female; Humans; Male; Middle Aged | 1994 |
Granulocyte colony-stimulating factor (CSF), macrophage-CSF, granulocyte-macrophage CSF, interleukin-3, and interleukin-6 levels in sera from children undergoing blood stem cell autografts.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Cytarabine; Daunorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-3; Interleukin-6; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphoma, Non-Hodgkin; Macrophage Colony-Stimulating Factor; Male; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Time Factors; Transplantation, Autologous | 1993 |
Prognosis of intracranial germ cell tumours: effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16).
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Child; Child, Preschool; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dysgerminoma; Etoposide; Female; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Rate; Teratoma | 1993 |
[A case of primary HCG-producing intracranial germinoma effectively treated by high-dose chemotherapy and autologous bone marrow transplantation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Carboplatin; Choriocarcinoma; Chorionic Gonadotropin; Combined Modality Therapy; Etoposide; Female; Germinoma; Humans; Neoplasms, Multiple Primary; Transplantation, Autologous | 1995 |
[Intensive and high-dose chemotherapy with peripheral blood stem cell transfusion for pediatric malignant brain tumor].
Topics: Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Ependymoma; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Nitrosourea Compounds; Pinealoma | 1995 |
Pretreatment with the polyamine analog 1,19-bis-(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4) inhibits etoposide cytotoxicity in U-251 MG (NCI) human brain tumor cells.
Topics: Brain Neoplasms; Cell Death; Cell Division; DNA, Neoplasm; Etoposide; Humans; Nuclear Matrix; Spermine; Tumor Cells, Cultured | 1994 |
Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Treatment Outcome; Vincristine | 1994 |
Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood-brain barrier disruption.
Topics: Adolescent; Adult; Blood-Brain Barrier; Brain; Brain Neoplasms; Carboplatin; Cisplatin; Etoposide; Female; Germinoma; Hearing Loss, High-Frequency; Humans; Magnetic Resonance Imaging; Male; Mannitol; Platinum; Treatment Outcome | 1994 |
[A case of cutaneous and brain metastasis of gastric carcinoma, treated effectively by chemotherapy with CDDP, MMC, etoposide and 5'-DFUR].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Drug Administration Schedule; Etoposide; Female; Floxuridine; Humans; Infusions, Intravenous; Mitomycin; Neoplasm Invasiveness; Skin Neoplasms; Stomach Neoplasms; Treatment Outcome | 1994 |
[Chemotherapy for metastatic brain tumors with CDDP and other agents: correlation between chemotherapeutic effects and the results of in vitro chemosensitivity tests using collagen gel-embedded culture combined with computerized image analysis in metastat
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Collagen; Drug Screening Assays, Antitumor; Etoposide; Female; Fluorouracil; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Tumor Cells, Cultured; Vindesine | 1994 |
Combination chemotherapy for primitive neuroectodermal and other malignant brain tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Humans; Infant; Male; Neuroectodermal Tumors, Primitive; Vincristine | 1994 |
Consolidative thoracic radiotherapy and prophylactic cranial irradiation in limited disease small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Lomustine; Lung Neoplasms; Methotrexate; Remission Induction; Survival Analysis; Thorax; Treatment Outcome; Vincristine | 1993 |
[Cisplatin-etoposide chemotherapy of an embryonal carcinoma arising in the basal ganglia of the cerebrum: a case report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia; Brain Neoplasms; Carcinoma, Embryonal; Cisplatin; Etoposide; Humans; Male | 1994 |
The role of cerebrospinal fluid cytology in radiotherapy planning for intracranial germinoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebrospinal Fluid; Child; Cisplatin; Combined Modality Therapy; Etoposide; Female; Germinoma; Humans; Male; Pineal Gland; Pinealoma; Spinal Cord Neoplasms; Teratoma | 1994 |
Considerations on radiotherapy dose intensity for limited small cell lung cancer.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Humans; Lung Neoplasms; Platinum; Radiotherapy Dosage; Time Factors | 1994 |
High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Hemorrhage; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia | 1994 |
Recurrent renal salt wasting in a child treated with carboplatin and etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Brain Neoplasms; Carboplatin; Child, Preschool; Esthesioneuroblastoma, Olfactory; Etoposide; Humans; Hyponatremia; Kidney Tubules, Proximal; Male; Recurrence; Sodium | 1994 |
Etoposide treatment in recurrent medulloblastoma.
Topics: Adult; Brain Neoplasms; Child; Child, Preschool; Etoposide; Female; Frontal Lobe; Humans; Male; Medulloblastoma; Neoplasm Metastasis; Prognosis; Recurrence; Spinal Cord Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 1994 |
[Sinus thrombosis during CDDP and VP-16 (PE) therapy for suprasellar germ-cell tumor: case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Diabetes Insipidus; Disseminated Intravascular Coagulation; Etoposide; Female; Germinoma; Humans; Pituitary Neoplasms; Sella Turcica; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed | 1993 |
[Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carotid Arteries; Cisplatin; Etoposide; Glioma; Humans; Infusions, Intra-Arterial; Infusions, Intravenous | 1994 |
Selective intra-arterial chemotherapy with a combination of etoposide and cisplatin for malignant gliomas: preliminary report.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Etoposide; Female; Glioma; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Treatment Outcome | 1994 |
[Brain SPECT by intraarterial infusion of 99mTc-HMPAO for assessing the cerebral distribution of carotid artery infusions in patients with brain tumor].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Carotid Artery, Internal; Etoposide; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nimustine; Organotechnetium Compounds; Oximes; Pulsatile Flow; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1993 |
Response to neoadjuvant chemotherapy in children with pineoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cranial Irradiation; Etoposide; Humans; Pinealoma; Remission Induction; Survival Rate; Vincristine | 1993 |
Management of small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging; Paraneoplastic Syndromes; Survival Rate | 1993 |
Prospective evaluation of the effect on initial brain metastases from small cell lung cancer of platinum-etoposide based induction chemotherapy followed by an alternating multidrug regimen.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Remission Induction; Survival Analysis; Tomography, X-Ray | 1993 |
Preirradiation chemotherapy for very young children with brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Ependymoma; Etoposide; Female; Follow-Up Studies; Glioblastoma; Humans; Infant; Male; Medulloblastoma; Neurologic Examination; Vinblastine | 1993 |
Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Metabolic Clearance Rate; Neoplasms; Neuroblastoma; Pineal Gland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma; Soft Tissue Neoplasms; Teratoma | 1993 |
Analysis and distribution of etoposide in rat brain tumor model: intracarotid versus intracarotid with angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Blood-Brain Barrier; Brain; Brain Chemistry; Brain Neoplasms; Carotid Arteries; Etoposide; Glioma; Injections, Intra-Arterial; Pseudotumor Cerebri; Rats; Rats, Inbred F344 | 1993 |
Recurrent brainstem gliomas treated with oral VP-16.
Topics: Administration, Oral; Adolescent; Adult; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local | 1993 |
[Leukoencephalopathy in a patient being treated for small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Cranial Irradiation; Etoposide; Humans; Leukoencephalopathy, Progressive Multifocal; Lung Neoplasms; Male; Middle Aged; Radiotherapy | 1995 |
Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carotid Arteries; Cisplatin; Etoposide; Glioma; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lung Neoplasms; Meningeal Neoplasms | 1996 |
Chemotherapy for progressive pilocytic astrocytomas in the chiasmo-hypothalamic regions.
Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Etoposide; Female; Humans; Hypothalamus; Infant; Magnetic Resonance Imaging; Male; Nimustine; Nitrosourea Compounds; Optic Chiasm | 1995 |
Long-term survival of a patient with primary sellar choriocarcinoma with pulmonary metastases: a case report.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Child; Choriocarcinoma; Cisplatin; Etoposide; Follow-Up Studies; Humans; Lung Neoplasms; Male; Prognosis | 1996 |
Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neuroblastoma; Predictive Value of Tests; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Tomography, Emission-Computed | 1996 |
Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Frontal Lobe; Humans; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Paclitaxel; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms; Vincristine | 1996 |
Metastatic cerebral choriocarcinoma coexistent with a viable pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Diagnosis, Differential; Etoposide; Female; Humans; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Vincristine | 1996 |
Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposide.
Topics: Amsacrine; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; Cell Cycle; Cell Line; Cell Survival; Cisplatin; Dexamethasone; DNA Topoisomerases, Type I; Doxorubicin; Drosophila; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Genetic Vectors; Humans; Kinetics; Mammary Tumor Virus, Mouse; Mice; Recombinant Proteins; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1996 |
ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Carcinoma, Ehrlich Tumor; Central Nervous System Neoplasms; DNA Topoisomerases, Type II; Etoposide; Female; Injections, Intraperitoneal; Lethal Dose 50; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Paclitaxel; Razoxane; Structure-Activity Relationship | 1996 |
Gangliogliomas involving the optic chiasm.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Combined Modality Therapy; Cranial Nerve Neoplasms; Cysts; Etoposide; Female; Ganglioglioma; Headache; Humans; Hypothalamus; Magnetic Resonance Imaging; Male; Mental Disorders; Neoplasm Invasiveness; Nerve Compression Syndromes; Optic Chiasm; Spinal Cord Neoplasms; Subarachnoid Space; Temporal Lobe; Ventriculoperitoneal Shunt; Vision Disorders; Visual Acuity | 1996 |
[Usefulness of neoadjuvant brachytherapy in the treatment of pineoblastoma: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Female; Humans; Pineal Gland; Pinealoma | 1996 |
Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Humans; Infant; Neoplasm Recurrence, Local; Pilot Projects; Survival Rate; Thiotepa; Transplantation, Autologous | 1996 |
Unusual presentation of a metastatic choriocarcinoma following a full term pregnancy: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dactinomycin; Etoposide; Fatal Outcome; Female; Humans; Liver Neoplasms; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 1996 |
Transfection of human topoisomerase II alpha into etoposide-resistant cells: transient increase in sensitivity followed by down-regulation of the endogenous gene.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Blotting, Northern; Brain Neoplasms; Dexamethasone; DNA; DNA Topoisomerases, Type II; DNA-Binding Proteins; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Enzymologic; Humans; Isoenzymes; Mice; Plasmids; Promoter Regions, Genetic; Restriction Mapping; RNA, Messenger; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1996 |
Gestational choriocarcinoma metastatic to the brain treated successfully by stereotactic radiosurgery and chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Radiosurgery; Tomography, X-Ray Computed; Treatment Outcome; Uterine Neoplasms; Vincristine | 1996 |
Treatment of small cell lung cancer: a single institutional experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Survival Rate; Vincristine | 1996 |
Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Pregnancy; Remission Induction; Trophoblastic Neoplasms; Uterine Neoplasms | 1997 |
Induction of resistance to etoposide and adriamycin in a human glioma cell line treated with antisense oligodeoxynucleotide complementary to the messenger ribonucleic acid of deoxyribonucleic acid topoisomerase II alpha.
Topics: Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Division; Cell Line, Transformed; Cell Survival; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Complementary; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Enzymologic; Glioma; Humans; Isoenzymes; Oligonucleotides, Antisense; RNA, Messenger; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1997 |
High-dose etoposide treatment for CNS involvement in a patient with primary non-Hodgkin's lymphoma of the breast.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms, Male; Cerebrospinal Fluid; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, Large-Cell, Immunoblastic; Magnetic Resonance Imaging; Male; Middle Aged; Prednisone; Vincristine | 1997 |
[High-dose chemotherapy with autologous stem cell rescue in patients with recurrent and high-risk pediatric brain tumors].
Topics: Age Factors; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Busulfan; Carboplatin; Child; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Risk Factors; Time Factors | 1997 |
Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Female; Germinoma; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Radiotherapy Dosage; Radiotherapy, Adjuvant; Remission Induction; Risk Factors; Treatment Outcome | 1998 |
The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Mesna; Middle Aged; Neuroectodermal Tumors, Primitive; Neutropenia; Sarcoma, Ewing; Vincristine | 1997 |
[A case of infantile anaplastic astrocytoma treated with surgery and chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Drug Administration Schedule; Etoposide; Female; Frontal Lobe; Glioblastoma; Humans; Infant; Parietal Lobe; Remission Induction | 1997 |
Radiation therapy for relapsed CNS germinoma after primary chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Child, Preschool; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Germinoma; Humans; Male; Neoplasm Recurrence, Local; Retrospective Studies | 1998 |
Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Thrombocytopenia; Transplantation, Autologous; Vincristine | 1998 |
[Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Child; Drug Administration Schedule; Etoposide; Female; Fever; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neutropenia; Osteosarcoma; Pilot Projects; Thrombocytopenia | 1998 |
Preclinical evaluation of 9-chloro-2-methylellipticinium acetate alone and in combination with conventional anticancer drugs for the treatment of human brain tumor xenografts.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carmustine; Chemical and Drug Induced Liver Injury; Cisplatin; Drug Screening Assays, Antitumor; Ellipticines; Etoposide; Feasibility Studies; Female; Glioma; Humans; Injections, Intraperitoneal; Injections, Intravenous; Mice; Mice, Nude; Neoplasm Transplantation; Survival Rate; Transplantation, Heterologous | 1998 |
Carboplatin and etoposide for recurrent malignant glioma: one department's experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Etoposide; Female; Glioma; Humans; Male; Middle Aged | 1998 |
Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide.
Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Drug Administration Schedule; Etoposide; Female; Mice; Mice, Inbred Strains; Razoxane; Survival Rate; Teniposide; Topoisomerase II Inhibitors | 1998 |
Synergistic cytotoxicity of topoisomerase I inhibitors with alkylating agents and etoposide in human brain tumor cell lines.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Camptothecin; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Humans; In Vitro Techniques; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured | 1998 |
Expression of topoisomerase II, bcl-2, and p53 in three human brain tumor cell lines and their possible relationship to intrinsic resistance to etoposide.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Resistance, Neoplasm; Etoposide; Humans; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 1995 |
High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Recurrence; Thiotepa; Transplantation, Autologous; Treatment Outcome | 1998 |
Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Platinum Compounds; Predictive Value of Tests; Survival Analysis; Treatment Outcome | 1998 |
[Intraarterial chemotherapy using a combination of etoposide and cisplatin for recurrent malignant lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cisplatin; Etoposide; Female; Humans; Infusions, Intra-Arterial; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging | 1998 |
Hyaluronidase additional to standard chemotherapy improves outcome for children with malignant brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Etoposide; Female; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome | 1998 |
Survival of patients with medulloblastoma treated with carboplatin and etoposide before and after radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Humans; Infant; Medulloblastoma; Remission Induction | 1998 |
[Successful management for chemorefractory testicular cancer with brain and lung metastases. A case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Carcinoma, Embryonal; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Salvage Therapy; Testicular Neoplasms | 1998 |
Severe ocular and orbital toxicity after intracarotid etoposide phosphate and carboplatin therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carotid Artery, Internal; Etoposide; Eye Diseases; Glioblastoma; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Orbital Diseases; Organophosphorus Compounds; Tomography, X-Ray Computed | 1999 |
Downbeat nystagmus caused by thiamine deficiency: an unusual presentation of CNS localization of large cell anaplastic CD 30-positive non-Hodgkin's lymphoma.
Topics: Adult; Anisocoria; Antineoplastic Combined Chemotherapy Protocols; Aphasia; Bleomycin; Brain Neoplasms; Cyclophosphamide; Cytarabine; Dizziness; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hemiplegia; Humans; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Mitoxantrone; Neoplastic Stem Cells; Nystagmus, Pathologic; Prednisone; Remission Induction; Thiamine; Vincristine; Vomiting; Wernicke Encephalopathy | 1999 |
Treatment outcome of patients with brain metastases from malignant germ cell tumors.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Humans; Male; Middle Aged; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Outcome | 1999 |
Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Carboplatin; Carotid Arteries; Etoposide; Glioma; Injections, Intra-Arterial; Male; Neoplasm Transplantation; Permeability; Rats; Rats, Wistar; Tumor Cells, Cultured | 1999 |
Preirradiation evaluation and technical assessment of involved-field radiotherapy using computed tomographic (CT) simulation and neoadjuvant chemotherapy for intracranial germinoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Intelligence; Magnetic Resonance Imaging; Male; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 1999 |
Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?
Topics: Adolescent; Adult; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Middle Aged; Patient Compliance; Pregnancy; Prognosis; Retrospective Studies; Risk Assessment; Trophoblastic Neoplasms; Uterine Neoplasms | 1999 |
Pharmacokinetics of etoposide and carboplatin in cerebrospinal fluid and plasma during hyperosmotic disruption of the blood brain barrier and intraarterial combination chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Etoposide; Glioma; Half-Life; Humans; Middle Aged; Osmosis | 1999 |
Synergistic cytotoxicity, apoptosis and protein-linked DNA breakage by etoposide and camptothecin in human U87 glioma cells: dependence on tyrosine phosphorylation.
Topics: Brain Neoplasms; Camptothecin; Cell Survival; Colonic Neoplasms; DNA Damage; Drug Synergism; Etoposide; Glioblastoma; Glioma; Humans; Mitotic Index; Phosphotyrosine; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1999 |
Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Cisplatin; Etoposide; Female; Glioblastoma; Hematoma; Humans; Infusions, Intra-Arterial; Lymphoma; Male; Middle Aged; Nausea; Retrospective Studies; Vomiting | 1999 |
Preliminary observations for a new treatment in children with primary intracranial yolk sac tumor or embryonal carcinoma. Report of five cases.
Topics: alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Carcinoma, Embryonal; Chemotherapy, Adjuvant; Child; Child, Preschool; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Cranial Irradiation; Disease-Free Survival; Endodermal Sinus Tumor; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Male; Pineal Gland; Radiotherapy Dosage; Radiotherapy, Adjuvant; Spinal Cord | 1999 |
Cisplatin resistant glioblastoma cells may have increased concentration of urokinase plasminogen activator and plasminogen activator inhibitor type 1.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Division; Cell Survival; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Enzyme-Linked Immunosorbent Assay; Etoposide; Glioblastoma; Humans; Kinetics; Plasminogen Activator Inhibitor 1; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator; Vincristine | 1999 |
Dose-intensive chemotherapy for breast cancer with brain metastases: a case series.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carboplatin; Carmustine; Cisplatin; Cyclophosphamide; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neoplasm Metastasis; Remission Induction; Survival Analysis; Thiotepa | 1999 |
The role of chemotherapy in intracranial germinoma: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carcinoma, Embryonal; Cisplatin; Etoposide; Humans; Male; Neoplasms, Multiple Primary; Pineal Gland; Pinealoma; Testicular Neoplasms; Treatment Outcome | 1999 |
Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma. A prospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cranial Irradiation; Etoposide; Humans; Lung Neoplasms; Melanoma; Prospective Studies; Skin Neoplasms; Survival Analysis | 1999 |
Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Body Height; Bone Marrow Transplantation; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Growth; Human Growth Hormone; Humans; Infant; Melphalan; Neuroblastoma; Retrospective Studies; Risk Factors; Thyroxine; Transplantation, Autologous; Whole-Body Irradiation | 1999 |
Chemotherapy in patients with recurrent and progressive central neurocytoma.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neurocytoma; Treatment Outcome | 2000 |
[A successfully operated case of choriocarcinoma with recurrent intratumoral hemorrhage].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebral Hemorrhage; Child; Choriocarcinoma; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Hydrocephalus; Ifosfamide; Male; Pineal Gland | 2000 |
Expression pattern of chemoresistance-related genes in human malignant brain tumors: a working knowledge for proper selection of anticancer drugs.
Topics: Antigens, CD; Antineoplastic Agents; Brain Neoplasms; Cisplatin; Doxorubicin; Etoposide; Genes, MDR; Glioma; Humans; Membrane Glycoproteins; Nimustine; RNA, Messenger; Tetraspanin 29; Tumor Cells, Cultured | 1999 |
[Chemotherapy of malignant inoperable gliomas. The association of fotemustine-cisplatine-etoposide as neoadjuvants].
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Cisplatin; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoadjuvant Therapy; Nitrosourea Compounds; Organophosphorus Compounds; Treatment Outcome | 2000 |
No responses to oral etoposide in 15 patients with recurrent brain tumors.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome | 2000 |
Up-front chemotherapy with fotemustine (F) / cisplatin (CDDP) / etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Etoposide; Female; France; Glioblastoma; Humans; Male; Middle Aged; Neoadjuvant Therapy; Nitrosourea Compounds; Organophosphorus Compounds; Survival Rate; Treatment Outcome | 2000 |
Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Brain Neoplasms; Caspases; Ceramides; Cisplatin; Culture Media, Serum-Free; Cytochrome c Group; Enzyme Activation; Etoposide; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Glioblastoma; Glioma; Humans; Mitochondria; Neoplasm Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Recombinant Fusion Proteins; Sphingomyelin Phosphodiesterase; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
Wild-type p53-dependent etoposide-induced apoptosis mediated by caspase-3 activation in human glioma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Caspase 1; Caspase 3; Caspases; Dose-Response Relationship, Drug; Etoposide; Genes, bcl-2; Genes, p53; Glioma; Humans; Tumor Cells, Cultured | 2000 |
[Correlation between DNA topoisomerase II alpha expression and sensitivity to etoposide in human glioma cell lines].
Topics: Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Cycle; Cell Division; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Etoposide; Flow Cytometry; Glioma; Humans; Immunohistochemistry; Isoenzymes; Tumor Cells, Cultured | 2000 |
Postpartum choriocarcinoma complicated by brain and lung metastases treated successfully with EMA/CO regimen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebral Hemorrhage; Choriocarcinoma; Cyclophosphamide; Etoposide; Female; Humans; Infant; Lung Neoplasms; Magnetic Resonance Imaging; Methotrexate; Pregnancy; Tomography, X-Ray Computed; Uterine Neoplasms; Vincristine | 2000 |
Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Blotting, Southern; Brain Neoplasms; Cell Division; Cell Transformation, Viral; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Herpesvirus 4, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; In Situ Hybridization; Interferon-gamma; Interleukin-10; Karyotyping; Lymphocyte Activation; Lymphoma, Large B-Cell, Diffuse; Male; Polymerase Chain Reaction; Prednisolone; Receptors, Interleukin-2; T-Lymphocytes; Tumor Necrosis Factor-alpha; Tumor Virus Infections; Vincristine | 2000 |
Long-term survival following extra-neural metastasis from a pineoblastoma.
Topics: Acetabulum; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Femoral Neoplasms; Humans; Ifosfamide; Ilium; Pineal Gland; Pinealoma; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Skin Neoplasms; Thigh; Vincristine | 2000 |
Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Radiography; Reproducibility of Results; Retrospective Studies; Survival Analysis; Time Factors | 2000 |
The ability in adhesion and invasion of drug-resistant human glioma cells.
Topics: Animals; Brain Neoplasms; Cell Adhesion; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Extracellular Matrix Proteins; Flow Cytometry; Glioma; Humans; Matrix Metalloproteinases; Mice; Neoplasm Proteins; Neural Cell Adhesion Molecules; Nimustine; Tumor Cells, Cultured; Vincristine | 2000 |
[Intramedullary spread of a cerebral oligodendroglioma. Two case reports].
Topics: Abducens Nerve Diseases; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carmustine; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Etoposide; Fatal Outcome; Female; Frontal Lobe; Humans; Intracranial Hypertension; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Oligodendroglioma; Paralysis; Prognosis; Radiography; Radiotherapy, Adjuvant; Spinal Cord Neoplasms | 2000 |
Successful combination chemotherapy (vincristine, procarbazine, etoposide, and prednisolone) in the treatment of inoperable, radioresistant low grade astrocytoma: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Etoposide; Female; Humans; Prednisolone; Procarbazine; Vincristine | 2000 |
Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity.
Topics: Adult; Aged; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Drug Interactions; Epilepsy; Etoposide; Female; Glioma; Hematologic Tests; Humans; Male; Middle Aged; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Retrospective Studies; Thrombocytopenia; Valproic Acid | 2001 |
Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Brain Diseases; Brain Neoplasms; Cachexia; Cerebral Hemorrhage; Cisplatin; Disease Progression; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Survival Analysis; Survival Rate; Thiotepa; Treatment Failure; Vincristine | 2000 |
[Post-operative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of German prospective randomised trial HIT'91].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Drug Administration Schedule; Etoposide; Germany; Humans; Ifosfamide; Lomustine; Medulloblastoma; Mesna; Nervous System Diseases; Neutropenia; Postoperative Period; Prospective Studies; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Treatment Outcome; Vincristine | 2001 |
Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Astrocytoma; Brain Neoplasms; Caspases; Cell Division; Drug Resistance, Neoplasm; Etoposide; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Isoenzymes; Middle Aged; Protein Kinase C; Protein Kinase C-alpha; Protein Kinase C-delta; Protein Structure, Tertiary; Recombinant Fusion Proteins; Signal Transduction; Tumor Cells, Cultured | 2001 |
Central nervous system involvement in gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Prospective Studies; Survival Analysis; Tomography, X-Ray Computed; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2001 |
Diazepam enhances etoposide-induced cytotoxicity in U-87 MG human glioma cell line.
Topics: Anticonvulsants; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Diazepam; Drug Interactions; Drug Screening Assays, Antitumor; Etoposide; Glioma; Humans; Tumor Cells, Cultured | 2001 |
Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma).
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Male; Pinealoma; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2001 |
Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction.
Topics: Adolescent; Animals; Antineoplastic Agents; Apoptosis; Astrocytoma; Brain Neoplasms; Cell Survival; Child; Child, Preschool; Colorimetry; Culture Media, Conditioned; DNA, Complementary; Drug Resistance, Neoplasm; Etoposide; Fas Ligand Protein; fas Receptor; Female; Ganglioglioma; Germinoma; Glioblastoma; Humans; Infant; Jurkat Cells; Male; Medulloblastoma; Membrane Glycoproteins; Mice; Neoplasm Proteins; Neuroblastoma; Neuroectodermal Tumors, Primitive; Pineal Gland; Pinealoma; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured | 2001 |
Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Glioma; Rats; Rats, Wistar; Tumor Cells, Cultured | 2001 |
Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cell Division; Dose-Response Relationship, Drug; Etoposide; Glioblastoma; Humans; Male; Matrix Metalloproteinase 2; Mice; Mice, Nude; Neovascularization, Pathologic; Peptide Fragments; Recombinant Proteins; Xenograft Model Antitumor Assays | 2001 |
Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Etoposide; Female; Germinoma; Humans; Ifosfamide; Prognosis; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2002 |
Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Brain Neoplasms; Etoposide; Female; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Immunohistochemistry; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Tumor Cells, Cultured; Vincristine | 2002 |
Brain metastases from fallopian tube carcinoma responsive to intra-arterial carboplatin and intravenous etoposide: a case report.
Topics: Adenocarcinoma, Papillary; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Brain Stem; Carboplatin; Carotid Arteries; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dacarbazine; Etoposide; Fallopian Tube Neoplasms; Fallopian Tubes; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Magnetic Resonance Imaging; Middle Aged; Paclitaxel; Physical Examination; Rupture, Spontaneous; Temozolomide; Temporal Lobe; Vertebral Artery | 2001 |
[An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Cisplatin; Dacarbazine; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Paclitaxel; Spinal Cord Neoplasms; Survivors; Taxoids; Vincristine; Vindesine | 2002 |
Influence of phenytoin on the disposition of irinotecan: a case report.
Topics: Adolescent; Anticonvulsants; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Brain Neoplasms; Camptothecin; Carboplatin; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dexamethasone; Disease Progression; Drug Interactions; Enzyme Induction; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Irinotecan; Male; Melphalan; Mixed Function Oxygenases; Neoplasm Recurrence, Local; Ondansetron; Phenobarbital; Phenytoin; Pineal Gland; Pinealoma; Prodrugs; Salvage Therapy; Seizures | 2002 |
Management of brain metastases in patients with high-risk gestational trophoblastic tumors.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cause of Death; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Prognosis; Remission Induction; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
Intracranial germ cell tumours: I. Experience with platinum based chemotherapy and implications for curative chemoradiotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Pinealoma; Vincristine | 1992 |
[Successful management of choriocarcinoma of the testis with brain metastasis: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Chemotherapy, Adjuvant; Choriocarcinoma; Cisplatin; Etoposide; Humans; Lung Neoplasms; Lymph Node Excision; Male; Neoplasms, Multiple Primary; Orchiectomy; Peplomycin; Remission Induction; Retroperitoneal Neoplasms; Teratoma; Testicular Neoplasms | 1992 |
Penetration of etoposide into human malignant brain tumors after intravenous and oral administration.
Topics: Administration, Oral; Adolescent; Adult; Aged; Brain Neoplasms; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Etoposide; Female; Glioma; Humans; Injections, Intravenous; Lymphoma; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Time Factors | 1992 |
Intracranial germ cell tumours: II. The application of a partial transmission block technique to reduce late morbidity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Neoplasms, Germ Cell and Embryonal; Pinealoma; Radiotherapy Dosage; Vincristine | 1992 |
[Successful treatment of congenital anaplastic astrocytoma by combining vinblastine, cisplatin and etoposide: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cisplatin; Etoposide; Humans; Infant, Newborn; Male; Vinblastine | 1992 |
Brain metastases and testicular tumors: long-term survival.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Choriocarcinoma; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Mesonephroma; Neoplasms, Germ Cell and Embryonal; Radiotherapy Dosage; Retrospective Studies; Teratoma; Testicular Neoplasms | 1992 |
Recurrent intracranial germinoma refractory to conventional irradiation: effective chemotherapy consisting of cisplatin and etoposide--case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Diabetes Insipidus; Etoposide; Humans; Lumbar Vertebrae; Male; Neoplasm Recurrence, Local; Pinealoma; Postoperative Complications; Radiation Tolerance; Remission Induction; Sacrum; Spinal Neoplasms | 1992 |
Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogeneic bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Bone Neoplasms; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Etoposide; Graft vs Host Disease; Humans; Lymphatic Metastasis; Male; Medulloblastoma; Prevalence; Remission Induction; Salvage Therapy; Transplantation, Homologous; Vincristine | 1992 |
[A case of adenocarcinoma of lung cancer with multiple brain metastasis and lymphangitis carcinomatosa responding well to chemotherapy with carboplatin, etoposide and ifosfamide].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymphangitis; Male; Radiotherapy Dosage | 1992 |
Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Vincristine | 1991 |
Postoperative chemotherapy for primary intracranial germ cell tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Leucovorin; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Postoperative Period; Vincristine | 1990 |
Clinical study of intracranial nongerminomatous germ cell tumors producing alpha-fetoprotein.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Brain Neoplasms; Cerebrospinal Fluid Shunts; Child; Chorionic Gonadotropin; Cisplatin; Cranial Irradiation; Etoposide; Female; Humans; Hydrocephalus; Male; Neoplasm Proteins; Neoplasms, Germ Cell and Embryonal; Pineal Gland; Remission Induction; Vinblastine; Zinostatin | 1990 |
Cytoreductive surgery in disseminated non-seminomatous germ cell tumours of testis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Teratoma; Testicular Neoplasms; Vincristine | 1991 |
Complete remission of metastatic teratoma from malignant testicular tumor using salvage chemotherapy with VP-16 (etoposide), CDDP, and ACNU--case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Etoposide; Humans; Male; Nimustine; Organoplatinum Compounds; Remission Induction; Salvage Therapy; Teratoma; Testicular Neoplasms | 1991 |
Improvement in survival from choriocarcinoma in Harare.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cause of Death; Choriocarcinoma; Dactinomycin; Etoposide; Female; Hospitals, Urban; Humans; Leucovorin; Methotrexate; Pregnancy; Prospective Studies; Retrospective Studies; Survival Analysis; Uterine Neoplasms; Zimbabwe | 1991 |
[A case of recurrent malignant glioma treated by superselective intraarterial chemotherapy with a combination of etoposide and cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Drug Administration Schedule; Etoposide; Glioma; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Recurrence, Local | 1992 |
Primary glial tumor patients treated by combining cis-platin and etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Drug Synergism; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Retrospective Studies; Survival Rate | 1991 |
Normal pregnancy after curative multiagent chemotherapy for choriocarcinoma with brain metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Primary Ovarian Insufficiency; Uterine Neoplasms | 1991 |
Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carotid Arteries; Cisplatin; Combined Modality Therapy; Etoposide; Female; Glioblastoma; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Radiotherapy Dosage | 1991 |
Lactobacillus septicemia, an unusual complication during the treatment of metastatic choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lactobacillus acidophilus; Methotrexate; Ovarian Neoplasms; Pregnancy; Sepsis; Uterine Neoplasms; Uterus; Vagina; Vincristine | 1991 |
[Selective enhancement of tumor blood flow and drug delivery to brain tumors in experimental rat gliomas under angiotensin II-induced hypertension].
Topics: Angiotensin II; Animals; Blood Pressure; Brain; Brain Neoplasms; Etoposide; Glioma; Male; Rats; Rats, Inbred F344; Regional Blood Flow | 1991 |
[Therapeutic efficacy of etoposide injected via carotid artery with angiotensin II-induced hypertension in experimental rat gliomas].
Topics: Angiotensin II; Animals; Blood Pressure; Brain Neoplasms; Carotid Artery, Internal; Combined Modality Therapy; Etoposide; Glioma; Injections, Intra-Arterial; Male; Rats; Rats, Inbred F344 | 1991 |
Concentrations of VP16 and VM26 in human brain tumors.
Topics: Adult; Aged; Brain; Brain Neoplasms; Chromatography, High Pressure Liquid; Etoposide; Female; Humans; Male; Middle Aged; Teniposide; Tissue Distribution | 1991 |
VP-16, vincristine and procarbazine with radiation therapy for treatment of malignant brain tumors.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Etoposide; Female; Glioblastoma; Humans; Male; Middle Aged; Procarbazine; Vincristine | 1990 |
Serum neuron-specific enolase as a marker of small-cell carcinoma of the esophagus.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Phosphopyruvate Hydratase; Skin Neoplasms; Vincristine | 1990 |
High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Diseases; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Drug Evaluation; Etoposide; Glioblastoma; Hearing Loss, Sensorineural; Humans; Infant; Medulloblastoma; Remission Induction | 1990 |
Combination therapy with platinum and etoposide of brain metastases from breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Platinum; Regression Analysis; Remission Induction | 1990 |
Modification of the 8 drugs in 1 day regimen: feasibility of substitution of other agents.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Male; Monitoring, Physiologic; Remission Induction; Risk Factors | 1990 |
Amplification and expression of a multidrug resistance gene in human glioma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Doxorubicin; Drug Resistance; Etoposide; Gene Amplification; Gene Expression; Glioma; Humans; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Vincristine | 1990 |
[Etoposide delivery to malignant brain tumors by induced hypertension with angiotensin II].
Topics: Angiotensin II; Animals; Blood Pressure; Brain; Brain Neoplasms; Carotid Artery, Internal; Etoposide; Glioma; Infusions, Intra-Arterial; Male; Rats; Rats, Inbred F344 | 1990 |
[Interstitial hyperthermia of malignant brain tumors using implant heating system (IHS)].
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Temperature; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Nimustine; Prostheses and Implants; Rabbits | 1990 |
[Chemotherapy of cerebral metastasis of lung cancer].
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 1990 |
[A case of complete remission in brain metastasis from lung adenocarcinoma with EAP (etoposide, adriamycin, cisplatin)].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Postoperative Period; Remission Induction | 1990 |
Klinefelter's syndrome, cerebral germinoma, Chiari malformation, and syrinx: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arnold-Chiari Malformation; Bleomycin; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Dysgerminoma; Etoposide; Humans; Klinefelter Syndrome; Male; Spina Bifida Occulta | 1986 |
Chemotherapy of advanced testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Dysgerminoma; Etoposide; Humans; Male; Raynaud Disease; Testicular Neoplasms; Vinblastine | 1985 |
Successful management of metastatic and primary germ cell tumors in the brain.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Child; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Tomography, X-Ray Computed; Vincristine | 1986 |
[A case report of advanced malignant mixed germ cell tumor of parasellar origin indicating marked efficacy of a salvage combined chemotherapy of CDDP and etoposide and subsequent chemotherapy using oral etoposide].
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Sella Turcica; Vinblastine | 1989 |
High dose etoposide for brain metastases of small cell lung cancer. A phase II study. The EORTC Lung Cancer Cooperative Group.
Topics: Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1989 |
Combination chemotherapy with cisplatin and etoposide for malignant intracranial germ-cell tumors. An experimental and clinical study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Cisplatin; DNA; Drug Screening Assays, Antitumor; Etoposide; Female; Flow Cytometry; Humans; Male; Neoplasms, Germ Cell and Embryonal; Tomography, X-Ray Computed; Tumor Cells, Cultured | 1989 |
Resolution of small cell lung cancer intracranial metastases with standard dose chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1989 |
Chemotherapy for non-seminomatous germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Teratoma; Testicular Neoplasms; Vinblastine; Vincristine | 1985 |
[Effect of high-dose cyclophosphamide plus high-dose etoposide in malignant brain tumors of children followed by autologous bone marrow rescue].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Glioma; Humans; Male; Remission Induction; Transplantation, Autologous | 1989 |
[Combined chemotherapy of CDDP and etoposide in intracranial germinomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Pinealoma; Remission Induction | 1989 |
[Intracranial fibrosarcoma fifteen years after radiotherapy in bilateral retinoblastomas: effect of combined chemotherapy with cisplatin and VP-16].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Eye Neoplasms; Fibrosarcoma; Frontal Lobe; Humans; Male; Neoplasms, Radiation-Induced; Orbital Neoplasms; Radiotherapy; Retinoblastoma | 1989 |
Podophyllotoxins for brain metastases of small cell lung cancer.
Topics: Brain Neoplasms; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide | 1988 |
Intensive alternating chemotherapy regimen in small cell carcinoma of the lung.
Topics: Actuarial Analysis; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrointestinal Hemorrhage; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Thrombocytopenia; Vincristine | 1985 |
Etoposide.
Topics: Brain Neoplasms; Etoposide; Female; Humans; Podophyllotoxin; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms | 1985 |
Neurologic dysfunction in patients treated for small cell carcinoma of the lung: a clinical and radiological study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Diseases; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Procarbazine; Vincristine | 1986 |
High-dose etoposide for central nervous system metastases of small cell lung cancer. Preliminary results.
Topics: Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Middle Aged | 1987 |
Intraocular involvement of Burkitt's lymphoma in a Bedouin child.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Burkitt Lymphoma; Carmustine; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Eye Neoplasms; Female; Humans; Hydrocortisone; Methotrexate; Vincristine; Vitreous Body | 1987 |
Death from chemotherapy in gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Necrosis; Pregnancy; Pulmonary Embolism; Uterine Neoplasms | 1988 |
Brain metastases of lung cancer: excessive toxicity of high dose VP 16 213.
Topics: Aged; Brain Neoplasms; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1988 |
Acute neurologic dysfunction after high-dose etoposide therapy for malignant glioma.
Topics: Acute Disease; Bone Marrow Transplantation; Brain Neoplasms; Dexamethasone; Etoposide; Glioma; Humans; Nervous System Diseases | 1988 |
Treatment of brain metastases of lung cancer with high doses of etoposide (VP16-213). Cooperative study from the Groupe Franais Pneumo-Cancérologie.
Topics: Adenocarcinoma; Aged; Brain; Brain Neoplasms; Carcinoma; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Tomography, X-Ray Computed | 1988 |
[Serum and cerebrospinal fluid levels after high dose of etoposide administrated intravenously].
Topics: Adult; Aged; Brain Neoplasms; Etoposide; Female; Humans; Injections, Intravenous; Male; Middle Aged | 1987 |
Intracarotid VP-16 in malignant brain tumors.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Carotid Artery, Internal; Child; Etoposide; Female; Glioma; Humans; Infusions, Intra-Arterial; Male; Middle Aged | 1987 |
[Complete remission of brain metastasis of testicular tumor by salvage chemotherapy. Report of a case].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Etoposide; Humans; Male; Neoplasms, Multiple Primary; Remission Induction; Teratoma; Testicular Neoplasms | 1986 |
High-dose carmustine and high-dose etoposide: a treatment regimen resulting in enhanced hepatic toxicity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carmustine; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Drug Evaluation; Etoposide; Humans | 1986 |
High-dose etoposide in the treatment of relapsed primary brain tumors.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin | 1985 |